0001140361-17-031484.txt : 20170814 0001140361-17-031484.hdr.sgml : 20170814 20170811212137 ACCESSION NUMBER: 0001140361-17-031484 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170814 DATE AS OF CHANGE: 20170811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RiceBran Technologies CENTRAL INDEX KEY: 0001063537 STANDARD INDUSTRIAL CLASSIFICATION: GRAIN MILL PRODUCTS [2040] IRS NUMBER: 870673375 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36245 FILM NUMBER: 171026627 BUSINESS ADDRESS: STREET 1: 2928 RAMCO STREET STREET 2: SUITE 120 CITY: WEST SACRAMENTO STATE: CA ZIP: 95691 BUSINESS PHONE: 6025223000 MAIL ADDRESS: STREET 1: 2928 RAMCO STREET STREET 2: SUITE 120 CITY: WEST SACRAMENTO STATE: CA ZIP: 95691 FORMER COMPANY: FORMER CONFORMED NAME: NUTRACEA DATE OF NAME CHANGE: 20030930 FORMER COMPANY: FORMER CONFORMED NAME: NUTRASTAR INC DATE OF NAME CHANGE: 20011221 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCE CONSUMER INTERNATIONAL INC DATE OF NAME CHANGE: 20010418 10-Q 1 form10q.htm 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark one)

☒
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2017

☐
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 0-32565
RiceBran Technologies
(Exact Name of Registrant as Specified in its Charter)

California
(State or other jurisdiction of incorporation or organization)
  
87-0673375
(I.R.S. Employer Identification No.)
2928 Ramco Street, Suite 120
West Sacramento, CA
(Address of Principal Executive Offices)
  
95691
(Zip Code)

Issuer’s telephone number, including area code:  (602) 522-3000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒  No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging company.  See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☒
     
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule l2b-2 of the Exchange Act).  Yes ☐ No ☒
 
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.   Yes ☒  No ☐
 
As of July 31, 2017, shares of the registrant’s common stock outstanding totaled 13,512,319.
 
RiceBran Technologies
Index
Form 10-Q

PART I. FINANCIAL INFORMATION
Page
 
Item 1.
3
    3
    4
    5
    6
    18
 
Item 2.
22
 
Item 3.
24
 
Item 4.
25
PART II. OTHER INFORMATION
  
 
Item 1.
25
 
Item 1A.
25
 
Item 2.
26
 
Item 3.
26
 
Item 4.
26
 
Item 5.
26
 
Item 6.
27
          28
 
Cautionary Note about Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue, liquidity or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services, products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.  Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words.  The forward-looking statements contained herein reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions.  Actual results may differ materially from those projected in such forward-looking statements due to a number of factors, risks and uncertainties, including the factors that may affect future results set forth in this Current Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2016.  We disclaim any obligation to update any forward looking statements as a result of developments occurring after the date of this quarterly report.

Unless the context requires otherwise, references to “we,” “us,” “our” and “the Company” refer to RiceBran Technologies and its consolidated subsidiaries.
 
2
PART I. FINANCIAL INFORMATION

Item 1.
Financial Statements.

RiceBran Technologies
Condensed Consolidated Statements of Operations
Three and Six Months Ended June 30, 2017 and 2016
(Unaudited) (in thousands, except share and per share amounts)

   
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
  
2016
  
                       
Revenues
  
$
3,146
    
$
3,233
    
$
6,761
    
$
6,499
  
Cost of goods sold
    
2,348
      
2,431
      
4,776
      
4,765
  
Gross profit
    
798
      
802
      
1,985
      
1,734
  
Selling, general and administrative expenses
    
2,667
      
3,676
      
4,933
      
6,288
  
Loss from operations
    
(1,869
)
    
(2,874
)
    
(2,948
)
    
(4,554
)
Other income (expense):
                                
Interest expense
    
(475
)
    
(454
)
    
(1,530
)
    
(1,132
)
Change in fair value of derivative warrant liabilities
    
22
      
(1,663
)
    
1,121
      
(852
)
Loss on extinguishment of debt
    
-
      
-
      
(1,680
)
    
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
-
      
-
      
1,598
  
Other income
    
37
      
-
      
37
      
-
  
Other expense
    
(4
)
    
-
      
(100
)
    
-
  
Total other income (expense)
    
(420
)
    
(2,117
 )    
(2,152
 )    
(386
 ) 
Loss before income taxes
    
(2,289
)
    
(4,991
)
    
(5,100
)
    
(4,940
)
Income tax benefit
    
515
      
515
      
912
      
907
  
Loss from continuing operations
    
(1,774
)
    
(4,476
)
    
(4,188
)
    
(4,033
)
Income (loss) from discontinued operations, net of tax
    
304
      
(3,640
)
    
117
      
(4,221
)
Net loss
    
(1,470
)
    
(8,116
)
    
(4,071
)
    
(8,254
)
Less - Net loss attributable to noncontrolling interest in discontinued operations
    
(248
)
    
(1,508
)
    
(567
)
    
(1,946
)
Net loss attributable to RiceBran Technologies shareholders
    
(1,222
)
    
(6,608
)
    
(3,504
)
    
(6,308
)
Less - Dividends on preferred stock--beneficial conversion feature
    
-
      
-
      
778
      
551
  
Net loss attributable to RiceBran Technologies common shareholders
  
$
(1,222
)
  
$
(6,608
)
  
$
(4,282
)
  
$
(6,859
)
                                 
Basic earnings (loss) per common share:
                                
Continuing operations
  
$
(0.18
)
  
$
(0.48
)
  
$
(0.51
)
  
$
(0.50
)
Discontinued operations
    
0.06
      
(0.24
)
    
0.07
      
(0.24
)
Basic loss per common share - RiceBran Technologies
  
$
(0.12
 )  
$
(0.72
 )  
$
(0.44
 )  
$
(0.74
 )
                                 
Diluted earnings (loss) per common share:
                                
Continuing operations
  
$
(0.18
)
  
$
(0.48
)
  
$
(0.51
)
  
$
(0.50
)
Discontinued operations
    
0.06
      
(0.24
)
    
0.07
      
(0.24
)
Diluted loss per common share - RiceBran Technologies
  
$
(0.12
 )  
$
(0.72
 )  
$
(0.44
 )  
$
(0.74
 )
                                 
Weighted average number of shares outstanding:
                                
Basic
    
9,794,405
      
9,231,619
      
9,726,268
      
9,223,651
  
Diluted
    
9,794,405
      
9,231,619
      
9,726,268
      
9,223,651
  

See Notes to Unaudited Condensed Consolidated Financial Statements
 
3
RiceBran Technologies
Condensed Consolidated Statements of Comprehensive Income (Loss)
Three and Six Months Ended June 30, 2017 and 2016
(Unaudited) (in thousands)

   
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
                         
Net loss
  
$
(1,470
)
  
$
(8,116
)
  
$
(4,071
)
  
$
(8,254
)
                                 
Other comprehensive income - foreign currency translation, net of tax
    
17
      
413
      
162
      
859
  
                                 
Comprehensive loss, net of tax
    
(1,453
)
    
(7,703
)
    
(3,909
)
    
(7,395
)
                                 
Less - Comprehensive loss attributable to noncontrolling interest, net of tax
    
(250
)
    
(1,375
)
    
(518
)
    
(1,668
)
                                 
Total comprehensive loss attributable to RiceBran Technologies shareholders
  
$
(1,203
)
  
$
(6,328
)
  
$
(3,391
)
  
$
(5,727
)

See Notes to Unaudited Condensed Consolidated Financial Statements
 
4
RiceBran Technologies
Condensed Consolidated Balance Sheets
June 30, 2017 (Unaudited) and December 31, 2016
(in thousands, except share amounts)

   
June 30,
2017
    
December 31,
2016
  
ASSETS
            
Current assets:
            
Cash and cash equivalents
  
$
3,184
    
$
342
  
Accounts receivable, net of allowance for doubtful accounts of $8 and $12
    
1,132
      
1,094
  
Inventories
    
943
      
933
  
Deposits and other current assets
    
471
      
824
  
Current assets held for sale
    
5,698
      
4,335
  
Total current assets
    
11,428
      
7,528
  
Property and equipment, net
    
6,810
      
7,025
  
Intangible assets, net
    
171
      
242
  
Noncurrent assets held for sale
    
13,172
      
14,050
  
Total assets
  
$
31,581
    
$
28,845
  
                 
LIABILITIES, TEMPORARY EQUITY AND EQUITY (DEFICIT)
                
Current liabilities:
                
Accounts payable
  
$
640
    
$
714
  
Accrued salary, wages and benefits
    
591
      
496
  
Accrued expenses
    
439
      
1,288
  
Current maturities of long-term debt
    
24
      
3,063
  
Current liabilities held for sale
    
16,589
      
15,801
  
Total current liabilities
    
18,283
      
21,362
  
Long-term debt, less current portion
    
5,892
      
5,964
  
Derivative warrant liabilities
    
472
      
1,527
  
Deferred tax liability
    
33
      
29
  
Noncurrent liabilities held for sale
    
41
      
44
  
Total liabilities
    
24,721
      
28,926
  
Commitments and contingencies
                
Temporary equity
                
Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding
    
-
      
551
  
Total temporary equity
    
-
      
551
  
Equity (deficit):
                
Equity (deficit) attributable to RiceBran Technologies shareholders:
                
Preferred stock, 20,000,0000 shares authorized:
                
Series F, convertible, 3,000 shares authorized, 2,685 issued and outstanding
    
493
      
-
  
Series G, convertible, 3,000 shares authorized and 1,989 issued and outstanding
    
988
      
-
  
Common stock, no par value, 50,000,000 shares authorized, 11,575,187  and 10,790,351 shares issued and outstanding
    
274,419
      
264,232
  
Accumulated deficit
    
(264,240
)
    
(259,819
)
Accumulated deficit attributable to noncontrolling interest in discontinued operation
    
(567
)
    
(699
)
Accumulated other comprehensive loss
    
(4,233
)
    
(4,346
)
Total equity (deficit) attributable to RiceBran Technologies shareholders
    
6,860
      
(632
)
Total liabilities, temporary equity and equity (deficit)
  
$
31,581
    
$
28,845
  

See Notes to Unaudited Condensed Consolidated Financial Statements
 
5
RiceBran Technologies
Condensed Consolidated Statements of Cash Flows
Six Months Ended June 30, 2017 and 2016
(Unaudited) (in thousands)

   
2017
    
2016
  
Cash flow from operating activities:
            
Net loss
  
$
(4,071
)
  
$
(8,254
)
Income (loss) from discontinued operations
    
117
      
(4,221
)
Loss from continuing operations
    
(4,188
)
    
(4,033
)
Adjustments to reconcile net loss to net cash used in operating activities of discontinued operations:
                
Depreciation and amortization
    
414
      
452
  
Stock and share-based compensation
    
654
      
477
  
Change in fair value of derivative warrant and conversion liabilities
    
(1,121
)
    
852
  
Loss on extinguishment of debt
    
1,680
      
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
(1,598
)
Interest accreted
    
893
      
403
  
Other
    
58
      
-
  
Cash provided by discontinued operations
    
(876
)
    
(1,763
)
Changes in operating assets and liabilities:
                
Accounts receivable
    
(38
)
    
(113
)
Inventories
    
(16
)
    
161
  
Accounts payable and accrued expenses
    
(824
)
    
186
  
Other
    
353
      
(52
)
Net cash used in operating activities of continuing operations
    
(3,011
)
    
(5,028
)
Net cash provided by operating activities of discontinued operations
    
973
      
3,244
  
Net cash used in operating activities
    
(2,038
)
    
(1,784
)
                 
Cash flows from investing activities:
                
Change in restricted cash
    
-
      
1,921
  
Purchases of property
    
(139
)
    
(209
)
Net cash (used in) provided by investing activities of continuing operations
    
(139
)
    
1,712
  
Net cash used in investing activities of discontinued operations
    
(108
)
    
(208
)
Net cash (used in) provided by investing activities
    
(247
)
    
1,504
  
                 
Cash flows from financing activities:
                
Payments of debt
    
(7,159
)
    
(15,703
)
Proceeds from issuance of debt, net of issuance costs
    
3,779
      
14,801
  
Proceeds from issuance of debt and warrants, net of issuance costs
    
5,518
      
300
  
Proceeds from issuance of preferred stock and warrants, net of issuance costs
    
1,747
      
2,554
  
Other
    
(12
)
    
(9
)
Net cash provided by financing activities of continuing operations
    
3,873
      
1,943
  
Net cash provided by (used in) financing activities of discontinued operations
    
1,112
      
(815
)
Net cash provided by financing activities
    
4,985
      
1,128
  
                 
Effect of exchange rate changes on cash and cash equivalents of discontinued operations
    
142
      
(38
)
Net change in cash and cash equivalents
    
2,842
      
810
  
Cash and cash equivalents, beginning of period
    
342
      
966
  
Cash and cash equivalents, end of period
  
$
3,184
    
$
1,776
  
                 
Supplemental disclosures:
                
Cash paid for interest
  
$
922
    
$
942
  
Cash paid for income taxes
    
-
      
-
  

See Notes to Unaudited Condensed Consolidated Financial Statements
 
6
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.

These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.

NOTE 2. DISCONTINUED OPERATIONS

Healthy Natural (HN) Discontinued Operations

The Company continuously assesses the composition of our portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.  In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).  In July 2017, we completed the sale of the assets of HN for $18.3 million in cash, net of assumed liabilities.  HN was reported as part of our USA segment.  The purchase price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.  The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.  We are providing certain support services under transition services agreement for a limited period of time.  These support services are not expected to have a material impact on our consolidated statements of operations in 2017.

The following table summarizes the initial distribution of proceeds (in thousands).

Purchase price, net of assumed liabilities
  
$
18,283
  
Estimated expenses
    
(934
)
Net proceeds
  
$
17,349
  
         
Repayment of senior debentures
  
$
6,600
  
Repayment of subordinated debt and related interest
    
5,963
  
Repayment of other liabilities
    
56
  
Escrow for working capital adjustments
    
225
  
Escrow for indemnity claims
    
550
  
   
$
13,394
  

We have not completed our accounting for the sale of HN.  On a preliminary basis, we estimate the net carrying value of HN as of the date of sale at $4.0 million and the third quarter 2017 gain on sale as $8.8 million, net of $4.5 million income tax provision.  The Internal Revenue Service rules in this area are complex and we have not yet completed an analysis of what net operating losses, if any, will be available to reduce the taxes owed on the gain.  In addition, we expect to recognize a third quarter 2017 expense from the proceeds from the sale of HN of approximately $6.0 million related to the extinguishment of the senior debentures and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest.  We will be required to accrete the senior debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.
 
7
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.  Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.

The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestitures of HN (in thousands).

   
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Revenues
  
$
5,064
    
$
5,546
    
$
9,481
    
$
10,034
  
Cost of goods sold
    
(3,336
)
    
(3,702
)
    
(6,358
)
    
(6,661
)
Selling, general and administrative expenses
    
(215
)
    
(329
)
    
(443
)
    
(704
)
Income from discontinued operations, before income taxes
    
1,513
      
1,515
      
2,680
      
2,669
  
Income taxes
    
(515
)
    
(515
)
    
(912
)
    
(907
)
Income from discontinued operations, net of tax
  
$
998
    
$
1,000
    
$
1,768
    
$
1,762
  
 
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale (in thousands).
 
 
June 30,
2017
    
December 31,
2016
  
Accounts receivable, net
  
$
1,362
    
$
592
  
Inventories
    
1,887
      
1,915
  
Other current asssets held for sale
    
32
      
23
  
Property and equipment
    
882
      
1,019
  
Intangible
    
791
      
791
  
Other noncurrent assets held for sale
    
24
      
24
  
Total assets held for sale
  
$
4,978
    
$
4,364
  
Accounts payable
  
$
567
    
$
443
  
Accrued expenses
    
346
      
382
  
Long term liabilities
    
41
      
44
  
Total liabilities held for sale
  
$
954
    
$
869
  

The following table summarizes the major line items included in cash flows from discontinued operations of HN for the six months ended June 30, 2017 and 2016 (in thousands).

   
Six Months Ended
  
   
2017
    
2016
  
             
Net cash provided by operating activities
  
$
2,141
    
$
2,235
  
Net cash used in investing activities
    
(15
)
    
(75
)
Net cash used in financing activities
    
(7
)
    
-
  
Net cash provided to continuing operations
  
$
(2,119
)
  
$
(2,160
)
 
Nutra SA Discontinued Operations
 
We hold a variable interest in our equity interest in Nutra SA.  Nutra SA’s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.  We are the primary beneficiary of Nutra SA, and as such, Nutra SA’s assets, liabilities and results of operations are included in our consolidated financial statements.  In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.  Accordingly, the Nutra SA consolidated results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.  Other equity holders’ (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.
 
8
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and six months ended June 30, 2017 and 2016 (in thousands).

   
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Revenues
  
$
2,960
    
$
1,767
    
$
6,363
    
$
4,064
  
Cost of goods sold
    
(2,800
)
    
(2,428
)
    
(6,275
)
    
(4,949
)
Selling, general and administrative expenses
    
(497
)
    
(640
)
    
(1,031
)
    
(1,382
)
Goodwill impairment
    
-
      
(3,024
)
    
-
      
(3,024
)
Other expense
    
(357
)
    
(315
)
    
(708
)
    
(692
)
Loss from discontinued operations, before income taxes
    
(694
)
    
(4,640
)
    
(1,651
)
    
(5,983
)
Income taxes
    
-
      
-
      
-
      
-
  
Loss from discontinued operations, net of tax
  
$
(694
)
  
$
(4,640
)
  
$
(1,651
)
  
$
(5,983
)

The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).

   
June 30,
2017
    
December 31,
2016
  
Cash and cash equivalents
  
$
41
    
$
109
  
Accounts receivable, net (restricted $363 and $398)
    
326
      
398
  
Inventories
    
1,138
      
925
  
Other current asssets held for sale
    
912
      
373
  
Property and equipment, net (restricted $2,508 and $2,599 )
    
10,249
      
10,889
  
Other noncurrent assets held for sale
    
1,226
      
1,327
  
Total assets held for sale
  
$
13,892
    
$
14,021
  
Accounts payable
  
$
2,222
    
$
2,553
  
Accrued expenses
    
6,290
      
5,607
  
Current maturities of long-term debt (nonrecourse)
    
7,164
      
6,816
  
Total liabilities held for sale
  
$
15,676
    
$
14,976
  

Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the LLC Agreement.  Therefore Nutra SA’s consolidated cash is classified as held for sale in our consolidated balance sheets.  Nutra SA’s debt is secured by Irgovel’s accounts receivable and property.  The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA’s debt.

The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the six months ended June 30, 2017 and 2016 (in thousands).

   
Six Months Ended
  
   
2017
    
2016
  
             
Net cash (used) provided by operating activities
  
$
(1,236
)
  
$
1,106
  
Net cash used in investing activities
    
(93
)
    
(156
)
Net cash provided (used) by financing activities
    
1,119
      
(815
)
Effect of exchange rate changes
    
142
      
(38
)
Net change in cash and cash equivalents
    
(68
)
    
97
  
Cash and cash equivalents, beginning of period
    
109
      
104
  
Cash and cash equivalents, end of period
  
$
41
    
$
201
  
 
9
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Nutra SA’s debt consists of the following (in thousands):
 
   
June 30
2017
    
December 31,
2016
  
Capital expansion loans
  
$
647
    
$
2,454
  
Working capital lines of credit
    
1,090
      
401
  
Advances on customer export orders
    
2,482
      
1,113
  
Special tax programs
    
2,838
      
2,767
  
Other
    
107
      
81
  
   
$
7,164
    
$
6,816
  

As of June 30, 2017, Irgovel had approximately $3.7 million (USD) of installment payments in arrears.  The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current in the accompanying consolidated balance sheet as of June 30, 2017. As of June 30, 2017, Irgovel had approximately $6.1 million of tax payments in arrears.  All taxes in arrears can be included in a new Brazil tax amnesty program, but to do so, the May 2017 and June 2017 installments (approximately $0.2 million) must be paid. All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.  The fair value of Nutra SA debt (Level 3 measurement) approximates the $7.1 million carrying value of that debt based on the current market rates for similar debt with similar maturities.

Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).

A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying balance sheets, for the three and six months ended June 30, 2017 and 2016 (in thousands) follows.
 
   
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Redeemable noncontrolling interest in Nutra SA, beginning of period
  
$
(416
)
  
$
(224
)
  
$
(699
)
  
$
69
  
Investors’ interest in net loss of Nutra SA
    
(249
)
    
(1,508
)
    
(567
)
    
(1,946
)
Investors’ interest in other comprehensive loss of Nutra SA
    
(2
)
    
133
      
49
      
278
  
Investors purchase of additional membership interest
    
100
      
-
      
650
      
-
  
Redeemable noncontrolling interest in Nutra SA, end of period
  
$
(567
)
  
$
(1,599
)
  
$
(567
)
  
$
(1,599
)
                                 
Investors’ average interest in Nutra SA during the period
    
35.8
%
    
32.4
%
    
35.4
%
    
32.1
%
Investors’ interest in Nutra SA at the end of the period
    
35.7
%
    
32.4
%
    
35.7
%
    
32.4
%

The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.  The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).  We may elect to exercise a right of first refusal to purchase the Investors’ interest instead of proceeding to a sale.  We have assessed the likelihood of the Investors exercising these rights as less than probable at June 30, 2017.  We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.  We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.

As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.  In exchange for the termination of this right, we paid the Investors $0.1 million.

Under the LLC Agreement, the business of Nutra SA is subject to the oversight of a management committee comprised of three of our representatives and two Investor representatives.  Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.  In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.
 
10
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
As of June 30, 2017, there have been no unwaived events of default.  Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are failure of Irgovel to meet minimum annual processing targets or failure to achieve EBITDA on a local currency basis of at least R$4.0 million annually.

As of June 30, 2017, there have been no qualifying events.  The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.

In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.  Until there is an event of default or a qualifying event, the Investors’ rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.  The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.  However, the Investors do have drag along rights in the future.  We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.

NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT’S PLAN

We have improved our cash position since December 31, 2016, as a result of a debt and equity raise in February 2017 and the sale of HN in July 2017.  However, on a consolidated basis, largely as a result of our Nutra SA losses, we continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.

In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  Consequently, we believe we are adequately funded at this time to allow us to operate and execute on our business strategy for achieving consistent and positive operational cash flows from our remaining US operations.  In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $18.3 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).  We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.  The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

Beginning in the second quarter of 2016 and through the second quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.  Due to Irgovel’s working capital issues, Irgovel did not have the funds necessary to meet scheduled debt payments.  As a result, Irgovel ceased making all bank debt payments in the second and third quarters of 2016.  In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through June 30, 2017.  In 2016, we invested $1.1 million in Nutra SA.  Our board has determined it will no longer contribute any additional funds to Nutra SA.

NOTE 4. RECENT ACCOUNTING GUIDANCE

Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We have not yet selected a transition method but have determined that we will utilize the deferred effective date of January 1, 2018, to adopt the standard.
 
11
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  It is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019.  Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.  We adopted the standard as of January 1, 2017, with no effect on our financial position or results of operations.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  The guidance is effective for our annual and interim periods beginning in 2017 with early adoption permitted.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.

NOTE 5. LOSS PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.  Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.  The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.
 
12
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and six months ended June 30, 2017 and 2016.
 
 
Three Months Ended
    
Six Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
NUMERATOR (in thousands):
                        
Basic and diluted - loss from continuing operations
  
$
(1,774
)
  
$
(4,476
)
  
$
(4,188
)
  
$
(4,033
)
Dividend on preferred stock--beneficial conversion feature
    
-
      
-
      
(778
)
    
(551
)
Basic and diluted - adjusted loss from continuing operations
  
$
(1,774
)
  
$
(4,476
)
  
$
(4,966
)
  
$
(4,584
)
                                 
DENOMINATOR:
                                
Basic EPS - weighted average number of common shares outstanding
    
9,794,405
      
9,231,619
      
9,726,268
      
9,223,651
  
Effect of dilutive securities outstanding
    
-
      
-
      
-
      
-
  
Diluted EPS - weighted average number of shares outstanding
    
9,794,405
      
9,231,619
      
9,726,268
      
9,223,651
  
                                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                                
Stock options
    
595,252
      
353,186
      
395,262
      
355,286
  
Warrants
    
23,460,192
      
10,842,006
      
20,547,647
      
9,777,065
  
Nonvested stock
    
1,217,650
      
1,265,386
      
1,206,997
      
1,066,236
  
Convertible preferred stock
    
3,879,603
      
2,000,000
      
3,469,299
      
1,417,582
  
Restricted stock unit awards
    
261,111
      
-
      
130,556
      
-
  
 
The impact of potentially dilutive securities outstanding at June 30, 2017 and 2016, was not included in the calculation of diluted EPS for the six months ended June 30, 2017 and 2016 because to do so would be antidilutive.  Those securities listed in the table above which were antidilutive for the periods presented, which remain outstanding, could potentially dilute EPS in the future.

NOTE 6. CONCENTRATIONS OF RISK

Our trade accounts receivable subject us to significant concentrations of credit risk.  We perform ongoing credit evaluations on our customers’ financial condition and generally do not require collateral.

Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the six months ended June 30, 2017 and 2016.

   
% of Total Revenue
Six Months Ended
    
% of Total Accounts Receivable
Six Months Ended
  
Customer
  
2017
    
2016
    
2017
    
2016
  
Customer 1
    
16
%
    
12
%
    
25
%
    
18
%
Customer 2
    
15
%
    
12
%
    
12
%
    
*
  
Customer 3
    
*
      
*
      
*
      
*
  
Customer 4
    
*
      
*
      
*
      
*
  
Customer 5
    
*
      
*
      
*
      
11
%
Others
    
69
%
    
69
%
    
63
%
    
71
%
Total
    
100
%
    
93
%
    
100
%
    
100
%
 
* Less than 10%
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the six months ended June 30, 2017 and 2016.
 
13
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
   
% of Total Purchases
Six Months Ended
  
Supplier
  
2017
    
2016
  
Supplier 1
    
11
%
    
15
%
Supplier 2
    
*
      
*
  
Supplier 3
    
*
      
*
  
Supplier 4
    
*
      
*
  
Supplier 5
    
*
      
*
  
Others
    
89
%
    
85
%
Total
    
100
%
    
100
%
                 
* Less than 10%

NOTE 7. DEBT

The following table summarizes current and long-term portions of debt (in thousands):
 
   
June 30,
2017
    
December 31,
2016
  
Senior debentures, net, maturing in February 2019, principal $6.6 million
  
$
589
    
$
-
  
Subordinated notes, net, maturing in May 2019, principal $5.9 million
    
5,285
      
6,310
  
Other
    
42
      
75
  
Senior revolving loan
    
-
      
1,725
  
Senior term loan, net
    
-
      
917
  
     
5,916
      
9,027
  
Current portion
    
24
      
3,063
  
Long-term portion
  
$
5,892
    
$
5,964
  

We repaid the senior debentures and the subordinated notes, in full, with the proceeds from the sale of HN in July 2017.  We expect to recognize a third quarter 2017 expense of approximately $6.0 million to accrete the debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest to accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.

We issued the senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017.  The transaction, and the accounting therefore, is described further in Note 8.  We accreted interest on the debentures at an effective rate of 160.6% per year.

In connection with the senior debenture private placement, in February 2017, we entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.  The entire transaction, and its accounting consequences, are described further in Note 8.  Beginning in February 2017, we accreted interest on the subordinated notes at an effective rate of 15.0% per year.
 
14
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS

 
 
                                      
         
Preferred
    
Common
    
Accumulated
    
Accumulated
Deficit
Attributable to
Non-controlling
Interest in
    
Accumulated
Other Comp-
rehensive
    
Equity
  
 
 
Shares
Preferred
   
Series F
    
Series G
    
Common
    
Stock
    
Stock
    
Deficit
    
Nutra SA
    
Loss
    
(Deficit)
  
Balance, December 31, 2016
    
-
      
-
      
10,790,351
    
$
-
    
$
264,232
    
$
(259,819
)
  
$
(699
)
  
$
(4,346
)
  
$
(632
)
Issuance of common stock awards under equity incentive plans
     -       -      
550,273
       -      
613
       -       -       -      
613
  
Dividend on preferred stock - beneficial conversion feature
    
-
      
-
      
-
      
-
      
778
      
(778
)
    
-
      
-
      
-
  
Modification of senior debenture holder warrants
    
-
      
-
      
-
      
-
      
582
      
-
      
-
      
-
      
582
  
Modification of subordinated note holder warrants
    
-
      
-
      
-
      
-
      
117
      
-
      
-
      
-
      
117
  
Change in classification of preferred stock to equity from liability
    
3,000
      
2,000
       -      
1,545
       -       -       -       -      
1,545
  
Change in classification of warrants to equity from liability
     -       -       -       -      
7,851
       -       -       -      
7,851
  
Conversion of preferred stock into common stock
    
(315
)
    
(11
)
    
220,439
      
(64
)
    
203
      
(139
)
    
-
      
-
      
-
  
Other
    
-
      
-
      
14,124
      
-
      
43
      
-
      
-
      
-
      
43
  
Proceeds from sale of membership interests
    
-
      
-
      
-
      
-
      
-
      
-
      
650
      
-
      
650
  
Foreign currency translation
    
-
      
-
      
-
      
-
      
-
      
-
      
49
      
113
      
162
  
Net loss
    
-
      
-
      
-
      
-
      
-
      
(3,504
)
    
(567
)
    
-
      
(4,071
)
Balance, June 30, 2017
    
2,685
      
1,989
      
11,575,187
    
$
1,481
    
$
274,419
    
$
(264,240
)
  
$
(567
)
  
$
(4,233
)
  
$
6,860
  
 
15
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
A summary of warrant activity for the six months ended June 30, 2017, follows.

   
Equity Warrants
    
Liability Warrants
  
   
Shares
Underlying
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
    
Shares
Underlying
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
  
Outstanding, December 31, 2016
    
6,364,110
      
5.77
      
2.4
      
4,474,868
    
$
1.82
      
3.3
  
Issued
    
-
    
NA
    
NA
      
11,783,163
      
0.96
      
5.0
  
Impact of repricing debenture purchaser warrants:
                                                
Prior to repricing
    
(875,000
)
    
5.49
      
2.1
      
-
    
NA
    
NA
  
After repricing
    
875,000
      
0.96
      
5.5
      
-
    
NA
    
NA
  
Impact of repricing subordinated note holder warants:
                                                
Prior to repricing
    
(289,669
)
    
5.25
      
3.3
      
-
    
NA
    
NA
  
After repricing
    
289,669
      
0.96
      
3.3
      
-
    
NA
    
NA
  
Impact of anti-dilution clauses:
                                                
Prior to impact
    
-
    
NA
    
NA
      
(1,489,868
)
    
1.50
      
0.8
  
After impact
    
-
    
NA
    
NA
      
2,327,919
      
0.96
      
0.8
  
Transfer from liability to equity
    
14,468,163
      
1.16
      
4.8
      
(14,468,163
)
    
1.16
      
4.8
  
Exercised
    
-
    
NA
    
NA
      
-
    
NA
    
NA
  
Forfeited, expired or cancelled
    
-
    
NA
    
NA
      
-
    
NA
    
NA
  
Outstanding, June 30, 2017
    
20,832,273
    
$
2.32
      
3.9
      
2,627,919
    
$
1.03
      
0.7
  
Exercisable, June 30, 2017
    
19,957,273
    
$
2.38
      
3.9
      
2,627,919
    
$
1.03
      
0.7
  

Common Stock

In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.

On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.

In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.  The amount was payable in either cash or stock at the chairman’s election.  The chairman elected to receive shares of common stock.

In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.  The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.

In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.  The common stock had a fair value at issuance of $0.2 million.  The difference between the fair value of the common stock issued and the carrying amount of the preferred stock was recorded as an increase in accumulated deficit.

In the third quarter of 2017, through the date of this filling, we issued 1,834,124 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 397 shares of Series G preferred stock.  The common stock had a fair value at issuance of $1.9 million.  The difference between the fair value of the common stock issued and the $0.6 million carrying amount of the preferred stock was recorded as an increase in accumulated deficit.
 
16
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
Share Sequencing

From June 2015 until March 2017, the minority interest holders in Nutra SA could elect to exchange units in Nutra SA for shares of our common stock, the number of common stock and warrants issuable upon this election, was variable and indeterminate.  For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.  Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock issued between June 2015 and March 2017, in temporary equity.  We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants’ fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks’ carrying amount on March 31, 2017.

Transactions with Preferred Stock Holders.

In February 2017, we issued and sold 2,000 shares of Series G preferred stock.  The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders’ election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.  The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.  If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.

In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).  A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.  The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.  On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.  We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.

Transactions with Senior Debenture Holders

In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).  We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.  Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.  We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.  We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.  We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.
 
17
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
Transaction with Subordinated Note Holders

In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%  to 7% (ii) an extension of the maturity date of the subordinated notes  to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of  $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.  We accounted for the transaction as an extinguishment of debt and issuance of new debt.  In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock $0.1 million for the change in the fair value of the existing warrants.

Full Ratchet Anti-Dilution

As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.
 
Equity Incentive Plan

In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).  The total shares authorized under the 2014 Plan is now 3,300,000 shares.

Option Issuances

In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.  The option vests as to 25,000 shares in August 2017 and the remaining shares vest in monthly installments through August 2020 and had a grant date fair value of $0.56 per share.

In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees.  The options vest in four equal annual installments beginning in the second quarter of 2018 at an average exercise price of $0.85 per share and had a grant date fair value of $0.62 per share.

Restricted Stock Unit Awards

In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.  The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.  Each RSU’s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.  The shares had a grant date fair value of $188 thousand which will be expensed ratably over a 3.5-year period beginning in July 2017.

Warrants

In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.  We issued 103,008 shares of common stock to the holder in a cashless transaction.
 
18
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
The following table summarizes information related to outstanding warrants as June 30, 2017 and December 31, 2016:

           
June 30, 2017
    
December 31, 2016
  
Range of
Exercise Prices
    
Type of
Warrant
    
Shares Under
Warrants
    
Weighted
Average
Exercise
Price
    
Weighted
Average
 Remaining
Contractual
Life (Years)
    
Shares Under
Warrants
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
  
$
0.96
    
 Liability (1)
      
2,327,919
    
$
0.96
      
0.4
      
-
    
$
-
      
-
  
$
0.96
    
 Equity
      
12,947,832
      
0.96
      
4.6
      
-
      
-
      
-
  
$
1.50
    
 Liability (2)
      
300,000
      
1.60
      
2.9
      
-
      
-
      
-
  
$
1.50 to $1.60
    
 Liability (1)(2)
      
-
      
-
      
-
      
1,789,868
      
1.52
      
1.3
  
$
2.00
    
 Liability (3)
      
-
      
-
      
-
      
2,660,000
      
2.00
      
4.6
  
$
2.00
    
 Equity
      
2,660,000
      
2.00
      
4.2
      
-
      
-
      
-
  
$
5.25
    
 Liability (3)
      
-
      
-
      
-
      
25,000
      
5.25
      
3.6
  
$
5.25 to $5.87
    
 Equity
      
3,156,670
      
5.33
      
2.2
      
4,296,339
      
5.36
      
2.7
  
$
6.55 to $16.80
    
 Equity
      
2,067,771
      
6.61
      
1.5
      
2,067,771
      
6.61
      
2.0
  
               
23,460,192
    
$
2.17
      
3.53
      
10,838,978
    
$
1.30
      
0.5
  

(1)
Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets.  Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.  In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.

NOTE 9. FAIR VALUE MEASUREMENTS

The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.  As of June 30, 2017, the fair value of our debt (Level 3 measurement) is approximately $4.6 million higher than the $5.9 million carrying value of that debt, based on current market rates for similar debt with similar maturities.

Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Certain assets and liabilities are presented in the financial statements at fair value.  Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.  Assets and liabilities measured at fair value on a non-recurring basis may include property.

We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

●
Level 1 – inputs include quoted prices for identical instruments and are the most observable.
●
Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.
●
Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.

For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.
 
19
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
   
Level 1
    
Level 2
    
Level 3
    
Total
  
Total liabilities at fair value, as of June 30, 2017 - derivative warrant liabilities
  
$
-
    
$
-
    
$
472
    
$
472
  
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
  
$
-
    
$
-
    
$
1,527
    
$
1,527
  

Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.  The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.  The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.

   
June 30, 2017
    
December 31, 2016
  
Risk-free interest rate
    
1.1%
 
    
0.6% -1.9%
 
   
(1.1% weighted average)
    
(1.6% weighted average)
  
Expected volatility
    
65%-75%
 
    
64%
 
   
(73% weighted average)
    
(64% weighted average)
  

The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):

Total Level 3 Fair Value
  
Fair Value
as of
Beginning of
Period
    
Total
Realized and
Unrealized
Gains
(Losses)
    
Issuance of
New
Instruments
    
Reclassify to
(Deficit)
Equity
    
Fair Value,
at End of
Period
  
         
(1)
 
                  
Six Months Ended June 30, 2017, derivative warrant liabilities
  
$
(1,527
)
  
$
1,121
    
$
(7,917
)
  
$
7,851
    
$
(472
)
Six Months Ended June 30, 2016, derivative warrant liabilities
  
$
(678
)
  
$
(852
)
  
$
(2,473
)
  
$
-
    
$
(4,003
)

(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.

NOTE 10. COMMITMENTS AND CONTINGENCIES

In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.  These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.  Defense costs are expensed as incurred and are included in professional fees.

Irgovel Litigation

Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.  The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.  None of these labor claims is individually significant.  Management believes it’s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.

Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.  The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.  We record amounts considered sufficient by our management to cover probable losses based on these elements.
 
20
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.
 
Irgovel - Events of Default

As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.  It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors.

Employment Contracts and Severance Payments

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.  In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control.

NOTE 11. RELATED PARTY TRANSACTIONS

Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.  As of June 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.  See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.  The notes were paid in full in July 2017 from the proceeds of the sale of HN.  In the three months ended June 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the six months ended June 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.

NOTE 12. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS

On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders’ equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders’ equity for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1).  As of June 30, 2016, we reported stockholders’ deficit of $36,000.

We submitted our plan to regain compliance in October 2016.  On November 15, 2016, based on information we submitted to Nasdaq, the Staff granted us the maximum allowable 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders’ equity requirement.  On February 16, 2017, we received a determination letter from the Nasdaq Listing Qualifications Staff stating that we had not regained compliance with the minimum stockholders’ equity requirement.  The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.

We requested and were granted a hearing before the panel to appeal the Letter on March 30, 2017.  After that hearing, on April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million.  We must also at that time provide the panel with updated projections showing stockholders’ equity through May 2018. As reported herein our equity is $7.9 million and exceeds the minimum as of March 31, 2017.

On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2).  Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum price of $1.00 for 10 consecutive business days.  Nasdaq rules allow for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.  If this appears unlikely as September 6, 2017, approaches, we are committed to taking actions that would enable us to regain compliance, including, if necessary, completing a reverse split of our common stock to increase its share price above the $1 minimum bid price.

On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.
 
21
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

See Note 2 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of divestitures and discontinued operations.

See Note 3 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of going concern considerations and management’s plans.

Results of Operations

During the second quarter of 2017, we began to separately report the results of our wholly-owned subsidiary, Healthy Natural, Inc. (HN) and our investment in Nutra SA as discontinued operations in our Consolidated Statements of Income, and present the related assets and liabilities as held for sale in the Consolidated Balance Sheets. These changes have been applied for all periods presented. Unless otherwise noted, amounts and percentages for all periods discussed below reflect the results of operations and financial condition from our continuing operations.  Refer to Note 2 to our consolidated financial statements for additional information on discontinued operations.

   
Three Months Ended
    
Change
    
Six Months Ended
    
Change
  
   
2017
    
2016
    
%
    
2017
    
2016
    
%
  
                                     
Revenues
  
$
3,146
    
$
3,233
      
(2.7
)
  
$
6,761
    
$
6,499
      
4.0
  
Cost of goods sold
    
2,348
 
    
2,431
 
    
3.4
      
4,776
 
    
4,765
 
    
(0.2
)
Gross profit
    
798
      
802
      
(0.5
)
    
1,985
      
1,734
      
14.5
  
Gross profit %
    
25.4
%
    
24.8
%
            
29.4
%
    
26.7
%
        
                                                 
Operating selling, general and administrative expenses
    
2,667
 
    
3,676
 
    
27.4
      
4,933
 
    
6,288
 
    
21.5
  
Loss from operations
    
(1,869
)
    
(2,874
)
    
35.0
      
(2,948
)
    
(4,554
)
    
35.3
  
Other income (expense):
                                                
Interest expense
    
(475
)
    
(454
)
            
(1,530
)
    
(1,132
)
        
Change in fair value of derivative warrant liabilities
    
22
      
(1,663
)
            
1,121
      
(852
)
        
Loss on extinguishment of debt
    
-
      
-
              
(1,680
)
    
-
          
Gain on resolution of Irgovel purchase litigation
    
-
      
-
              
-
      
1,598
          
Other income net
    
33
      
-
              
(63
)
    
-
          
Total other income (expense)
    
(420
)
    
(2,117
)
            
(2,152
)
    
(386
)
        
Loss before income taxes
  
$
(2,289
)
  
$
(4,991
)
          
$
(5,100
)
  
$
(4,940
)
        

THREE MONTHS ENDED JUNE 30, 2017 and 2016

Revenues decreased $0.1 million, or 2.7%, quarter over quarter.  Animal feed product revenues increased 17% over prior year levels driven by the supply and cooperation agreement entered into with Kentucky Equine Research (KER) at the end of December 2015.  Food product revenues decreased 13%, quarter over quarter. The decrease in food product revenue was primarily attributable to decreased buying from the existing customer base and specifically the contract manufacturing accounts.

Gross profit percentage was relatively constant at 25% for the second quarter of 2017 versus the prior year quarter.  As noted above, animal nutrition revenues increase was offset by food revenue decrease quarter over quarter.  In the second quarter of 2017, the raw bran supplier for our Mermentau facility that produces animal feed products was not producing for eight weeks.  Additionally, raw bran prices have remained relatively flat when comparing quarter over quarter.

Operating selling, general and administrative expenses (SG&A) were $1.1 million for the second quarter of 2017, compared to $1.3 million for the second quarter of 2016, a decrease of $0.2 million.  The decrease is related to our continued strategic effort to manage costs and expenses.  Due to the reduction of staff and outside sales consultants, the SG&A salary, bonus, wages and benefit related expenses decreased $0.2 million.

Corporate SG&A expenses in the second quarter of 2017 were $1.6 million, a decrease of $0.8 million over the prior year quarter primarily due to the additional expenses during the second quarter of 2016 as a result of the proxy contest in connection with the 2016 Annual Shareholder Meeting.  The expenses incurred included legal fees, investor relations and proxy solicitation consulting fees, incremental electronic filing fees, shareholder mailing costs and the settlement payment made to the dissident group.
 
22
Other income (expense) was $0.4 million of other expense for the second quarter of 2017 compared to $2.1 million of other expense for the second quarter of 2016.  The $1.7 million decrease in expense is related to the change in the fair value of derivative warrant liabilities in the prior year quarter.

SIX MONTHS ENDED JUNE 30, 2017 and 2016

Revenues increased $0.3 million, or 4.0%, in the six months ended June 30, 2017 compared to the six months ended June 30, 2016. Animal feed product revenues increased 13%. Animal nutrition revenue growth was driven by the supply and cooperation agreement entered into with Kentucky Equine Research (KER) at the end of December 2015.  Food product revenues remained relatively constant period over period.

Gross profit percentage increased 2.7 percentage points to 29.4% in the first six months of 2017, from 26.7% in the first six months of 2016.  The increase was primarily attributable to the approximately 7.8% decrease in raw bran prices during the first six months of 2017 compared to the same period of the previous year.  Additionally, the raw bran supplier for our Mermentau facility that produces animal feed products was not producing for eight weeks during the second quarter of 2017.  As noted above, animal nutrition revenues were up during the first six months of 2017 as compared to prior year.

Operating expenses were $1.9 million for the first six months of 2017, compared to $2.6 million for the first six months of 2016, a decrease of $0.6 million, or 25%.  The decrease is related to our continued strategic effort to manage costs and expenses.  Due to the reduction of staff and outside sales consultants, the SG&A salary, bonus, wages and benefit related expenses decreased $0.5 million.  Additionally, travel expenses and marketing expenses decreased $0.1 million.

Corporate SG&A expenses decreased $0.7 million, or 19.1%, in the first half of 2017.  This was primarily related to the additional expenses during the second quarter of 2016 incurred as a result of the proxy contest in connection with the 2016 Annual Shareholder Meeting.

Other income (expense) increased $1.8 million from the prior year period.  The $0.4 million increase in interest expense and the $1.7 million loss on extinguishment of debt was related to the extinguishment and replacement of subordinated notes and the payoff of the senior revolving loan and term loan debt in February 2017 (see Note 8), offset by $2.0 million of other income related to the adjustment in fair value of derivative warrant liabilities.

Liquidity, Going Concern and Capital Resources

See Note 3 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of going concern considerations and management’s plans.

Cash used in operating activities of continuing operations for the six months ended June 30, 2017 and 2016, is presented below (in thousands).

   
2017
    
2016
  
Cash flow from operating activities:
            
Loss from continuing operations
  
$
(4,188
)
  
$
(4,033
)
Adjustments to reconcile net loss to net cash used in operating activities:
                
Depreciation and amortization
    
414
      
452
  
Stock and share-based compensation
    
654
      
477
  
Change in fair value of derivative warrant and conversion liabilities
    
(1,121
)
    
852
  
Loss on extinguishment of debt
    
1,680
      
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
(1,598
)
Interest accreted
    
893
      
403
  
Cash provided by discontinued operations
    
(876
)
    
(1,763
)
Other
    
58
      
-
  
Changes in operating assets and liabilities:
                
Accounts receivable
    
(38
)
    
(113
)
Inventories
    
(16
)
    
161
  
Accounts payable and accrued expenses
    
(824
)
    
186
  
Other
    
353
      
(52
)
Net cash used in operating activities of continuing operations
  
$
(3,011
)
  
$
(5,028
)
 
23
We used $3.0 million of operating cash during the first six months of 2017, compared to using $5.0 million of operating cash in the first six months of 2016.  We funded the use of cash with available cash on hand derived from the debt and equity raise in February 2017 (February 2017 Transactions).  We received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants from the February 2017 Transactions.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  See Note 8 of our Notes to Unaudited Condensed Consolidated Financial Statements for additional information.

In July 2017, we completed the sale of the assets of HN for $18.3 million in cash, net of assumed liabilities (see Note 2 of our Notes to Unaudited Condensed Consolidated Financial Statements for additional information).  HN was reported as part of our USA segment.  The purchase price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.

We have not completed our accounting for the sale of HN.  On a preliminary basis, we estimate the net carrying value of HN as of the date of sale at $4.0 million and the third quarter 2017 gain on sale as $8.8 million, net of $4.5 million income tax provision.  The Internal Revenue Service rules in this area are complex and we have not yet completed an analysis of what net operating losses, if any, will be available to reduce the taxes owed on the gain.  A portion of the proceeds from the sale of HN will be used to payoff senior debentures and subordinated debt.  We expect to recognize a third quarter 2017 expense of approximately $6.0 million related to the extinguishment of the senior debentures and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest.  We will be required to accrete the senior debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.

As of June 30, 2017, our cash balance is $3.2 million compared to $0.3 million as of December 31, 2016.

Off-Balance Sheet Arrangements

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risk, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing and liquidity support or market risk or credit support risk to us.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses and disclosures on the date of the financial statements.  On an ongoing basis, we evaluate the estimates, including, but not limited to, those related to revenue recognition.  We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments.  Actual results could differ from those estimates.

For further information about other critical accounting policies, see the discussion of critical accounting policies in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Recent Accounting Pronouncements

See Note 4 in the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

Item 3.
Quantitative and Qualitative Disclosures about Market Risk

Not applicable
 
24
Item 4.
Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosures.

We evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f).  Under the supervision and with the participation of our management, including our Chief Executive Officer, Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2016 based on the guidelines established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO 2013).  Our internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.

Changes in Internal Control over Financial Reporting

During the most recently completed fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.
Legal Proceedings

See Note 10 in the Notes to Unaudited Condensed Consolidated Financial Statements for information regarding certain legal proceedings to which we are a party.

We are involved in or subject to, or may become involved in or subject to, routine litigation, claims, disputes, proceedings and investigations in the ordinary course of business.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position, results of operations or cash flows.  We record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.
 
In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.

Item 1A.
Risk Factors

In addition to the other information set forth in this Quarterly Report and the risk factor set forth below, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016, which could materially affect our business, financial condition, liquidity or future results.  The risks described in our Annual Report on Form 10-K are not the only risks facing our company.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, liquidity or future results.

Our ability to use certain net operating loss (NOLs) carryforwards to offset future taxable income for U.S. federal income tax could be limited.

NOLs are generally available for use to offset future taxable income.  If, however, we were to experience an “ownership change,” as defined in Section 382 of the Internal Revenue Code, our ability to utilize our NOLs could be substantially limited.  In general, an ownership change occurs if the percentage of the stock owned by one or more “5% shareholders” is more than 50 percentage points higher than the lowest percentage of stock owned by such shareholders at any time during the prior three-year period.  If we were to experience an ownership change, Section 382 would limit our annual utilization of our NOLs generated prior to the ownership change.  In addition, depending on the severity of the annual NOL limitation resulting from an ownership change, we could potentially lose permanently our ability to use a significant amount of our accumulated NOLs.  An issuance of new stock to a new or current 5% shareholder could, under some circumstances, contribute to, or result in, a Section 382 ownership change.  Any such ownership change could result in a potential tax liability with respect to the sale of HN.
 
25
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended June 30, 2017, we issued the securities described below without registration under the Securities Act.  Unless otherwise indicated below, the securities were issued pursuant to the private placement exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended.  All issuances below were made without any public solicitation, to a limited number of persons and were acquired for investment purposes only.

In May 2017, we issued 10,439 shares of common stock upon the conversion of 11 shares of Series G convertible preferred stock.

Item 3.
Defaults upon Senior Securities

None

Item 4.
Mine Safety Disclosures

None

Item 5.
Other Information

None
 
26
Item 6.
Exhibits

The following exhibits are attached hereto and filed herewith:
 
       
Incorporated by Reference
    
Exhibit
Number
  
Exhibit Description
  
Form
  
File No.
  
Exhibit
Number
  
Filing/Effective
Date
  
Filed
Here-
with
10.01
  
2014 Equity Incentive Plan, as amended.
  
8-K
  
001-36245
  
10.1
  
June 27, 2017
    
10.02
  
Asset Purchase Agreement dated July 14, 2017, among the Registrant, Healthy Natural, Inc. and United Laboratories Manufacturing, LLC
  
8-K
  
001-36245
  
2.1
  
July 17, 2017
    
 
Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
                  
X
 
Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
                  
X
 
Certification by CEO and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
                  
X
101.INS (1)
  
XBRL Instance Document
                  
X
101.SCH (1)
  
XBRL Taxonomy Extension Schema Document
                  
X
101.CAL (1)
  
XBRL Taxonomy Extension Calculation Linkbase Document
                  
X
101.DEF (1)
  
XBRL Taxonomy Extension Calculation Definition Linkbase Document
                  
X
101.LAB (1)
  
XBRL Taxonomy Extension Calculation Label Linkbase Document
                  
X
101.PRE (1)
  
XBRL Taxonomy Extension Calculation Presentation Linkbase Document
                  
X

(1)
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
27
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated:  August 11, 2017
    
     
 
/s/ Robert Smith
  
 
Robert Smith
 
Chief Executive Officer

 
/s/ Brent Rystrom
  
 
Brent Rystrom
 
Chief Financial Officer
 
 
28
 EX-31.1 2 ex31_1.htm EXHIBIT 31.1
Exhibit 31.1

Certification of Principal Executive Officer
 Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Robert Smith, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  August 11, 2017
/s/ Robert Smith
  
    
 
Name: Robert Smith
 
Title: Chief Executive Officer
 
 
 EX-31.2 3 ex31_2.htm EXHIBIT 31.2
Exhibit 31.2

Certification of Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brent Rystrom, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  August 11, 2017
/s/ Brent Rystrom
  
    
 
Name: Brent Rystrom
 
Title: Chief Financial Officer
 
 
 EX-32.1 4 ex32_1.htm EXHIBIT 32.1
Exhibit 32.1

Certification of Principal Executive Officer and Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of RiceBran Technologies (the Company) for the period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Company.

Dated:  August 11, 2017
    
     
 
/s/ Robert Smith
  
 
Robert Smith
 
Chief Executive Officer

 
/s/ Brent Rystrom
  
 
Brent Rystrom
 
Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No. 34-47551 and shall not be considered filed as part of the Form 10-Q.
 
 
 EX-101.INS 5 ribt-20170630.xml XBRL INSTANCE DOCUMENT 0001063537 2017-01-01 2017-06-30 0001063537 2017-07-31 0001063537 2017-04-01 2017-06-30 0001063537 2016-04-01 2016-06-30 0001063537 2016-01-01 2016-06-30 0001063537 2017-06-30 0001063537 2016-12-31 0001063537 us-gaap:SeriesFPreferredStockMember 2017-06-30 0001063537 us-gaap:SeriesFPreferredStockMember 2016-12-31 0001063537 us-gaap:SeriesGPreferredStockMember 2017-06-30 0001063537 us-gaap:SeriesGPreferredStockMember 2016-12-31 0001063537 2015-12-31 0001063537 2016-06-30 0001063537 ribt:HealthyNaturalIncMember 2017-01-01 2017-06-30 0001063537 ribt:NutraSAMember 2017-01-01 2017-06-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-31 0001063537 us-gaap:ScenarioForecastMember ribt:HealthyNaturalIncMember 2017-09-30 0001063537 us-gaap:ScenarioForecastMember ribt:HealthyNaturalIncMember 2017-07-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SubordinatedDebtMember 2017-01-01 2017-06-30 0001063537 us-gaap:SecuredDebtMember ribt:HealthyNaturalIncMember 2017-01-01 2017-06-30 0001063537 us-gaap:SecuredDebtMember ribt:HealthyNaturalIncMember 2017-06-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SubordinatedDebtMember 2017-06-30 0001063537 ribt:HealthyNaturalIncMember 2016-04-01 2016-06-30 0001063537 ribt:NutraSAMember 2016-01-01 2016-06-30 0001063537 ribt:NutraSAMember 2017-04-01 2017-06-30 0001063537 ribt:HealthyNaturalIncMember 2017-04-01 2017-06-30 0001063537 ribt:NutraSAMember 2016-04-01 2016-06-30 0001063537 ribt:HealthyNaturalIncMember 2016-01-01 2016-06-30 0001063537 ribt:NutraSAMember 2016-12-31 0001063537 ribt:NutraSAMember 2017-06-30 0001063537 ribt:HealthyNaturalIncMember 2016-12-31 0001063537 ribt:HealthyNaturalIncMember 2017-06-30 0001063537 ribt:NutraSAMember 2015-12-31 0001063537 ribt:NutraSAMember 2016-06-30 0001063537 ribt:NutraSAMember ribt:IrgovelMember 2017-06-30 0001063537 ribt:NutraSAMember country:BR 2017-06-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-03-31 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-12-31 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2015-12-31 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-03-31 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-01-01 2016-06-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-04-01 2016-06-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-04-01 2017-06-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-06-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-06-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-06-30 0001063537 us-gaap:InvestorMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2017-06-30 0001063537 us-gaap:InvestorMember us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-06-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:InvestorMember 2016-01-01 2016-12-31 0001063537 2017-02-28 2017-02-28 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-01-01 2016-12-31 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-06-30 0001063537 us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001063537 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2017-04-01 2017-06-30 0001063537 ribt:TemporaryEquityStockMember 2016-04-01 2016-06-30 0001063537 us-gaap:WarrantMember 2016-04-01 2016-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-06-30 0001063537 ribt:TemporaryEquityStockMember 2017-04-01 2017-06-30 0001063537 ribt:TemporaryEquityStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:RestrictedStockMember 2016-04-01 2016-06-30 0001063537 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001063537 us-gaap:WarrantMember 2017-04-01 2017-06-30 0001063537 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2016-04-01 2016-06-30 0001063537 us-gaap:RestrictedStockMember 2016-01-01 2016-06-30 0001063537 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0001063537 us-gaap:RestrictedStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0001063537 us-gaap:EmployeeStockOptionMember 2016-04-01 2016-06-30 0001063537 ribt:TemporaryEquityStockMember 2016-01-01 2016-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001063537 us-gaap:WarrantMember 2017-01-01 2017-06-30 0001063537 us-gaap:WarrantMember 2016-01-01 2016-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier1Member 2016-01-01 2016-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:Supplier3Member ribt:PurchasesMember 2017-01-01 2017-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember ribt:Customer1Member us-gaap:AccountsReceivableMember 2017-01-01 2017-06-30 0001063537 us-gaap:AccountsReceivableMember ribt:Customer1Member us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 us-gaap:SalesRevenueGoodsNetMember ribt:Customer1Member us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2016-01-01 2016-06-30 0001063537 ribt:OtherCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-06-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 us-gaap:AccountsReceivableMember ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:FifthCustomerMember 2017-01-01 2017-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:Supplier4Member ribt:PurchasesMember 2017-01-01 2017-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember ribt:Customer3Member us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-06-30 0001063537 us-gaap:AccountsReceivableMember ribt:FourthCustomerMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:OtherSuppliersMember 2016-01-01 2016-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2017-01-01 2017-06-30 0001063537 us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-06-30 0001063537 us-gaap:SalesRevenueGoodsNetMember ribt:OtherCustomersMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:Customer2Member 2016-01-01 2016-06-30 0001063537 us-gaap:AccountsReceivableMember ribt:Customer2Member us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-06-30 0001063537 ribt:Customer3Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-06-30 0001063537 ribt:FourthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-06-30 0001063537 ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-06-30 0001063537 us-gaap:SalesRevenueGoodsNetMember ribt:Customer1Member us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:Supplier3Member ribt:PurchasesMember 2016-01-01 2016-06-30 0001063537 ribt:FourthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember ribt:Supplier1Member 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember ribt:Supplier2Member us-gaap:SupplierConcentrationRiskMember 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:OtherSuppliersMember 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier4Member 2016-01-01 2016-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember ribt:OtherCustomersMember 2016-01-01 2016-06-30 0001063537 ribt:OtherCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2017-01-01 2017-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:Customer3Member 2017-01-01 2017-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:Customer2Member 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier5Member 2016-01-01 2016-06-30 0001063537 us-gaap:AccountsReceivableMember ribt:Customer2Member us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-06-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:Supplier5Member ribt:PurchasesMember 2017-01-01 2017-06-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:FourthCustomerMember 2017-01-01 2017-06-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier2Member 2016-01-01 2016-06-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ribt:Customer3Member 2016-01-01 2016-06-30 0001063537 us-gaap:NotesPayableOtherPayablesMember 2017-06-30 0001063537 ribt:DebtDueMay2019Member us-gaap:SubordinatedDebtMember 2016-12-31 0001063537 us-gaap:RevolvingCreditFacilityMember 2016-12-31 0001063537 us-gaap:RevolvingCreditFacilityMember 2017-06-30 0001063537 us-gaap:SecuredDebtMember ribt:DebtDueFebruary2019Member 2017-06-30 0001063537 us-gaap:SubordinatedDebtMember ribt:DebtDueMay2019Member 2017-06-30 0001063537 us-gaap:NotesPayableOtherPayablesMember 2016-12-31 0001063537 us-gaap:SeniorNotesMember 2016-12-31 0001063537 us-gaap:SecuredDebtMember ribt:DebtDueFebruary2019Member 2016-12-31 0001063537 us-gaap:SeniorNotesMember 2017-06-30 0001063537 us-gaap:SubordinatedDebtMember ribt:DebtDueMay2019Member 2017-01-01 2017-06-30 0001063537 us-gaap:SecuredDebtMember ribt:DebtDueFebruary2019Member 2017-01-01 2017-06-30 0001063537 ribt:DebtDueMay2019Member us-gaap:SubordinatedDebtMember 2016-01-01 2016-12-31 0001063537 ribt:DebtDueMay2019Member us-gaap:SubordinatedDebtMember 2017-01-01 2017-03-31 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2016-12-31 0001063537 us-gaap:PreferredStockMember 2016-12-31 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001063537 us-gaap:RetainedEarningsMember 2016-12-31 0001063537 us-gaap:CommonStockMember 2016-12-31 0001063537 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2016-12-31 0001063537 us-gaap:PreferredStockMember us-gaap:SeriesFPreferredStockMember 2016-12-31 0001063537 us-gaap:CommonStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-06-30 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2017-01-01 2017-06-30 0001063537 us-gaap:RetainedEarningsMember 2017-01-01 2017-06-30 0001063537 us-gaap:PreferredStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:PreferredStockMember us-gaap:SeriesGPreferredStockMember 2017-01-01 2017-06-30 0001063537 us-gaap:PreferredStockMember 2017-06-30 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0001063537 us-gaap:RetainedEarningsMember 2017-06-30 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2017-06-30 0001063537 us-gaap:CommonStockMember 2017-06-30 0001063537 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2017-06-30 0001063537 us-gaap:PreferredStockMember us-gaap:SeriesGPreferredStockMember 2017-06-30 0001063537 ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:EquityWarrantMember 2017-01-01 2017-06-30 0001063537 ribt:LiabilityWarrantMember 2017-01-01 2017-06-30 0001063537 ribt:EquityWarrantMember 2017-06-30 0001063537 ribt:LiabilityWarrantMember 2017-06-30 0001063537 ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember 2016-01-01 2016-12-31 0001063537 2017-02-28 0001063537 2017-01-31 0001063537 ribt:FormerEmployeeMember 2017-02-14 2017-02-14 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2017-06-01 2017-06-30 0001063537 us-gaap:DirectorMember 2017-06-01 2017-06-30 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2017-01-01 2017-03-31 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2016-07-01 2016-12-31 0001063537 us-gaap:CommonStockMember us-gaap:ScenarioForecastMember 2017-07-01 2017-09-30 0001063537 us-gaap:SeriesFPreferredStockMember us-gaap:ScenarioForecastMember 2017-08-11 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember us-gaap:ScenarioForecastMember 2017-08-11 2017-09-30 0001063537 us-gaap:ScenarioForecastMember us-gaap:PreferredStockMember 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember 2017-02-28 0001063537 us-gaap:SeriesGPreferredStockMember 2017-02-01 2017-02-28 0001063537 ribt:ExpirationFebruary2022Member us-gaap:WarrantsNotSettleableInCashMember 2017-02-28 0001063537 us-gaap:SubordinatedDebtMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember us-gaap:SecuredDebtMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember 2016-12-31 0001063537 us-gaap:WarrantsNotSettleableInCashMember us-gaap:SubordinatedDebtMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember us-gaap:SubordinatedDebtMember 2016-12-31 0001063537 us-gaap:SubordinatedDebtMember 2017-02-01 2017-02-28 0001063537 us-gaap:SecuredDebtMember 2017-02-01 2017-02-28 0001063537 us-gaap:SubordinatedDebtMember us-gaap:WarrantsNotSettleableInCashMember 2017-02-01 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember us-gaap:SecuredDebtMember 2017-02-01 2017-02-28 0001063537 us-gaap:SecuredDebtMember 2016-01-01 2016-12-31 0001063537 us-gaap:SubordinatedDebtMember 2016-12-31 0001063537 ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 ribt:EquityIncentivePlan2014Member 2017-06-30 0001063537 ribt:ExecutiveOfficerAndEmployeesMember 2017-04-01 2017-06-30 0001063537 us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-03-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeThreeMember 2017-01-01 2017-06-30 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2017-01-01 2017-06-30 0001063537 ribt:EquityWarrantMember ribt:RangeSixMember 2017-01-01 2017-06-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2017-01-01 2017-06-30 0001063537 ribt:EquityWarrantMember ribt:RangeOneMember 2017-01-01 2017-06-30 0001063537 ribt:RangeFiveMember ribt:LiabilityWarrantMember 2017-01-01 2017-06-30 0001063537 ribt:RangeOneMember ribt:LiabilityWarrantMember 2017-01-01 2017-06-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeFourMember 2017-01-01 2017-06-30 0001063537 ribt:RangeFourMember ribt:EquityWarrantMember 2017-01-01 2017-06-30 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2017-06-30 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2017-06-30 0001063537 ribt:RangeFourMember ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2016-12-31 0001063537 ribt:RangeThreeMember ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:RangeOneMember ribt:LiabilityWarrantMember 2017-06-30 0001063537 ribt:RangeFourMember ribt:LiabilityWarrantMember 2017-06-30 0001063537 ribt:RangeThreeMember ribt:LiabilityWarrantMember 2017-06-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeFiveMember 2017-06-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeOneMember 2016-12-31 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember us-gaap:SubsequentEventMember 2017-07-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2017-06-30 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2016-12-31 0001063537 ribt:RangeSixMember ribt:EquityWarrantMember 2017-06-30 0001063537 ribt:RangeFiveMember ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:RangeFourMember ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSixMember 2016-12-31 0001063537 ribt:RangeFourMember ribt:EquityWarrantMember 2017-06-30 0001063537 2016-01-01 2016-12-31 0001063537 ribt:RangeThreeMember ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSixMember 2016-01-01 2016-12-31 0001063537 ribt:RangeOneMember ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeFourMember 2016-01-01 2016-12-31 0001063537 ribt:RangeFourMember ribt:EquityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeFiveMember 2016-01-01 2016-12-31 0001063537 us-gaap:RestrictedStockUnitsRSUMember ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 ribt:LiabilityWarrantMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-31 0001063537 ribt:EquityIncentivePlan2014Member us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001063537 ribt:ShareBasedCompensationAwardVestingThreeMember ribt:EquityIncentivePlan2014Member us-gaap:RestrictedStockUnitsRSUMember 2017-06-01 2017-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember ribt:EquityIncentivePlan2014Member ribt:ShareBasedCompensationAwardVestingOneMember 2017-06-01 2017-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember ribt:EquityIncentivePlan2014Member ribt:ShareBasedCompensationAwardVestingTwoMember 2017-06-01 2017-06-30 0001063537 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2017-06-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-06-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:WeightedAverageMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-06-30 0001063537 us-gaap:WeightedAverageMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-06-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0001063537 ribt:IrgovelMember 2017-06-30 0001063537 us-gaap:MinimumMember ribt:IrgovelMember 2017-01-01 2017-06-30 0001063537 us-gaap:DirectorMember 2017-01-01 2017-06-30 0001063537 us-gaap:SubordinatedDebtMember us-gaap:DirectorMember 2016-01-01 2016-06-30 0001063537 us-gaap:DirectorMember us-gaap:SubordinatedDebtMember 2016-04-01 2016-06-30 0001063537 us-gaap:DirectorMember us-gaap:SubordinatedDebtMember 2017-04-01 2017-06-30 0001063537 us-gaap:SubordinatedDebtMember us-gaap:DirectorMember 2017-01-01 2017-06-30 0001063537 2016-08-18 0001063537 2017-03-31 0001063537 us-gaap:SubsequentEventMember 2017-08-01 0001063537 2017-03-10 0001063537 us-gaap:SubsequentEventMember 2017-08-01 2017-08-01 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ribt:Representative ribt:Investor ribt:Installment ribt:Warrant iso4217:BRL false --12-31 2017-06-30 No No Yes Smaller Reporting Company RiceBran Technologies 0001063537 13512319 2017 Q2 10-Q 640000 714000 1094000 1132000 893000 403000 1288000 439000 -4233000 -4346000 12000 8000 261111 2000000 10842006 0 3879603 3469299 1265386 395262 23460192 355286 0 1066236 595252 1206997 1217650 353186 1417582 130556 20547647 9777065 31581000 28845000 4364000 14021000 13892000 4978000 4335000 5698000 11428000 7528000 3184000 342000 966000 1776000 2842000 810000 1112000 -815000 -815000 0 -7000 1119000 -208000 -108000 -156000 -75000 -15000 -93000 3244000 973000 2235000 2141000 -1236000 1106000 1423488 3484675 2327919 6875000 1489868 2067771 12947832 2660000 0 1789868 2327919 0 0 0 0 0 781522 300000 2067771 3156670 25000 0 4296339 23460192 2660000 10838978 0.96 0.96 0.96 1.50 0.96 0.96 5.25 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 10. COMMITMENTS AND CONTINGENCIES</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.&#160; These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.&#160; When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.&#160; While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.&#160; Defense costs are expensed as incurred and are included in professional fees.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Irgovel Litigation</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.&#160; The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.&#160; None of these labor claims is individually significant.&#160; Management believes it&#8217;s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.&#160; The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.&#160; We record amounts considered sufficient by our management to cover probable losses based on these elements. <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; text-align: justify;">In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.&#160; In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.&#160; In June 2014, Irgovel filed a motion to annul the enforcement proceedings.&#160; The enforcement proceedings were dismissed in September 2015.&#160; In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.</div></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>Irgovel - Events of Default</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.&#160; It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors. </div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>Employment Contracts and Severance Payments</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.&#160; In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control.</div></div> 10790351 11575187 6000000 0 0 50000000 50000000 50000000 25000000 264232000 274419000 11575187 10790351 0 10790351 0 2685 1989 11575187 -6328000 -1203000 -3391000 -5727000 -518000 -1375000 -250000 -1668000 -7703000 -3909000 -7395000 -1453000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 6. CONCENTRATIONS OF RISK</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our trade accounts receivable subject us to significant concentrations of credit risk.&#160; We perform ongoing credit evaluations on our customers&#8217; financial condition and generally do not require collateral.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the <font style="font-size: 10pt; font-family: 'Times New Roman';">six months ended June 30, 2017</font> and 2016.</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Revenue</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Accounts Receivable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Customer</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">63</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">71</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 4px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div>&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: bottom;">* Less than 10%</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the <font style="font-size: 10pt; font-family: 'Times New Roman';">six months ended June 30, 2017</font> and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Purchases</div>Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Supplier</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">89</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">85</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div>&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td colspan="9" valign="bottom" style="width: 26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">* Less than 10%</div></td></tr></table></div></div> 0.15 0.93 0.25 0.18 0.12 1 0.63 1 0.11 1 0.85 1 1 0.69 0.12 0.16 0.11 0.89 0.71 0.69 0.15 0.12 1897983 4765000 2348000 2431000 4776000 948.9915 100000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 7. DEBT</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes current and long-term portions of debt (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior debentures, net, maturing in February 2019, principal $6.6 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Subordinated notes, net, maturing in May 2019, principal $5.9 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,285</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,310</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior revolving loan</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior term loan, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,916</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,027</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Long-term portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,892</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,964</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We repaid the senior debentures and the subordinated notes, in full, with the proceeds from the sale of HN in July 2017.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">We expect to recognize a third quarter 2017 expense of approximately $6.0 million to accrete the debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest to accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.</font></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We issued the senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017<font style="font-size: 10pt; font-family: 'Times New Roman';">.&#160; The transaction, and the accounting therefore, is</font> described further in Note 8.&#160; We accreted interest on the debentures at an effective rate of 160.6% per year.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In connection with the senior debenture private placement, in February 2017, we entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The entire transaction, and its accounting consequences, are</font> described further in Note 8.&#160; Beginning in February 2017, we accreted interest on the subordinated notes at an effective rate of 15.0% per year.</div></div> 180 600000 5300000 0.1175 0.07 6600000 6000000 6600000 5900000 6600000 200000 300000 0.1175 0.07 2019-05-31 2019-02-28 1.606 0.150 400000 29000 33000 452000 414000 1527000 472000 8800000 515000 912000 907000 0 515000 0 0 0 -1651000 -5983000 2669000 2680000 1515000 -694000 -4640000 1513000 4500000 6275000 4949000 2428000 3336000 2800000 6358000 3702000 6661000 791000 791000 5546000 4064000 2960000 6363000 9481000 5064000 1767000 10034000 1382000 640000 1031000 443000 329000 704000 215000 497000 109000 41000 104000 201000 32000 373000 912000 23000 2222000 443000 2553000 567000 357000 315000 708000 692000 1226000 24000 24000 1327000 6290000 5607000 346000 382000 13172000 14050000 882000 10249000 1019000 10889000 1138000 925000 1887000 1915000 592000 1362000 398000 326000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 2. DISCONTINUED OPERATIONS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Healthy Natural (HN) Discontinued Operations</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">The Company continuously assesses the composition of our portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.&#160; In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).&#160; </font>In July 2017, we completed the sale of the assets of HN for $18.3 million in cash, net of assumed liabilities.&#160; HN was reported as part of our USA segment.&#160; The purchase price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.&#160; The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.&#160; We are providing certain support services under transition services agreement for a limited period of time.&#160; These support services are not expected to have a material impact on our consolidated statements of operations in 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the initial distribution of proceeds (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Purchase price, net of assumed liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,283</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Estimated expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(934</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net proceeds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">17,349</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of senior debentures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,600</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of subordinated debt and related interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,963</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">56</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Escrow for working capital adjustments</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">225</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Escrow for indemnity claims</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">550</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,394</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We have not completed our accounting for the sale of HN.&#160; On a preliminary basis, we estimate the net carrying value of HN as of the date of sale at $4.0 million and the third quarter 2017 gain on sale as $8.8 million, net of $4.5 million income tax provision.&#160; The Internal Revenue Service rules in this area are complex and we have not yet completed an analysis of what net operating losses, if any, will be available to reduce the taxes owed on the gain.&#160; In addition, we expect to recognize a third quarter 2017 expense from the proceeds from the sale of HN of approximately $6.0 million related to the extinguishment of the senior debentures and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest.&#160; We will be required to accrete the senior debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.&#160; Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.&#160; In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestitures of HN (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,064</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,546</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,481</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,034</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,336</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,702</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,358</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,661</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(215</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(329</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(704</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,513</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,680</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,669</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(907</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">998</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,768</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,762</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,362</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,887</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other current asssets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">882</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other noncurrent assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,364</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Long term liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">44</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">954</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">869</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from discontinued operations of HN for the six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,141</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,235</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided to continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,119</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,160</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>Nutra SA Discontinued Operations</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; background-color: #ffffff;">We hold a variable interest in our equity interest in Nutra SA.&#160; Nutra SA&#8217;s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.&#160; We are the primary beneficiary of Nutra SA, and as such, Nutra SA&#8217;s assets, liabilities and results of operations are included in our consolidated financial statements.&#160; In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.&#160; Accordingly, the Nutra SA consolidated results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.&#160; In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.&#160; Other equity holders&#8217; (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,960</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,363</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,064</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,428</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,275</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,949</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(497</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,031</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Goodwill impairment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(357</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(315</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(708</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(692</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(694</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,983</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(694</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,983</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts receivable, net (restricted $363 and $398)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">326</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">398</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,138</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">925</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other current asssets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">373</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Property and equipment, net (restricted $2,508 and $2,599 )</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,249</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,889</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other noncurrent assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,226</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,327</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,892</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,021</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,222</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,290</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,607</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Current maturities of long-term debt (nonrecourse)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,164</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,676</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,976</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the LLC Agreement.&#160; Therefore Nutra SA&#8217;s consolidated cash is classified as held for sale in our consolidated balance sheets.&#160; Nutra SA&#8217;s debt is secured by Irgovel&#8217;s accounts receivable and property.&#160; The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA&#8217;s debt.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash (used) provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,236</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,106</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(156</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided (used) by financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,119</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(815</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of exchange rate changes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">142</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net change in cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(68</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">97</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">104</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">201</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Nutra SA&#8217;s debt consists of the following (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expansion loans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,454</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Working capital lines of credit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Advances on customer export orders</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,482</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Special tax programs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,838</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">107</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">81</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,164</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of June 30, 2017, Irgovel had approximately $3.7 million (USD) of installment payments in arrears.&#160; The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current in the accompanying consolidated balance sheet as of June 30, 2017. As of June 30, 2017, Irgovel had approximately $6.1 million of tax payments in arrears.&#160; All taxes in arrears can be included in a new Brazil tax amnesty program, but to do so, the May 2017 and June 2017 installments (approximately $0.2 million) must be paid. All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.&#160; The fair value of Nutra SA debt (Level 3 measurement) approximates the $7.1 million carrying value of that debt based on the current market rates for similar debt with similar maturities.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying balance sheets, for the three and six months ended June 30, 2017 and 2016 (in thousands) follows.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(224</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in net loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(249</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,508</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,946</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in other comprehensive loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">133</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">278</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors purchase of additional membership interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' average interest in Nutra SA during the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in Nutra SA at the end of the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.&#160; The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).&#160; We may elect to exercise a right of first refusal to purchase the Investors&#8217; interest instead of proceeding to a sale.&#160; We have assessed the likelihood of the Investors exercising these rights as less than probable at June 30, 2017.&#160; We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.&#160; We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">In exchange for the termination of this right, we paid the Investors $0.1 million.</font></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Under the LLC Agreement, the business of Nutra SA is subject to the oversight of a management committee comprised of three of our representatives and two Investor representatives.&#160; Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.&#160; In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of June 30, 2017, there have been no unwaived events of default.&#160; Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are failure of Irgovel to meet minimum annual processing targets or failure to achieve EBITDA on a local currency basis of at least R$4.0 million annually.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of June 30, 2017, there have been no qualifying events.&#160; The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.&#160; Until there is an event of default or a qualifying event, the Investors&#8217; rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.&#160; The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.&#160; However, the Investors do have drag along rights in the future.&#160; We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.</div></div> -778000 0 0 0 778000 0 1000 -0.12 -0.44 -0.72 -0.74 -0.12 -0.72 -0.44 -0.74 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 5. LOSS PER SHARE (EPS)</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.&#160; Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.&#160; The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.&#160; The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.</div><div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and six months ended June 30, 2017 and 2016.</div></div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">NUMERATOR (in thousands):</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic and diluted - loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,774</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,476</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,188</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,033</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock--beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic and diluted - adjusted loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,774</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,476</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,966</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,584</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">DENOMINATOR:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic EPS - weighted average number of common shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,794,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,231,619</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,726,268</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,223,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of dilutive securities outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Diluted EPS - weighted average number of shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,794,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,231,619</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,726,268</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,223,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">595,252</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">353,186</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">395,262</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">355,286</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,460,192</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,842,006</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,547,647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,777,065</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Nonvested stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,217,650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,265,386</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,206,997</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,066,236</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Convertible preferred stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,879,603</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,469,299</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,417,582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Restricted stock unit awards</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">261,111</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">130,556</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The impact of potentially dilutive securities outstanding at June 30, 2017 and 2016, was not included in the calculation of diluted EPS<font style="font-size: 10pt; font-family: 'Times New Roman';"> for the six months ended June 30, 2017</font> and 2016 because to do so would be antidilutive.&#160; Those securities listed in the table above which were antidilutive<font style="font-size: 10pt; font-family: 'Times New Roman';"> for the periods presented</font>, which remain outstanding, could potentially dilute EPS in the future.</div></div> 142000 -38000 -38000 142000 496000 591000 500000 100000 700000 6000000 3800000 0 7851000 0.011 0.011 0.016 0.019 0.006 4600000 2300000 0.73 0.65 0.75 0.64 0.64 2473000 7917000 1527000 678000 4003000 472000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 9. FAIR VALUE MEASUREMENTS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.&#160; As of June 30, 2017, the fair value of our debt (Level 3 measurement) is approximately $4.6 million higher than the $5.9 million carrying value of that debt, based on current market rates for similar debt with similar maturities.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160; Certain assets and liabilities are presented in the financial statements at fair value.&#160; Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.&#160; Assets and liabilities measured at fair value on a non-recurring basis may include property.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:</div><div><br /></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 1 &#8211; inputs include quoted prices for identical instruments and are the most observable.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 2 &#8211; inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 3 &#8211; inputs are not observable in the market and include management&#8217;s judgments about the assumptions market participants would use in pricing the asset or liability.</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of June 30, 2017 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.&#160; The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.&#160; The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.&#160; Additional assumptions that were used to calculate fair value follow.</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 56%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Risk-free interest rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">1.1%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">0.6% -1.9%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.1% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.6% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expected volatility</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">65%-75%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">64%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(73% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(64% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):</div><div><br /></div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 7.2pt; text-indent: -7.2pt;">Total Level 3 Fair Value</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">as of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Beginning of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Period</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Realized and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Gains</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Losses)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Issuance of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">New</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Instruments</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Reclassify to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair Value,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">at End of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Period</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Six Months Ended June 30, 2017, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,121</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Six Months Ended June 30, 2016, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(678</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(852</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,473</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,003</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of June 30, 2017 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):</div><div><br /></div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 7.2pt; text-indent: -7.2pt;">Total Level 3 Fair Value</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">as of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Beginning of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Period</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Realized and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Gains</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Losses)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Issuance of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">New</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Instruments</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Reclassify to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair Value,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">at End of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Period</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Six Months Ended June 30, 2017, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,121</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(472</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Six Months Ended June 30, 2016, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(678</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(852</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,473</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,003</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.</div></td></tr></table></div></div> 1121000 -852000 1598000 0 0 0 0 -1680000 0 0 -1500000 -100000 1985000 1734000 802000 798000 0.06 -0.24 0.07 -0.24 -0.48 -0.51 -0.50 -0.18 117000 304000 -3640000 -4221000 -1651000 998000 -4640000 -5983000 1762000 1000000 1768000 -694000 -0.24 0.06 0.07 -0.24 -5100000 -4940000 -4991000 -2289000 -0.50 -0.51 -0.48 -0.18 -912000 -515000 -907000 -515000 0 0 -1946000 -567000 -248000 -1508000 -4188000 -4033000 -1774000 -4476000 113000 38000 52000 -353000 186000 -824000 16000 -161000 0 -1921000 171000 242000 475000 454000 1530000 1132000 300000 942000 922000 200000 100000 100000 200000 933000 943000 24721000 28926000 41000 44000 41000 44000 16589000 15801000 954000 869000 15676000 14976000 28845000 31581000 0 1527000 0 472000 0 0 1527000 472000 18283000 21362000 4600000 42000 6310000 1725000 5916000 0 589000 5285000 75000 917000 9027000 0 0 3063000 24000 5964000 5892000 300000 1100000 0.357 0.324 -2038000 -1784000 2160000 2119000 -139000 1712000 1943000 3873000 1504000 -247000 -5028000 -3011000 -3504000 -1222000 -6608000 -6308000 -1946000 -1508000 -249000 -567000 1128000 4985000 -6859000 -1222000 -6608000 -4282000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recent accounting standards not yet adopted</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.&#160; Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&#160; An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.&#160; The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.&#160; We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We have not yet selected a transition method but have determined that we will utilize the deferred effective date of January 1, 2018, to adopt the standard.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2016, the FASB issued guidance which changes the accounting for leases.&#160; Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease&#8217;s classification as a finance or operating lease.&#160; For both types of leases, lessees will recognize a right-of-use asset and a lease liability.&#160; For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.&#160; The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.&#160; Early adoption is allowed.&#160; We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recently adopted accounting standards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.&#160; The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.&#160; It is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019.&#160; Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.&#160; We adopted the standard as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.&#160; The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.&#160; In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.&#160; The guidance also allows us to repurchase more of an employee&#8217;s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee&#8217;s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.&#160; The guidance is effective for our annual and interim periods beginning in 2017 with early adoption permitted.&#160; We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.&#160; This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.&#160; Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).&#160; As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.</div></div> -386000 -2117000 -2152000 -420000 -4554000 -2874000 -1869000 -2948000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 1. BASIS OF PRESENTATION</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted.&#160; The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; </font>The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.</div></div> 413000 162000 859000 17000 -58000 0 824000 471000 0 37000 37000 0 4000 0 0 100000 49000 133000 -2000 278000 0 0 49000 162000 113000 0 500000 209000 139000 1989 2685 2000 3000 3000 20000000 2685 1989 988000 0 493000 0 600000 -12000 -9000 3779000 14801000 0 100000 650000 0 18283000 1700000 700000 300000 5518000 5500000 1700000 -4071000 -1470000 -8116000 -8254000 -3504000 -567000 0 0 0 6810000 7025000 -416000 -699000 69000 -224000 -1599000 -567000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 11. RELATED PARTY TRANSACTIONS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.&#160; As of June 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.&#160; See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.&#160; The notes were paid in full in July 2017 from the proceeds of the sale of HN.&#160; In the three months ended June 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the six months ended June 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.</div></div> 3800000 6600000 5963000 500000 200000 7159000 15703000 500000 56000 -264240000 -259819000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT&#8217;S PLAN</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We have improved our cash position since December 31, 2016, as a result of a debt and equity raise in February 2017 and the sale of HN in July 2017.&#160; However, on a consolidated basis, largely as a result of our Nutra SA losses, we continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.&#160; The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).&#160; Consequently, we believe we are adequately funded at this time to allow us to operate and execute on our business strategy for achieving consistent and positive operational cash flows from our remaining US operations.&#160; In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $18.3 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).&#160; We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.&#160; The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Beginning in the second quarter of 2016 and through the second quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.&#160; Due to Irgovel&#8217;s working capital issues, Irgovel did not have the funds necessary to meet scheduled debt payments.&#160; As a result, Irgovel ceased making all bank debt payments in the second and third quarters of 2016.&#160; In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through June 30, 2017.&#160; In 2016, we invested $1.1 million in Nutra SA.&#160; Our board has determined it will no longer contribute any additional funds to Nutra SA.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS</u></div><div><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 19%; vertical-align: bottom;"></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td rowspan="5" valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Attributable to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Non-controlling</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Interest in</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Other Comp-</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">rehensive</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div></td></tr><tr><td colspan="6" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series F</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series G</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nutra SA</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Loss</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, December 31, 2016</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,790,351</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">264,232</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(259,819</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(632</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issuance of common stock awards under equity incentive plans</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">550,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock - beneficial conversion feature</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of senior debenture holder warrants</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of subordinated note holder warrants</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in classification of preferred stock to equity from liability</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in classification of warrants to equity from liability</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Conversion of preferred stock into common stock</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(315</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">220,439</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(64</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">203</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(139</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,124</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of membership interests</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Foreign currency translation</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">162</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net loss</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,504</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,071</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, June 30, 2017</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,685</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,989</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,575,187</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,481</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">274,419</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(264,240</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,233</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,860</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">A summary of warrant activity for the six months ended June 30, 2017, follows.</div><div><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Liability Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,364,110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.77</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,474,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.82</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issued</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,783,163</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.0</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing debenture purchaser warrants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.49</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.5</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing subordinated note holder warants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of anti-dilution clauses:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,489,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Transfer from liability to equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited, expired or cancelled</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, June 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,627,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.03</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable, June 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">19,957,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,627,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.03</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Common Stock</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.&#160; The amount was payable in either cash or stock at the chairman&#8217;s election.&#160; The chairman elected to receive shares of common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.&#160; The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.&#160; The common stock had a fair value at issuance of $0.2 million.&#160; The difference between the fair value of the common stock issued and the carrying amount of the preferred stock was recorded as an increase in accumulated deficit.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the third quarter of 2017, through the date of this filling, we issued 1,834,124 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 397 shares of Series G preferred stock.&#160; The common stock had a fair value at issuance of $1.9 million.&#160; The difference between the fair value of the common stock issued and the $0.6 million carrying amount of the preferred stock was recorded as an increase in accumulated deficit.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Share Sequencing</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">From June 2015 until March 2017, the minority interest holders in Nutra SA could elect </font>to exchange units in Nutra SA for shares of our common stock<font style="font-size: 10pt; font-family: 'Times New Roman';">, the number of common stock and warrants issuable upon this election, was variable and indeterminate.&#160; For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.&#160; Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">issued between June 2015 and March 2017, </font>in temporary equity.&#160; We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants&#8217; fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks&#8217; carrying amount on March 31, 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transactions with Preferred Stock Holders.</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, we issued and sold 2,000 shares of Series G preferred stock.&#160; The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders&#8217; election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.&#160; The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.&#160; If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).&#160; A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.&#160; The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.&#160; On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.&#160; We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transactions with Senior Debenture Holders</u></div><div style="text-align: left;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).&#160; We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.&#160; Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.&#160; We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.&#160; We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.&#160; We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transaction with Subordinated Note Holders</u></div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%&#160; to 7% (ii) an extension of the maturity date of the subordinated notes&#160; to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of&#160; $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.&#160; We accounted for the transaction as an extinguishment of debt and issuance of new debt.&#160; In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock $0.1 million for the change in the fair value of the existing warrants.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Full Ratchet Anti-Dilution</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Equity Incentive Plan</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).&#160; The total shares authorized under the 2014 Plan is now 3,300,000 shares.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Option Issuances</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.&#160; The option vests as to 25,000 shares in August 2017 and the remaining shares vest in monthly installments through August 2020 and had a grant date fair value of $0.56 per share.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees.&#160; The options vest in four equal annual installments beginning in the second quarter of 2018 at an average exercise price of $0.85 per share and had a grant date fair value of $0.62 per share.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Restricted Stock Unit Awards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.&#160; The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.&#160; Each RSU&#8217;s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.&#160; The shares had a grant date fair value of $188 thousand which will be expensed ratably over a 3.5-year period beginning in July 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Warrants</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.&#160; We issued 103,008 shares of common stock to the holder in a cashless transaction.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes information related to outstanding warrants as June 30, 2017 and December 31, 2016:</div><div><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Range of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise Prices</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Type of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrant</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,947,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50 to $1.60</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)(2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,789,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.52</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25 to $5.87</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,156,670</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.33</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,296,339</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.55 to $16.80</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.0</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,460,192</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.17</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.53</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,838,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.30</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets.&#160; Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.&#160; In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(2)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.&#160; Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(3)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.</div></td></tr></table></div></div> 0.6 0.1 0.3 3146000 3233000 6761000 6499000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes current and long-term portions of debt (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior debentures, net, maturing in February 2019, principal $6.6 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Subordinated notes, net, maturing in May 2019, principal $5.9 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,285</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,310</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior revolving loan</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Senior term loan, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,916</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,027</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 66%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Long-term portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,892</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,964</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.&#160; Additional assumptions that were used to calculate fair value follow.</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 56%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Risk-free interest rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">1.1%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">0.6% -1.9%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.1% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.6% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expected volatility</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">65%-75%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">64%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(73% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(64% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and six months ended June 30, 2017 and 2016.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">NUMERATOR (in thousands):</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic and diluted - loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,774</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,476</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,188</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,033</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock--beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic and diluted - adjusted loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,774</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,476</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,966</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,584</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">DENOMINATOR:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Basic EPS - weighted average number of common shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,794,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,231,619</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,726,268</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,223,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of dilutive securities outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Diluted EPS - weighted average number of shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,794,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,231,619</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,726,268</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,223,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">595,252</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">353,186</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">395,262</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">355,286</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,460,192</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,842,006</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,547,647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,777,065</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Nonvested stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,217,650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,265,386</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,206,997</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,066,236</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Convertible preferred stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,879,603</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,469,299</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,417,582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Restricted stock unit awards</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">261,111</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">130,556</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 19%; vertical-align: bottom;"></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td rowspan="5" valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Attributable to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Non-controlling</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Interest in</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Other Comp-</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">rehensive</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" rowspan="5" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" rowspan="5" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td colspan="10" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div></td></tr><tr><td colspan="6" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series F</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series G</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nutra SA</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Loss</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, December 31, 2016</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,790,351</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">264,232</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(259,819</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(632</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issuance of common stock awards under equity incentive plans</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">550,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock - beneficial conversion feature</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of senior debenture holder warrants</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of subordinated note holder warrants</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in classification of preferred stock to equity from liability</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in classification of warrants to equity from liability</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;">-</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Conversion of preferred stock into common stock</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(315</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">220,439</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(64</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">203</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(139</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,124</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of membership interests</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Foreign currency translation</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">162</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net loss</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,504</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,071</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 19%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, June 30, 2017</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,685</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,989</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 5.79%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,575,187</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,481</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">274,419</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(264,240</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 0.78%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,233</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 6%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,860</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">A summary of warrant activity for the six months ended June 30, 2017, follows.</div><div><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Liability Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,364,110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.77</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,474,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.82</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issued</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,783,163</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.0</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing debenture purchaser warrants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.49</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.5</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing subordinated note holder warants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of anti-dilution clauses:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,489,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Transfer from liability to equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited, expired or cancelled</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, June 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,627,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.03</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable, June 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">19,957,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,627,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.03</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the <font style="font-size: 10pt; font-family: 'Times New Roman';">six months ended June 30, 2017</font> and 2016.</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Revenue</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Accounts Receivable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Customer</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Customer 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">63</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">71</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: bottom; padding-bottom: 4px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div>&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: bottom;">* Less than 10%</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the <font style="font-size: 10pt; font-family: 'Times New Roman';">six months ended June 30, 2017</font> and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Purchases</div>Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Supplier</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Supplier 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">89</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">85</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div>&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td colspan="9" valign="bottom" style="width: 26%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">* Less than 10%</div></td></tr></table></div></div> 4933000 2667000 3676000 6288000 654000 477000 0.76 0.85 P3Y3M18D P3Y10M24D P2Y4M24D P0Y8M12D P0Y6M P4Y2M12D P2Y2M12D P1Y3M18D P0Y P0Y P0Y4M24D P2Y8M12D P0Y P4Y7M6D P0Y P0Y P2Y P4Y7M6D P3Y6M11D P0Y P0Y P3Y7M6D P2Y10M24D P1Y6M P3Y P4Y 0 0 0 0 355500 100000 1700000 6364110 4474868 20832273 2627919 0 11783163 3300000 96372 345205 0.90 0.62 0.56 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 4. RECENT ACCOUNTING GUIDANCE</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recent accounting standards not yet adopted</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.&#160; Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&#160; An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.&#160; The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.&#160; We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We have not yet selected a transition method but have determined that we will utilize the deferred effective date of January 1, 2018, to adopt the standard.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2016, the FASB issued guidance which changes the accounting for leases.&#160; Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease&#8217;s classification as a finance or operating lease.&#160; For both types of leases, lessees will recognize a right-of-use asset and a lease liability.&#160; For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.&#160; The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.&#160; Early adoption is allowed.&#160; We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recently adopted accounting standards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.&#160; The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.&#160; It is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019.&#160; Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.&#160; We adopted the standard as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.&#160; The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.&#160; In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.&#160; The guidance also allows us to repurchase more of an employee&#8217;s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee&#8217;s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.&#160; The guidance is effective for our annual and interim periods beginning in 2017 with early adoption permitted.&#160; We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.&#160; This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.&#160; Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).&#160; As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.</div></div> 0 0 550273 108696 -64000 -139000 0 0 0 203000 1900000 1175000 103008 220439 -315 -11 1834124 2186 397 613000 0 0 0 0 613000 100000 0 0 0 43000 0 43000 6860000 -632000 -699000 0 -4346000 -259819000 264232000 1481000 -4233000 -264240000 -567000 274419000 7900000 -36000 0 0 14124 -100000 -900000 3000 0 551000 778000 0 551000 0 3000 20000000 0 551000 -1663000 -852000 22000 1121000 1100000 9794405 9231619 9223651 9726268 9231619 9223651 9794405 9726268 0 0 0 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 12. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders&#8217; equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders&#8217; equity for continued listing<font style="font-size: 10pt; font-family: 'Times New Roman';"> pursuant to Nasdaq Listing Rule 5550(b)(1)</font>.&#160; As of June 30, 2016, we reported stockholders&#8217; deficit of $36,000.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We submitted our plan to regain compliance in October 2016.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">On November 15, 2016, based on information we submitted to Nasdaq, the Staff granted us the maximum allowable 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders&#8217; equity requirement.&#160; On February 16, 2017, we received a determination letter from the Nasdaq Listing Qualifications Staff stating that we had not regained compliance with the minimum stockholders&#8217; equity requirement.&#160; The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.</font></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; background-color: #ffffff;">We requested and were granted a hearing before the panel to appeal the Letter on March 30, 2017.&#160; After that hearing, o<font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">n April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million.&#160; We must also at that time provide the panel with updated projections showing stockholders&#8217; equity through May 2018. As reported herein our equity is $7.9 million and exceeds the minimum as of March 31, 2017.</font></div><div style="background-color: #ffffff;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2).&#160; </font>Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum price of $1.00 for 10 consecutive business days.&#160; Nasdaq rules allow for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">If this appears unlikely as September 6, 2017, approaches, we are committed to taking actions that would enable us to regain compliance, including, if necessary, completing a reverse split of our common stock to increase its share price above the $1 minimum bid price.</font></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.</div></div> P10D P10D 1.0 1.0 P180D P180D 2500000 0.43 3024000 3024000 0 0 -68000 97000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the initial distribution of proceeds (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Purchase price, net of assumed liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,283</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Estimated expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(934</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net proceeds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">17,349</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of senior debentures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,600</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of subordinated debt and related interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,963</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Repayment of other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">56</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Escrow for working capital adjustments</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">225</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Escrow for indemnity claims</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">550</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,394</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Nutra SA&#8217;s debt consists of the following (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expansion loans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,454</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Working capital lines of credit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Advances on customer export orders</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,482</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Special tax programs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,838</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">107</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">81</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,164</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,362</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,887</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other current asssets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">882</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other noncurrent assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,364</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Long term liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">44</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">954</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">869</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts receivable, net (restricted $363 and $398)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">326</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">398</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,138</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">925</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other current asssets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">373</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Property and equipment, net (restricted $2,508 and $2,599 )</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,249</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,889</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other noncurrent assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,226</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,327</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,892</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,021</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,222</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,290</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,607</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Current maturities of long-term debt (nonrecourse)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,164</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,676</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,976</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying balance sheets, for the three and six months ended June 30, 2017 and 2016 (in thousands) follows.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(224</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in net loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(249</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,508</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,946</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in other comprehensive loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">133</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">278</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors purchase of additional membership interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' average interest in Nutra SA during the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in Nutra SA at the end of the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from discontinued operations of HN for the six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,141</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,235</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided to continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,119</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,160</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash (used) provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,236</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,106</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(156</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided (used) by financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,119</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(815</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of exchange rate changes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">142</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net change in cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(68</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">97</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">104</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">41</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">201</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestitures of HN (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,064</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,546</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,481</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,034</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,336</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,702</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,358</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,661</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(215</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(329</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(704</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,513</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,680</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,669</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(907</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">998</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,768</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,762</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and six months ended June 30, 2017 and 2016 (in thousands).</div><div><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,960</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,363</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,064</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,428</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,275</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,949</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(497</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,031</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Goodwill impairment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(357</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(315</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(708</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(692</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(694</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,983</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(694</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,640</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,983</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div></div> -567000 -699000 4000000 4000000 -1774000 -4966000 -4584000 -4476000 550000 17349000 P5Y 934000 225000 13394000 4000000 3700000 81000 107000 6816000 7164000 647000 2454000 2838000 2767000 1090000 401000 1113000 2482000 6100000 200000 2 3 50000000 3 100000 2 0.324 0.358 0.354 0.321 1747000 2554000 7200000 876000 1763000 398000 363000 2508000 2599000 0.96 P0Y9M18D 5.49 P5Y P4Y9M18D P4Y9M18D 9027 7035 1.82 5.77 1.03 2.32 1.52 0 6.61 2.00 5.36 6.61 0 2.17 1.30 0 5.33 1.60 0.96 0.96 0 0 0 0.96 0 2.00 5.25 1.03 2.38 8333 10000 5.25 1.50 0.96 0.96 1.16 1.16 P2Y1M6D P3Y10M24D P0Y8M12D P3Y3M18D P5Y6M 289669 0 2627919 19957273 -14468163 14468163 875000 0 0 1489868 2327919 0 P3Y3M18D 0.96 P0Y9M18D 0 875000 0 289669 289669 875000 100000 100000 4 1000000 25000 5.49 1200000 800000 P2Y1M6D P5Y6M 1545000 0 0 0 0 1545000 0 2000 3000 0 0 650000 0 650000 0 7851000 0 7851000 0 0 0 0 0 582000 0 0 582000 0 0 0 117000 0 117000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes information related to outstanding warrants as June 30, 2017 and December 31, 2016:</div><div><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Range of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise Prices</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Type of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrant</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,947,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50 to $1.60</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)(2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,789,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.52</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25 to $5.87</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,156,670</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.33</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,296,339</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.55 to $16.80</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.0</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,460,192</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.17</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.53</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,838,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.30</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets.&#160; Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.&#160; In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(2)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.&#160; Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(3)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.</div></td></tr></table></div></div> 1 5.87 1.50 0.96 5.25 0.96 16.80 1.60 2.00 2.00 P3Y6M 0.98 188000 P65D 15.00 10.00 5.00 2 1.50 6.55 5.25 The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017. Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision. Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant. Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets. Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants. In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock. Less than 10% Included in change in fair value of derivative warrant liabilities in our unaudited condensed consolidated statements of operations. EX-101.SCH 6 ribt-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - RECENT ACCOUNTING GUIDANCE link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - LOSS PER SHARE (EPS) link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - CONCENTRATIONS OF RISK link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS link:presentationLink link:calculationLink link:definitionLink 070400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - LOSS PER SHARE (EPS) (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - CONCENTRATIONS OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) link:presentationLink link:calculationLink link:definitionLink 090204 - Disclosure - DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 090206 - Disclosure - DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 090208 - Disclosure - DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 090210 - Disclosure - DISCONTINUED OPERATIONS, Components of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 090212 - Disclosure - DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - LOSS PER SHARE (EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - CONCENTRATIONS OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090802 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090804 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 090806 - Disclosure - EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 090902 - Disclosure - FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ribt-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ribt-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ribt-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity [Domain] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Legal Entity [Axis] Document Type Award Type [Axis] RECENT ACCOUNTING GUIDANCE [Abstract] Accounts Receivable [Member] Accounts payable Accounts receivable, net of allowance for doubtful accounts of $8 and $12 Interest accreted Accrued expenses Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Adjustments to reconcile net loss to net cash used in operating activities of discontinued operations: Accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Antidilutive Securities [Axis] Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Total assets Assets Total assets held for sale Disposal Group, Including Discontinued Operation, Assets ASSETS Assets [Abstract] Current assets held for sale Current assets: Total current assets Assets, Current Board of Directors Chairman [Member] Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and Cash Equivalents, at Carrying Value Net change in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Net cash provided (used) by financing activities Net cash provided by (used in) financing activities of discontinued operations Cash Provided by (Used in) Financing Activities, Discontinued Operations Net cash used in investing activities Net cash used in investing activities of discontinued operations Net cash (used) provided by operating activities Net cash provided by operating activities of discontinued operations Chief Executive Officer [Member] Warrants to purchase shares of common stock (in shares) Shares under warrants, outstanding (in shares) Class of Warrant or Right [Axis] Class of Stock [Domain] Exercise price per warrant (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right [Domain] Variable Interest Entity, Classification [Domain] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Commitments and contingencies Commitments and Contingencies COMMITMENTS AND CONTINGENCIES [Abstract] Common Stock [Member] Common stock, shares issued (in shares) Aggregate subscription amount Common Stock, Value, Subscriptions Common stock, par value (in dollars per share) Common stock, shares authorized (in shares) Increase in authorized number of shares of common stock (in shares) Common stock, no par value, 50,000,000 shares authorized, 11,575,187 and 10,790,351 shares issued and outstanding Common Stock, Value, Issued Common stock, shares outstanding (in shares) Balance at end of period (in shares) Balance at beginning of period (in shares) Total comprehensive loss attributable to RiceBran Technologies shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Less - Comprehensive loss attributable to noncontrolling interest, net of tax Comprehensive loss, net of tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Concentration Risk Benchmark [Axis] Concentration Risk Type [Axis] CONCENTRATIONS OF RISK Concentration Risk [Line Items] Concentration Risk Benchmark [Domain] Concentration Risk [Table] Concentration Risk Type [Domain] Concentration risk, percentage Preferred shares converted into common stock (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Cost of goods sold Credit Facility [Axis] Credit Facility [Domain] Customer Concentration Risk [Member] Debt Instrument [Line Items] Preferred stock conversion ratio to common stock Debt conversion amount DEBT Debt Disclosure [Text Block] Expiration August, 2021 [Member] Debt Instrument, Redemption, Period Two [Member] Debt Instrument, Redemption, Period [Axis] DEBT [Abstract] Debt conversion, stock (in shares) Debt Instrument, Redemption, Period [Domain] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Carrying value of debt Long-term Debt, Gross Expiration January, 2021 [Member] Debt Instrument, Redemption, Period One [Member] Variable interest rate Aggregate principal amount Face value of debentures upon extinguishment Debt Instrument, Name [Domain] Payment of note principal Debt Instrument, Periodic Payment, Principal Payment of accrued note interest Debt Instrument, Periodic Payment, Interest Annual interest rate Maturity date of note Effective interest rate Debt issuance cost Debt Issuance Costs, Net Deferred tax liability Depreciation and amortization Derivative Warrant Liabilities [Member] Derivative warrant liabilities Halpern [Member] Director [Member] Directors [Member] EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract] Gain on sale of business Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Income taxes Discontinued Operation, Tax Effect of Discontinued Operation Income (loss) from discontinued operations, before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax DISCONTINUED OPERATIONS [Abstract] Tax provision for gain on sale of business Cost of goods sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Intangible Revenues Disposal Group Classification [Domain] Selling, general and administrative expenses Disposal Group, Including Discontinued Operation, General and Administrative Expense Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract] Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and cash equivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Other current assets held for sale Disposal Group Classification [Axis] Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Income (Loss) from Discontinued Operations [Abstract] Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Other expense Disposal Group, Including Discontinued Operation, Other Expense Other noncurrent assets held for sale Accrued expenses Disposal Group, Including Discontinued Operation, Accrued Liabilities Noncurrent assets held for sale Disposal Group, Including Discontinued Operation, Assets, Noncurrent Property and equipment, net Inventories Accounts receivable, net Disposal Group Name [Domain] DISCONTINUED OPERATIONS Dividend on preferred stock - beneficial conversion feature Dividends, Preferred Stock Preferred stock, dividend Basic earnings (loss) per common share: Diluted earnings (loss) per common share: Basic loss per common share - RiceBran Technologies (in dollars per share) Earnings Per Share, Basic Diluted loss per common share - RiceBran Technologies (in dollars per share) Earnings Per Share, Diluted Weighted average number of shares outstanding: LOSS PER SHARE (EPS) Earnings Per Share [Text Block] LOSS PER SHARE (EPS) [Abstract] Effect of exchange rate changes on cash and cash equivalents of discontinued operations Effect of exchange rate changes Accrued salary, wages and benefits Employee-related Liabilities, Current Stock Options [Member] Employee Stock Option [Member] Equity Component [Domain] Fair value increase in common stock Extinguishment of term loan Extinguishment of debt Reclassify to (Deficit) Equity Risk-free interest rate Additional assumptions used to calculate fair value [Abstract] Fair value of derivative warrant liabilities Fair Value Adjustment of Warrants Fair Value, Hierarchy [Axis] Measurement Frequency [Axis] FAIR VALUE MEASUREMENTS [Abstract] Expected volatility Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Measurement Frequency [Domain] Recurring [Member] Fair Value, Measurements, Recurring [Member] Issuance of New Instruments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, at End of Period Fair Value as of Beginning of Period Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair Value Hierarchy [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Fair values by input hierarchy of items measured at fair value on a recurring basis Level 3 [Member] Level 1 [Member] Level 2 [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Changes in level 3 items measured at fair value on a recurring basis [Roll Forward] Changes in level 3 items measured at fair value Total Realized and Unrealized Gains (Losses) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Financial Instrument [Axis] Gain on resolution of Irgovel purchase litigation Gain on resolution of Irgovel purchase litigation Gain (Loss) Related to Litigation Settlement Loss on extinguishment of debt Loss on extinguishment of debt Gross profit Gross Profit Discontinued operations (in dollars per share) Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Income (loss) from discontinued operations Income (loss) from discontinued operations, net of tax Income (loss) from discontinued operations, net of tax Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Continuing operations (in dollars per share) Income tax benefit Income Tax Expense (Benefit) Condensed Consolidated Statements of Operations (Unaudited) [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Cash paid for income taxes Less - Net loss attributable to noncontrolling interest in discontinued operations Basic and diluted - loss from continuing operations Loss from continuing operations Loss from continuing operations Accounts receivable Increase (Decrease) in Accounts Receivable Other Increase (Decrease) in Other Current Assets Accounts payable and accrued expenses Inventories Increase (Decrease) in Inventories Changes in operating assets and liabilities: Change in restricted cash Increase (Decrease) in Restricted Cash Increase (Decrease) in Stockholders' Equity [Roll Forward] Intangible assets, net Interest expense Interest Expense Interest expense debt Interest Expense, Debt Cash paid for interest Interest paid Inventories Inventory, Net Investors [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Total liabilities Liabilities Noncurrent liabilities held for sale Long term liabilities Current liabilities held for sale Total liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Total liabilities, temporary equity and equity (deficit) Liabilities and Equity LIABILITIES, TEMPORARY EQUITY AND EQUITY (DEFICIT) Total liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract] Total current liabilities Liabilities, Current Current liabilities: Line of Credit Facility [Abstract] Fair value of debt Long-term Debt, Fair Value Total debt Carrying value of debt Long-term Debt Current maturities of long-term debt Current portion Long-term Debt, Current Maturities Long-term debt, less current portion Long-term portion Contingent liability Loss Contingencies [Table] Loss Contingencies [Line Items] Litigation [Abstract] Loss Contingency, Information about Litigation Matters [Abstract] Damages sought by plaintiff Customers [Axis] Maximum [Member] Minimum [Member] Investors' interest in Nutra SA at the end of the period Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling Interest [Table] Noncontrolling Interest [Line Items] Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Customer [Domain] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net cash provided to continuing operations Net Cash Provided by (Used in) Discontinued Operations Net Cash Provided by (Used in) Discontinued Operations [Abstract] Net cash (used in) provided by investing activities of continuing operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash provided by financing activities of continuing operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash flows from financing activities: Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Net cash used in operating activities of continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from investing activities: Cash flow from operating activities: NUMERATOR [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Net loss attributable to RiceBran Technologies shareholders Net Income (Loss) Attributable to Parent Investors' interest in net loss of Nutra SA Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net loss attributable to RiceBran Technologies common shareholders Net Income (Loss) Available to Common Stockholders, Basic New Accounting Pronouncements or Change in Accounting Principle [Table] RECENT ACCOUNTING GUIDANCE New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Total other income (expense) Nonoperating Income (Expense) Other income (expense): Other [Member] Notes Payable, Other Payables [Member] Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Loss from operations Operating Income (Loss) BASIS OF PRESENTATION [Abstract] BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other comprehensive income - foreign currency translation, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Irgovel - Events of Default [Abstract] Other Commitments [Abstract] Other Other Noncash Income (Expense) Deposits and other current assets Other income Other expense Other Nonoperating Expense Investors' interest in other comprehensive loss of Nutra SA Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Foreign currency translation Placement fees and allocation expenses Purchases of property Payments to Acquire Property, Plant, and Equipment Plan Name [Domain] Plan Name [Axis] Convertible preferred stock, shares issued (in shares) Preferred stock issued (in shares) Preferred Stock [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Convertible preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Preferred stock Carrying value of preferred stock Other Proceeds from issuance of debt, net of issuance costs Investors purchase of additional membership interest Proceeds from Noncontrolling Interests Purchase price, net of assumed liabilities Cash proceeds from sale of business, net of expenses Minority partner contribution amount Proceeds from issuance of debt and warrants, net of issuance costs Proceeds from issuance of debt and warrants, net of issuance costs Net proceeds from the exchange of subordinated notes Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Property and equipment, net Property, Plant and Equipment, Net Range [Axis] Range [Domain] Redeemable noncontrolling interest in Nutra SA, end of period Redeemable noncontrolling interest in Nutra SA, beginning of period Redeemable Noncontrolling Interest, Equity, Carrying Amount RELATED PARTY TRANSACTIONS Related Party [Domain] Related Party Transaction [Line Items] Related Party [Axis] RELATED PARTY TRANSACTIONS [Abstract] Repayment of debt Repayments of Long-term Debt Repayment of senior debentures Repayments of Senior Debt Repayment of subordinated debt and related interest Repayment of subordinated note Repayments of Subordinated Debt Payments of debt Repayment of debt Repayment of other liabilities Repayments of Other Debt Restricted Stock Unit Awards [Member] Restricted Stock Award [Member] Nonvested Stock [Member] Restricted Stock [Member] Accumulated Deficit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Senior Revolving Loan [Member] Revolving Credit Facility [Member] CONCENTRATIONS OF RISK [Abstract] LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Substantial Doubt about Going Concern [Text Block] EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Shareholders' Equity and Share-based Payments [Text Block] Vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Revenues Sales Revenue, Goods, Net Revenue [Member] Forecast [Member] Scenario, Unspecified [Domain] Current and long-term debt Schedule of Debt [Table Text Block] Additional assumptions used to calculate fair value Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Reconciliations of numerators and denominators in EPS computations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of equity activity Summary of warrant activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Concentrations of risk Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Senior Debentures, Net [Member] Senior Secured Debt [Member] Geographical [Domain] Discontinued Operations [Member] Selling, general and administrative expenses Senior Term Loan, Net [Member] Senior Notes [Member] Series F Convertible Preferred Stock [Member] Series F Convertible Preferred Stock [Member] Series F Preferred Stock [Member] Series G Convertible Preferred Stock [Member] Series G Preferred Stock [Member] Equity and Liability Warrants, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Stock and share-based compensation Granted exercise price (in dollars per share) Outstanding, weighted average remaining contractual life Weighted average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Shares Under Warrants [Roll Forward] Award vesting period Forfeited, expired or cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Increase in common shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Number of shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Equity Award [Domain] Grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Supplier [Axis] Exercise Price Range [Axis] RECENT ACCOUNTING GUIDANCE Class of Stock [Axis] Statement [Line Items] Equity Components [Axis] Condensed Consolidated Statements of Cash Flows (Unaudited) [Abstract] Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) [Abstract] Statement [Table] Condensed Consolidated Balance Sheets (Unaudited) [Abstract] Scenario [Axis] Geographical [Axis] Issuance of common stock awards under equity incentive plans (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Common stock issued for former employee (in shares) Stock Issued During Period, Shares, Issued for Services Conversion of preferred stock into common stock Fair value of common stock issued Stock Issued During Period, Value, Conversion of Convertible Securities Common stock issued (in shares) Conversion of preferred stock into common stock (in shares) Number of preferred stock for conversion (in shares) Preferred shares converted into common stock (in shares) Issuance of common stock awards under equity incentive plans Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Cash paid in lieu of bonus Other Stockholders' Equity, Other Equity (deficit): Equity (deficit) attributable to RiceBran Technologies shareholders: Equity (deficit) attributable to RiceBran Technologies shareholders: Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity (deficit) Total equity (deficit) attributable to RiceBran Technologies shareholders Balance at beginning of period Balance at end of period Other (in shares) Stockholders' Equity, Other Shares Decrease in subordinated debt Subordinated Notes [Member] Subordinated Notes, Net [Member] Subordinated Debt [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Supplemental disclosures: Supplier Concentration Risk [Member] Convertible preferred stock, shares issued (in shares) Dividend on preferred stock--beneficial conversion feature Less - Dividends on preferred stock--beneficial conversion feature Total temporary equity Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Temporary Equity Temporary Equity [Abstract] Convertible preferred stock, shares outstanding (in shares) Preferred stock, shares authorized (in shares) Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding Relationship to Entity [Domain] Title of Individual [Axis] Financial Instruments [Domain] Change in fair value of derivative warrant liabilities Change in fair value of derivative warrant and conversion liabilities Unrealized Gain (Loss) on Derivatives Vesting [Domain] Vesting [Axis] Variable Interest Entities [Axis] Investments in variable interest entity Variable Interest Entity, Financial or Other Support, Amount Nutra SA [Member] Variable Interest Entity, Primary Beneficiary [Member] Warrants [Member] Warrant [Member] Warrants [Member] Warrants Not Settleable in Cash [Member] Diluted (in shares) Diluted EPS - weighted average number of shares outstanding (in shares) Weighted Average [Member] DENOMINATOR [Abstract] Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (in shares) Basic EPS - weighted average number of common shares outstanding (in shares) Effect of dilutive securities outstanding (in shares) Brazil [Member] BRAZIL FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Abstract] The entire disclosure pertaining to the entity's compliance with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1). FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Text Block] FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Schedule of quantitative and qualitative information pertaining to comply with NASDAQ listing requirements. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Table [Table] FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Line Items] Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 for 10 consecutive business days. Nasdaq Compliance, Minimum Bid Price Requirement, Number of Consecutive Business Days Number of consecutive business days under minimum bid requirement The Nasdaq Stock Market LLC ("Nasdaq"), under Nasdaq Listing Rule 5550(a)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum bid price for ten consecutive business days. Nasdaq Compliance, Minimum Bid Price Requirement Nasdaq minimum bid price requirement (in dollars per share) A period of time that the Nasdaq may grant an entity that has failed to comply with the Nasdaq Capital Market required minimum level of stockholders' equity for continued listing under the Nasdaq Listing Rule 5550(b)(1). The period is measured in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Nasdaq Compliance, Minimum Stockholders' Equity Requirement, Grant Extension Period Nasdaq grant of extension period to regain compliance under minimum stockholders' equity requirement A period of time that the Nasdaq may grant an entity that has failed to comply with the Nasdaq Capital Market required minimum bid price for continued listing under the Nasdaq Listing Rule 5550(a)(2). The period is measured in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Nasdaq Compliance, Minimum Bid Price Requirement, Grant Extension Period Nasdaq grant of extension period to regain compliance under minimum bid requirement The Nasdaq Stock Market LLC ("Nasdaq"), under Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain a minimum amount of stockholders' equity to maintain continued listing. Minimum Stockholders Equity Requirement for Nasdaq Capital Market Listing Nasdaq minimum stockholders' equity listing requirement Refers to the percentage of outstanding debt of the entity held by a related party. Percentage of Outstanding Debt Held by Related Party Percentage of outstanding debt retained by related party Amount of goodwill impairment attributable to disposal group, including, but not limited to, discontinued operations. Disposal Group Including Discontinued Operations Goodwill Impairment Goodwill impairment Refers to the disposed or discontinued entity. Healthy Natural Inc [Member] HN [Member] Refers to the disposed or discontinued entity. Nutra SA [Member] Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net change in cash and cash equivalents Tabular disclosure for initial distribution of proceeds of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Initial Distribution of Proceeds [Table Text Block] Initial distribution of proceeds Tabular disclosure of information related to components of debt from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Components of Debt [Table Text Block] Components of debt Tabular disclosure of information related to major classes of assets and liabilities classified as held for sale from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Assets and Liabilities Classified as Held for Sale [Table Text Block] Assets and liabilities classified as held for sale Tabular disclosure of changes redeemable noncontrolling interest reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations of a disposal group. Disposal Groups Including, Discontinued Operations, Summary of Changes in Redeemable Noncontrolling Interest [Table Text Block] Summary of changes in redeemable noncontrolling interest in discontinued operations Tabular disclosure of information related to cash flows from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Cash Flows from Discontinued Operations [Table Text Block] Cash flows from discontinued operations Tabular disclosure of information related to income (loss) from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary Of Income (Loss) from Discontinued Operations [Table Text Block] Income (loss) from discontinued operations The cumulative amount of the reporting entity's undistributed earnings or deficit attributable to noncontrolling interest in discontinued operations. Retained Earnings (Accumulated Deficit) Attributable to Noncontrolling Interest in Discontinued Operations Accumulated deficit attributable to noncontrolling interest in discontinued operation The EBITDA that must be achieved to prevent default status. EBITDA triggering default status A subsidiary Industrial Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil, which manufactures RBO and DRB products for both the human and animal food markets in Brazil and internationally. Irgovel [Member] Net income after adjustments for dividends on preferred stock. Net Income (Loss) Available to Common Stockholders, Basic and Diluted After Dividend on Preferred Stock Basic and diluted - adjusted loss from continuing operations Temporary equity that may be exchanged into common shares or other types of securities at the owner's option. Temporary Equity Stock [Member] Convertible Preferred Stock [Member] A major external customer. Fourth customer [Member] Customer 4 [Member] A major external customer. Fifth customer [Member] Customer 5 [Member] A major external customer. Customer 2 [Member] Customer 2 [Member] A major external customer. Customer 3 [Member] Customer 3 [Member] Purchases during the period in the normal course of business after deducting returns, allowances and discounts, when it serves as a benchmark in a concentration of risk calculation. Purchases [Member] A major external customer. Other Customers [Member] Others [Member] A major supplier. Supplier 5 [Member] Supplier 5 [Member] A major supplier. Supplier 4 [Member] Supplier 4 [Member] A major supplier. Supplier 2 [Member] Supplier 2 [Member] A major supplier. Supplier 3 [Member] Supplier 3 [Member] Major other suppliers. Other Suppliers [Member] Others [Member] A major supplier. Supplier 1 [Member] Supplier 1 [Member] A major external customer. Customer 1 [Member] Customer 1 [Member] Initial Distribution of Proceeds [Abstract] Refers to an escrow account established for indemnity claims. Escrow for Indemnity Claims Escrow for indemnity claims The net cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period after certain expenses and costs related to the disposal of the discontinued operations. Disposal Group Including Discontinued Operations Net proceeds Net proceeds Refers to the period of customary indemnification provisions and provisions that restrict the entity from engaging in a business conducted by disposed of or sold entity. Disposal Group, Discontinued Operations, Restriction Period to Engage in Business Conducted by Sold Entity Restriction period to engage in business conducted by sold entity Refers to estimated expenses related to the disposal of discontinued operations. Disposal Group Including Discontinued Operations Estimated expenses Estimated expenses Refers to an escrow account established for working capital adjustments. Escrow for Working Capital Adjustments Escrow for working capital adjustments Refers to total distribution of proceeds for repayments of obligations and funding escrow accounts as part of a divestiture of businesses. Divestiture of Businesses, Distribution of Proceeds for Repayments of Obligations and Escrow Accounts Total distribution of proceeds Refers to the carrying value of discontinuing operations. Disposal Group Discontinued Operations Carrying Value Net carrying value of discontinued operations Amount classified as installment payments in arrears attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Installment Payments in Arrears Installment payments in arrears Disposal Group Including Discontinued Operation Components of Debt [Abstract] Components of Debt [Abstract] Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations classified as other debt, due within one year or the normal operating cycle, if longer, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Other Debt, Current Other Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Long Term Debt, Current Total debt Current maturities of long-term debt (nonrecourse) Amount classified as capital expansion loans attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Capital Expansion Loans Capital expansion loans The carrying value as of the balance sheet date of the current portion of special tax programs attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Special Tax Programs Current Special tax programs The carrying value as of the balance sheet date of the current portion of long-term obligations attributable to disposal group held for sale or disposed of drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Disposal Group Including Discontinued Operations Lines of Credit, Current Working capital lines of credit The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from advances on customer export orders attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Advances on Customer Export Orders, Current Advances on customer export orders Amount of tax payment in arrears attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Income Tax Payment Arrears Tax payments in arrears Amount of export installment payments attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Export Installment Payments Export installment payments Represents the number of investors on the management committee, which oversees the manager under the LLC agreement. Number of Investors on Management Committee Number of Investors on Management Committee Represents the number of representatives on the management committee upon an event of default or a qualifying event under the LLC agreement. Number of representatives on management committee upon default Number of representatives on management committee upon default The amount of a Nutra SA initial public offering that would trigger the termination of Drag Along rights which would allow the Investors to force the sale of all Nutra SA assets. Drag Along Right termination amount Drag along right, amount of initial public offering Represents the number of representatives on the management committee, which oversees the manager under the LLC agreement. Number of representatives on management committee Number of representatives on management committee The amount paid to investors in exchange for the termination of rights. The rights relate to an agreement in which investors have a right to elect to exchange units in a variable interest entity of the parent entity for common stock of the parent entity. Amount Paid In Exchange for Termination of Rights Amount paid exchange for termination of rights Represents the number of investors on the management committee upon an event of default or a qualifying event under the LLC agreement. Number of Investors on Management Committee Upon Default Number of investors on management committee upon default The average equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. Average Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Investors' average interest in Nutra SA during the period Proceeds from issuance of stock which is not included within permanent equity net of issuance costs. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Proceeds from Issuance of Temporary Equity, and Warrants, Net Proceeds from issuance of preferred stock and warrants, net of issuance costs Proceeds from preference stock and warrants Refers to cash outflows associated with cash provided by discontinued operations. Cash Provided By Discontinued Operations Cash provided by discontinued operations Document and Entity Information [Abstract] This element represents domestic or foreign debt that matures in May 2019. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets. Debt Due May 2019 [Member] Maturity Due May 2019 [Member] This element represents domestic or foreign debt that matures in February 2019. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets. Debt Due February 2019 [Member] Maturity Due February 2019 [Member] Amount classified as accounts receivable restricted, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Accounts Receivable Restricted Accounts receivable restricted Amount classified as property, plant and equipment restricted, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Property Plant and Equipment Restricted Property and equipment restricted A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward] Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing debenture purchaser warrants after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants Of Weighted Average Exercise Price, After Repricing Impact of repricing debenture purchaser warrants, After repricing (in dollars per share) Weighted average remaining contractual term for equity-based awards excluding options equity instruments impact of anti dilution clauses prior to impact, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Impact Of Anti Dilution Clauses Weighted Average Remaining Contractual Terms, Prior to Impact Impact of anti-dilution clauses, Prior to impact Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing debenture purchaser warrants prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants Of Weighted Average Exercise Price, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing (in dollars per share) Weighted average remaining contractual term for equity-based awards excluding options issued, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options, Issued, Weighted Average Remaining Contractual Terms Issued Weighted average remaining contractual term for equity-based awards excluding options equity instruments transfer from liability to equity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Transfer from Liability to Equity Weighted Average Remaining Contractual Terms Transfer from liability to equity Gross number of shares (or other type of equity) issued on a monthly basis in lieu of cash compensation during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans. Stock Issued During Period, Shares, Share-based Compensation In lieu of Cash, Monthly Gross Transitional monthly compensation awarded in lieu of cash (in shares) Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Weighted average exercise price (in dollars per share) The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the stock option plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price Exercisable at end of period (in dollars per share) Monthly expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. Officers' Compensation, Monthly Payment Transitional monthly compensation awarded Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing subordinated note holder warrants prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants Of Weighted Average Exercise Price, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing (in dollars per share) Change in the weighted average exercise price of non-option equity instruments due to the impact of anti-dilution clauses prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Anti-Dilution Clauses Of Weighted Average Exercise Price, Prior to Repricing Impact of anti-dilution clauses, Prior to impact (in dollars per share) Change in the weighted average exercise price of non-option equity instruments due to the impact of anti-dilution clauses after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Anti-Dilution Clauses Of Weighted Average Exercise Price, After Repricing Impact of anti-dilution clauses, After impact (in dollars per share) Weighted average price at which grantees can acquire the shares reserved for issuance on warrants awarded. Share based Compensation Arrangements by Share based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price Issued (in dollars per share) Change in the number of shares of non-option equity instruments due to the transfer of shares from liability to equity weighted average exercise price. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Transfer from Liability to Equity Weighted Average Exercise Price Transfer from liability to equity (in dollars per share) Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing debenture purchaser warrants prior to repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Debenture Purchaser Warrants Weighted Average Remaining Contractual Term, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding and currently exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Exercisable Weighted Average Remaining Contractual Term Exercisable, weighted average remaining contractual life Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing subordinated note holder warrants after repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Subordinated Note Holder Warrants Weighted Average Remaining Contractual Term, After Repricing Impact of repricing subordinated note holder warrants, After pricing Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing debenture purchaser warrants after repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Debenture Purchaser Warrants Weighted Average Remaining Contractual Term, After Repricing Impact of repricing debenture purchaser warrants, After repricing Change in the number of shares of non-option equity instruments due to the impact of repricing subordinated note holder warrants after repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants, After Repricing Impact of repricing subordinated note holder warrants, After repricing (in shares) The number of shares into which fully or partially vested non options outstanding as of the balance sheet date can be currently converted. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number Exercisable at end of period (in shares) Change in the number of shares of non-option equity instruments due to the transfer of shares from liability to equity. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Transfer from Liability to Equity Transfer from liability to equity (in shares) Change in the number of shares of non-option equity instruments due to the Impact of repricing debenture purchaser warrants prior to repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing (in shares) Change in the number of shares of non-option equity instruments due to the impact of anti-dilution clauses in equity and liability contracts, prior to impact. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Impact of Anti-dilution Clauses Prior to Impact Impact of anti-dilution clauses, Prior to impact (in shares) Change in the number of shares of non-option equity instruments due to the impact of anti-dilution clauses in equity and liability contracts, after impact. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Impact of Anti-dilution Clauses After Impact Impact of anti-dilution clauses, After impact (in shares) Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing subordinated note holder warrants prior to repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Subordinated Note Holder Warants Weighted Average Remaining Contractual Term, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing subordinated note holder warrants after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants Of Weighted Average Exercise Price, After Repricing Impact of repricing subordinated note holder warrants, After repricing (in dollars per share) Weighted average remaining contractual term for equity-based awards excluding options equity instruments impact of anti dilution clauses after impact, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Impact Of Anti Dilution Clauses Weighted Average Remaining Contractual Terms, After Impact Impact of anti-dilution clauses, After impact A former employee of the entity. Former Employee [Member] Change in the number of shares of non-option equity instruments due to the Impact of repricing debenture purchaser warrants after repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants, After Repricing Impact of repricing debenture purchaser warrants, After repricing (in shares) Change in the number of shares of non-option equity instruments due to the impact of repricing subordinated note holder warrants prior to repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing (in shares) Equity warrants. Equity Warrant [Member] Equity Warrants [Member] Equity Warrants [Member] Liability warrants. Liability Warrant [Member] Liability Warrants [Member] Liability Warrants [Member] The equity-based compensation arrangement plan adopted by the board of directors in 2014. Equity Incentive Plan 2014 [Member] 2014 Equity Incentive Plan [Member] The amount of increase or decrease due to a change in the terms of an existing plan or the initiation of a new plan. A plan amendment may increase or decrease benefits, including those attributed to years of service already rendered. Amendment Of Existing Warrants Amendment of existing warrants (in shares) Element represents derivative warrant liability, to record the warrants at fair value. Warrants Recorded At Fair Value Warrants recorded at fair value Refers to the expenses associated with the sale of a borrowing supported by a written promise to pay an obligation. Allocated Cash Offering Expenses For Exchange Of Subordinated Notes Cash offering expenses Refers to number of equal annual installments for options to vest. Number of equal annual installments Number of equal annual installments The cash inflow from issuance of warrants and other forms of equity identified as being convertible into another form of financial instrument allocated to derivative warrant liability. Proceeds from Offering Allocated to Derivative Warrant Liability Proceeds allocated to derivative warrant liability Gross number of share options (or share units) vested during the period. Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period One Vested in August 2017 (in shares) Exercise price one per share or per unit of warrants or rights outstanding. Exercise Price Per Warrant One Exercise price per warrant one (in dollars per share) The cash inflow from issuing of warrants allocated to preferred stock. Proceeds Allocated To Preferred Stock Proceed recorded as preferred stock The cash inflow from issuing of warrants allocated to dividend for preferred stock. Proceeds Allocated to dividend for preferred stock Recorded dividend for preferred stock One of the ranking officers of the entity, appointed to the position by the board of directors and employees. Executive Officer and Employees [Member] Executive Officer and Employees [Member] Period eight representing eighth most current period of debt redemption features under terms of the debt agreement. Debt Instrument, Redemption, Period Eight [Member] Expiration April 30, 2021 [Member] Period eight representing eighth most current period of debt redemption features under terms of the debt agreement. Expiration February, 2022 [Member] Expiration February, 2022 [Member] Refers to the exercisable term of warrants. Warrants Exercisable Term Warrants exercisable term The cumulative amount of the reporting entity's undistributed earnings or deficit attributable to noncontrolling interest. Retained Earnings Attributable To Noncontrolling Interest [Member] Accumulated Deficit Attributable to Noncontrolling Interest in Nutra SA [Member] Element refers to change in classification of preferred stock to equity from liability. Change in classification of preferred stock to equity from liability Change in classification of preferred stock to equity from liability Element refers to number of shares from change in classification of preferred stock to equity from liability. Change in classification of preferred stock to equity from liability, shares Change in classification of preferred stock to equity from liability (in shares) Amount of interest from sale of a portion of the membership interests. Proceeds from sale of membership interests Proceeds from sale of membership interests Element refers to change in classification of warrants to equity from liability. Change in classification of warrants to equity from from liability Change in classification of warrants to equity from liability Element refers to modification of senior debenture holder warrants. Modification of senior debenture holder warrants Element refers to modification of subordinated note holder warrants. Modification of subordinated note holder warrants Modification of subordinated note holder warrants Tabular disclosure of warrant exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of warrants, weighted average exercise price and remaining contractual warrant terms. Schedule of Share based Compensation, Warrants, by Exercise Price Range [Table Text Block] Summary of outstanding warrants LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN [Abstract] Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding warrants by ranges of exercise prices. Schedule of Share based Compensation, Shares Authorized under Stock Warrant Plans, by Exercise Price Range [Table] First portion of share-based compensation award vesting. Share Based Compensation Award Vesting One [Member] Vesting Price Equals or Exceeds $5.00 [Member] Second portion of share-based compensation award vesting. Share Based Compensation Award Vesting Two [Member] Vesting Price Equals or Exceeds $10.00 [Member] Option exercise price range. Range Two [Member] $1.50 [Member] Option exercise price range. Range Seven [Member] $6.55 to $16.80 [Member] Option exercise price range. Range Five [Member] $5.25 [Member] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Line Items] Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Abstract] Summary of information related to outstanding and exercisable warrants [Abstract] Refers to number of warrants exercised during the period. Number of warrants Exercised Number of warrants exercised The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrant awards on all stock warrant plans and other required information pertaining to awards in the customized range. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range, Upper Range Limit Exercise price range, upper range limit (in dollars per share) Expensed ratably contractual term for shares issued, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Expensed Ratably Period for shares issued Expensed ratably term Conversion price at which grantees can acquire the shares reserved for issuance under the plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Conversion price Conversion price (in dollars per share) Fair value of stock issued during the period. Grant Date Fair Value of Stock Issued During Period Grant date fair value The number of trading days considered in delivery of shares. Number of trading days Refers to vesting price of share-based compensation awards. Share based Compensation Arrangement By Share based Payment Award Award Vesting price Vesting price (in dollars per share) Third portion of share-based compensation award vesting. Share Based Compensation Award Vesting Three [Member] Vesting Price Equals or Exceeds $15.00 [Member] Refers to number of warrants. Number of Warrants Number of warrants Option exercise price range. Range One [Member] $0.96 [Member] Option exercise price range. Range Three [Member] $1.50 to $1.60 [Member] The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrant awards on all stock warrant plans and other required information pertaining to awards in the customized range. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range, Lower Range Limit Exercise price range, lower range limit (in dollars per share) Option exercise price range. Range Six [Member] $5.25 to $5.87 [Member] Option exercise price range. Range Four [Member] $2.00 [Member] EX-101.PRE 10 ribt-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2017
Jul. 31, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name RiceBran Technologies  
Entity Central Index Key 0001063537  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   13,512,319
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q2  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2017  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Condensed Consolidated Statements of Operations (Unaudited) [Abstract]        
Revenues $ 3,146 $ 3,233 $ 6,761 $ 6,499
Cost of goods sold 2,348 2,431 4,776 4,765
Gross profit 798 802 1,985 1,734
Selling, general and administrative expenses 2,667 3,676 4,933 6,288
Loss from operations (1,869) (2,874) (2,948) (4,554)
Other income (expense):        
Interest expense (475) (454) (1,530) (1,132)
Change in fair value of derivative warrant liabilities 22 (1,663) 1,121 (852)
Loss on extinguishment of debt 0 0 (1,680) 0
Gain on resolution of Irgovel purchase litigation 0 0 0 1,598
Other income 37 0 37 0
Other expense (4) 0 (100) 0
Total other income (expense) (420) (2,117) (2,152) (386)
Loss before income taxes (2,289) (4,991) (5,100) (4,940)
Income tax benefit 515 515 912 907
Loss from continuing operations (1,774) (4,476) (4,188) (4,033)
Income (loss) from discontinued operations, net of tax 304 (3,640) 117 (4,221)
Net loss (1,470) (8,116) (4,071) (8,254)
Less - Net loss attributable to noncontrolling interest in discontinued operations (248) (1,508) (567) (1,946)
Net loss attributable to RiceBran Technologies shareholders (1,222) (6,608) (3,504) (6,308)
Less - Dividends on preferred stock--beneficial conversion feature 0 0 778 551
Net loss attributable to RiceBran Technologies common shareholders $ (1,222) $ (6,608) $ (4,282) $ (6,859)
Basic earnings (loss) per common share:        
Continuing operations (in dollars per share) $ (0.18) $ (0.48) $ (0.51) $ (0.50)
Discontinued operations (in dollars per share) 0.06 (0.24) 0.07 (0.24)
Basic loss per common share - RiceBran Technologies (in dollars per share) (0.12) (0.72) (0.44) (0.74)
Diluted earnings (loss) per common share:        
Continuing operations (in dollars per share) (0.18) (0.48) (0.51) (0.50)
Discontinued operations (in dollars per share) 0.06 (0.24) 0.07 (0.24)
Diluted loss per common share - RiceBran Technologies (in dollars per share) $ (0.12) $ (0.72) $ (0.44) $ (0.74)
Weighted average number of shares outstanding:        
Basic (in shares) 9,794,405 9,231,619 9,726,268 9,223,651
Diluted (in shares) 9,794,405 9,231,619 9,726,268 9,223,651
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) [Abstract]        
Net loss $ (1,470) $ (8,116) $ (4,071) $ (8,254)
Other comprehensive income - foreign currency translation, net of tax 17 413 162 859
Comprehensive loss, net of tax (1,453) (7,703) (3,909) (7,395)
Less - Comprehensive loss attributable to noncontrolling interest, net of tax (250) (1,375) (518) (1,668)
Total comprehensive loss attributable to RiceBran Technologies shareholders $ (1,203) $ (6,328) $ (3,391) $ (5,727)
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 3,184 $ 342
Accounts receivable, net of allowance for doubtful accounts of $8 and $12 1,132 1,094
Inventories 943 933
Deposits and other current assets 471 824
Current assets held for sale 5,698 4,335
Total current assets 11,428 7,528
Property and equipment, net 6,810 7,025
Intangible assets, net 171 242
Noncurrent assets held for sale 13,172 14,050
Total assets 31,581 28,845
Current liabilities:    
Accounts payable 640 714
Accrued salary, wages and benefits 591 496
Accrued expenses 439 1,288
Current maturities of long-term debt 24 3,063
Current liabilities held for sale 16,589 15,801
Total current liabilities 18,283 21,362
Long-term debt, less current portion 5,892 5,964
Derivative warrant liabilities 472 1,527
Deferred tax liability 33 29
Noncurrent liabilities held for sale 41 44
Total liabilities 24,721 28,926
Commitments and contingencies
Temporary Equity    
Total temporary equity 0 551
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Common stock, no par value, 50,000,000 shares authorized, 11,575,187 and 10,790,351 shares issued and outstanding 274,419 264,232
Accumulated deficit (264,240) (259,819)
Accumulated deficit attributable to noncontrolling interest in discontinued operation (567) (699)
Accumulated other comprehensive loss (4,233) (4,346)
Total equity (deficit) attributable to RiceBran Technologies shareholders 6,860 (632)
Total liabilities, temporary equity and equity (deficit) 31,581 28,845
Series F Convertible Preferred Stock [Member]    
Temporary Equity    
Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding 0 551
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock 493 0
Series G Convertible Preferred Stock [Member]    
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock $ 988 $ 0
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Accounts receivable, allowance for doubtful accounts $ 8 $ 12
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 20,000,000  
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 11,575,187 10,790,351
Common stock, shares outstanding (in shares) 11,575,187 10,790,351
Series F Convertible Preferred Stock [Member]    
Temporary Equity    
Preferred stock, shares authorized (in shares)   20,000,000
Convertible preferred stock, shares issued (in shares)   3,000
Convertible preferred stock, shares outstanding (in shares)   3,000
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 3,000  
Convertible preferred stock, shares issued (in shares) 2,685  
Convertible preferred stock, shares outstanding (in shares) 2,685  
Series G Convertible Preferred Stock [Member]    
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 3,000  
Convertible preferred stock, shares issued (in shares) 1,989  
Convertible preferred stock, shares outstanding (in shares) 1,989  
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flow from operating activities:    
Net loss $ (4,071) $ (8,254)
Income (loss) from discontinued operations 117 (4,221)
Loss from continuing operations (4,188) (4,033)
Adjustments to reconcile net loss to net cash used in operating activities of discontinued operations:    
Depreciation and amortization 414 452
Stock and share-based compensation 654 477
Change in fair value of derivative warrant and conversion liabilities (1,121) 852
Loss on extinguishment of debt 1,680 0
Gain on resolution of Irgovel purchase litigation 0 (1,598)
Interest accreted 893 403
Other 58 0
Cash provided by discontinued operations (876) (1,763)
Changes in operating assets and liabilities:    
Accounts receivable (38) (113)
Inventories (16) 161
Accounts payable and accrued expenses (824) 186
Other 353 (52)
Net cash used in operating activities of continuing operations (3,011) (5,028)
Net cash provided by operating activities of discontinued operations 973 3,244
Net cash used in operating activities (2,038) (1,784)
Cash flows from investing activities:    
Change in restricted cash 0 1,921
Purchases of property (139) (209)
Net cash (used in) provided by investing activities of continuing operations (139) 1,712
Net cash used in investing activities of discontinued operations (108) (208)
Net cash (used in) provided by investing activities (247) 1,504
Cash flows from financing activities:    
Payments of debt (7,159) (15,703)
Proceeds from issuance of debt, net of issuance costs 3,779 14,801
Proceeds from issuance of debt and warrants, net of issuance costs 5,518 300
Proceeds from issuance of preferred stock and warrants, net of issuance costs 1,747 2,554
Other (12) (9)
Net cash provided by financing activities of continuing operations 3,873 1,943
Net cash provided by (used in) financing activities of discontinued operations 1,112 (815)
Net cash provided by financing activities 4,985 1,128
Effect of exchange rate changes on cash and cash equivalents of discontinued operations 142 (38)
Net change in cash and cash equivalents 2,842 810
Cash and cash equivalents, beginning of period 342 966
Cash and cash equivalents, end of period 3,184 1,776
Supplemental disclosures:    
Cash paid for interest 922 942
Cash paid for income taxes $ 0 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION
 6 Months Ended
Jun. 30, 2017
BASIS OF PRESENTATION [Abstract]  
BASIS OF PRESENTATION
NOTE 1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.

These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS
 6 Months Ended
Jun. 30, 2017
DISCONTINUED OPERATIONS [Abstract]  
DISCONTINUED OPERATIONS
NOTE 2. DISCONTINUED OPERATIONS

Healthy Natural (HN) Discontinued Operations

The Company continuously assesses the composition of our portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.  In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).  In July 2017, we completed the sale of the assets of HN for $18.3 million in cash, net of assumed liabilities.  HN was reported as part of our USA segment.  The purchase price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.  The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.  We are providing certain support services under transition services agreement for a limited period of time.  These support services are not expected to have a material impact on our consolidated statements of operations in 2017.

The following table summarizes the initial distribution of proceeds (in thousands).

Purchase price, net of assumed liabilities
 
$
18,283
 
Estimated expenses
  
(934
)
Net proceeds
 
$
17,349
 
     
Repayment of senior debentures
 
$
6,600
 
Repayment of subordinated debt and related interest
  
5,963
 
Repayment of other liabilities
  
56
 
Escrow for working capital adjustments
  
225
 
Escrow for indemnity claims
  
550
 
  
$
13,394
 

We have not completed our accounting for the sale of HN.  On a preliminary basis, we estimate the net carrying value of HN as of the date of sale at $4.0 million and the third quarter 2017 gain on sale as $8.8 million, net of $4.5 million income tax provision.  The Internal Revenue Service rules in this area are complex and we have not yet completed an analysis of what net operating losses, if any, will be available to reduce the taxes owed on the gain.  In addition, we expect to recognize a third quarter 2017 expense from the proceeds from the sale of HN of approximately $6.0 million related to the extinguishment of the senior debentures and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest.  We will be required to accrete the senior debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.
 
We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.  Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.

The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestitures of HN (in thousands).

  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
5,064
  
$
5,546
  
$
9,481
  
$
10,034
 
Cost of goods sold
  
(3,336
)
  
(3,702
)
  
(6,358
)
  
(6,661
)
Selling, general and administrative expenses
  
(215
)
  
(329
)
  
(443
)
  
(704
)
Income from discontinued operations, before income taxes
  
1,513
   
1,515
   
2,680
   
2,669
 
Income taxes
  
(515
)
  
(515
)
  
(912
)
  
(907
)
Income from discontinued operations, net of tax
 
$
998
  
$
1,000
  
$
1,768
  
$
1,762
 
 
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale (in thousands).
 
 
June 30,
2017
  
December 31,
2016
 
Accounts receivable, net
 
$
1,362
  
$
592
 
Inventories
  
1,887
   
1,915
 
Other current asssets held for sale
  
32
   
23
 
Property and equipment
  
882
   
1,019
 
Intangible
  
791
   
791
 
Other noncurrent assets held for sale
  
24
   
24
 
Total assets held for sale
 
$
4,978
  
$
4,364
 
Accounts payable
 
$
567
  
$
443
 
Accrued expenses
  
346
   
382
 
Long term liabilities
  
41
   
44
 
Total liabilities held for sale
 
$
954
  
$
869
 

The following table summarizes the major line items included in cash flows from discontinued operations of HN for the six months ended June 30, 2017 and 2016 (in thousands).

  
Six Months Ended
 
  
2017
  
2016
 
       
Net cash provided by operating activities
 
$
2,141
  
$
2,235
 
Net cash used in investing activities
  
(15
)
  
(75
)
Net cash used in financing activities
  
(7
)
  
-
 
Net cash provided to continuing operations
 
$
(2,119
)
 
$
(2,160
)

Nutra SA Discontinued Operations

We hold a variable interest in our equity interest in Nutra SA.  Nutra SA’s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.  We are the primary beneficiary of Nutra SA, and as such, Nutra SA’s assets, liabilities and results of operations are included in our consolidated financial statements.  In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.  Accordingly, the Nutra SA consolidated results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.  Other equity holders’ (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.

The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and six months ended June 30, 2017 and 2016 (in thousands).

  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
2,960
  
$
1,767
  
$
6,363
  
$
4,064
 
Cost of goods sold
  
(2,800
)
  
(2,428
)
  
(6,275
)
  
(4,949
)
Selling, general and administrative expenses
  
(497
)
  
(640
)
  
(1,031
)
  
(1,382
)
Goodwill impairment
  
-
   
(3,024
)
  
-
   
(3,024
)
Other expense
  
(357
)
  
(315
)
  
(708
)
  
(692
)
Loss from discontinued operations, before income taxes
  
(694
)
  
(4,640
)
  
(1,651
)
  
(5,983
)
Income taxes
  
-
   
-
   
-
   
-
 
Loss from discontinued operations, net of tax
 
$
(694
)
 
$
(4,640
)
 
$
(1,651
)
 
$
(5,983
)

The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).

  
June 30,
2017
  
December 31,
2016
 
Cash and cash equivalents
 
$
41
  
$
109
 
Accounts receivable, net (restricted $363 and $398)
  
326
   
398
 
Inventories
  
1,138
   
925
 
Other current asssets held for sale
  
912
   
373
 
Property and equipment, net (restricted $2,508 and $2,599 )
  
10,249
   
10,889
 
Other noncurrent assets held for sale
  
1,226
   
1,327
 
Total assets held for sale
 
$
13,892
  
$
14,021
 
Accounts payable
 
$
2,222
  
$
2,553
 
Accrued expenses
  
6,290
   
5,607
 
Current maturities of long-term debt (nonrecourse)
  
7,164
   
6,816
 
Total liabilities held for sale
 
$
15,676
  
$
14,976
 

Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the LLC Agreement.  Therefore Nutra SA’s consolidated cash is classified as held for sale in our consolidated balance sheets.  Nutra SA’s debt is secured by Irgovel’s accounts receivable and property.  The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA’s debt.

The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the six months ended June 30, 2017 and 2016 (in thousands).

  
Six Months Ended
 
  
2017
  
2016
 
       
Net cash (used) provided by operating activities
 
$
(1,236
)
 
$
1,106
 
Net cash used in investing activities
  
(93
)
  
(156
)
Net cash provided (used) by financing activities
  
1,119
   
(815
)
Effect of exchange rate changes
  
142
   
(38
)
Net change in cash and cash equivalents
  
(68
)
  
97
 
Cash and cash equivalents, beginning of period
  
109
   
104
 
Cash and cash equivalents, end of period
 
$
41
  
$
201
 
 
Nutra SA’s debt consists of the following (in thousands):
 
  
June 30
2017
  
December 31,
2016
 
Capital expansion loans
 
$
647
  
$
2,454
 
Working capital lines of credit
  
1,090
   
401
 
Advances on customer export orders
  
2,482
   
1,113
 
Special tax programs
  
2,838
   
2,767
 
Other
  
107
   
81
 
  
$
7,164
  
$
6,816
 

As of June 30, 2017, Irgovel had approximately $3.7 million (USD) of installment payments in arrears.  The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current in the accompanying consolidated balance sheet as of June 30, 2017. As of June 30, 2017, Irgovel had approximately $6.1 million of tax payments in arrears.  All taxes in arrears can be included in a new Brazil tax amnesty program, but to do so, the May 2017 and June 2017 installments (approximately $0.2 million) must be paid. All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.  The fair value of Nutra SA debt (Level 3 measurement) approximates the $7.1 million carrying value of that debt based on the current market rates for similar debt with similar maturities.

Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).

A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying balance sheets, for the three and six months ended June 30, 2017 and 2016 (in thousands) follows.
 
  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Redeemable noncontrolling interest in Nutra SA, beginning of period
 
$
(416
)
 
$
(224
)
 
$
(699
)
 
$
69
 
Investors' interest in net loss of Nutra SA
  
(249
)
  
(1,508
)
  
(567
)
  
(1,946
)
Investors' interest in other comprehensive loss of Nutra SA
  
(2
)
  
133
   
49
   
278
 
Investors purchase of additional membership interest
  
100
   
-
   
650
   
-
 
Redeemable noncontrolling interest in Nutra SA, end of period
 
$
(567
)
 
$
(1,599
)
 
$
(567
)
 
$
(1,599
)
                 
Investors' average interest in Nutra SA during the period
  
35.8
%
  
32.4
%
  
35.4
%
  
32.1
%
Investors' interest in Nutra SA at the end of the period
  
35.7
%
  
32.4
%
  
35.7
%
  
32.4
%

The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.  The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).  We may elect to exercise a right of first refusal to purchase the Investors’ interest instead of proceeding to a sale.  We have assessed the likelihood of the Investors exercising these rights as less than probable at June 30, 2017.  We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.  We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.

As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.  In exchange for the termination of this right, we paid the Investors $0.1 million.

Under the LLC Agreement, the business of Nutra SA is subject to the oversight of a management committee comprised of three of our representatives and two Investor representatives.  Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.  In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.
 
As of June 30, 2017, there have been no unwaived events of default.  Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are failure of Irgovel to meet minimum annual processing targets or failure to achieve EBITDA on a local currency basis of at least R$4.0 million annually.

As of June 30, 2017, there have been no qualifying events.  The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.

In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.  Until there is an event of default or a qualifying event, the Investors’ rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.  The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.  However, the Investors do have drag along rights in the future.  We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN
 6 Months Ended
Jun. 30, 2017
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN [Abstract]  
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN
NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT’S PLAN

We have improved our cash position since December 31, 2016, as a result of a debt and equity raise in February 2017 and the sale of HN in July 2017.  However, on a consolidated basis, largely as a result of our Nutra SA losses, we continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.

In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  Consequently, we believe we are adequately funded at this time to allow us to operate and execute on our business strategy for achieving consistent and positive operational cash flows from our remaining US operations.  In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $18.3 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).  We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.  The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

Beginning in the second quarter of 2016 and through the second quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.  Due to Irgovel’s working capital issues, Irgovel did not have the funds necessary to meet scheduled debt payments.  As a result, Irgovel ceased making all bank debt payments in the second and third quarters of 2016.  In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through June 30, 2017.  In 2016, we invested $1.1 million in Nutra SA.  Our board has determined it will no longer contribute any additional funds to Nutra SA.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
RECENT ACCOUNTING GUIDANCE
 6 Months Ended
Jun. 30, 2017
RECENT ACCOUNTING GUIDANCE [Abstract]  
RECENT ACCOUNTING GUIDANCE
NOTE 4. RECENT ACCOUNTING GUIDANCE

Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We have not yet selected a transition method but have determined that we will utilize the deferred effective date of January 1, 2018, to adopt the standard.
 
In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  It is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019.  Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.  We adopted the standard as of January 1, 2017, with no effect on our financial position or results of operations.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  The guidance is effective for our annual and interim periods beginning in 2017 with early adoption permitted.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
LOSS PER SHARE (EPS)
 6 Months Ended
Jun. 30, 2017
LOSS PER SHARE (EPS) [Abstract]  
LOSS PER SHARE (EPS)
NOTE 5. LOSS PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.  Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.  The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.
 
Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and six months ended June 30, 2017 and 2016.
 
 
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
NUMERATOR (in thousands):
            
Basic and diluted - loss from continuing operations
 
$
(1,774
)
 
$
(4,476
)
 
$
(4,188
)
 
$
(4,033
)
Dividend on preferred stock--beneficial conversion feature
  
-
   
-
   
(778
)
  
(551
)
Basic and diluted - adjusted loss from continuing operations
 
$
(1,774
)
 
$
(4,476
)
 
$
(4,966
)
 
$
(4,584
)
                 
DENOMINATOR:
                
Basic EPS - weighted average number of common shares outstanding
  
9,794,405
   
9,231,619
   
9,726,268
   
9,223,651
 
Effect of dilutive securities outstanding
  
-
   
-
   
-
   
-
 
Diluted EPS - weighted average number of shares outstanding
  
9,794,405
   
9,231,619
   
9,726,268
   
9,223,651
 
                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                
Stock options
  
595,252
   
353,186
   
395,262
   
355,286
 
Warrants
  
23,460,192
   
10,842,006
   
20,547,647
   
9,777,065
 
Nonvested stock
  
1,217,650
   
1,265,386
   
1,206,997
   
1,066,236
 
Convertible preferred stock
  
3,879,603
   
2,000,000
   
3,469,299
   
1,417,582
 
Restricted stock unit awards
  
261,111
   
-
   
130,556
   
-
 
 
The impact of potentially dilutive securities outstanding at June 30, 2017 and 2016, was not included in the calculation of diluted EPS for the six months ended June 30, 2017 and 2016 because to do so would be antidilutive.  Those securities listed in the table above which were antidilutive for the periods presented, which remain outstanding, could potentially dilute EPS in the future.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONCENTRATIONS OF RISK
 6 Months Ended
Jun. 30, 2017
CONCENTRATIONS OF RISK [Abstract]  
CONCENTRATIONS OF RISK
NOTE 6. CONCENTRATIONS OF RISK

Our trade accounts receivable subject us to significant concentrations of credit risk.  We perform ongoing credit evaluations on our customers’ financial condition and generally do not require collateral.

Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the six months ended June 30, 2017 and 2016.

  
% of Total Revenue
Six Months Ended
  
% of Total Accounts Receivable
Six Months Ended
 
Customer
 
2017
  
2016
  
2017
  
2016
 
Customer 1
  
16
%
  
12
%
  
25
%
  
18
%
Customer 2
  
15
%
  
12
%
  
12
%
  
*
 
Customer 3
  
*
   
*
   
*
   
*
 
Customer 4
  
*
   
*
   
*
   
*
 
Customer 5
  
*
   
*
   
*
   
11
%
Others
  
69
%
  
69
%
  
63
%
  
71
%
Total
  
100
%
  
93
%
  
100
%
  
100
%
 
* Less than 10%
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the six months ended June 30, 2017 and 2016.
 
  
% of Total Purchases
Six Months Ended
 
Supplier
 
2017
  
2016
 
Supplier 1
  
11
%
  
15
%
Supplier 2
  
*
   
*
 
Supplier 3
  
*
   
*
 
Supplier 4
  
*
   
*
 
Supplier 5
  
*
   
*
 
Others
  
89
%
  
85
%
Total
  
100
%
  
100
%
 
* Less than 10%
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
DEBT
 6 Months Ended
Jun. 30, 2017
DEBT [Abstract]  
DEBT
NOTE 7. DEBT

The following table summarizes current and long-term portions of debt (in thousands):
 
  
June 30,
2017
  
December 31,
2016
 
Senior debentures, net, maturing in February 2019, principal $6.6 million
 
$
589
  
$
-
 
Subordinated notes, net, maturing in May 2019, principal $5.9 million
  
5,285
   
6,310
 
Other
  
42
   
75
 
Senior revolving loan
  
-
   
1,725
 
Senior term loan, net
  
-
   
917
 
   
5,916
   
9,027
 
Current portion
  
24
   
3,063
 
Long-term portion
 
$
5,892
  
$
5,964
 

We repaid the senior debentures and the subordinated notes, in full, with the proceeds from the sale of HN in July 2017.  We expect to recognize a third quarter 2017 expense of approximately $6.0 million to accrete the debentures from their $0.6 million carrying amount to their $6.6 million face value upon extinguishment and approximately $0.7 million related to the extinguishment of the subordinated debt and related interest to accrete the subordinated debt from their $5.3 million carrying amount to their $6.0 million face value upon extinguishment.
 
We issued the senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017.  The transaction, and the accounting therefore, is described further in Note 8.  We accreted interest on the debentures at an effective rate of 160.6% per year.

In connection with the senior debenture private placement, in February 2017, we entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.  The entire transaction, and its accounting consequences, are described further in Note 8.  Beginning in February 2017, we accreted interest on the subordinated notes at an effective rate of 15.0% per year.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS
 6 Months Ended
Jun. 30, 2017
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract]  
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS
NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS

 
 
                   
     
Preferred
  
Common
  
Accumulated
  
Accumulated
Deficit
Attributable to
Non-controlling
Interest in
  
Accumulated
Other Comp-
rehensive
  
Equity
 
 
 
Shares
Preferred
  
Series F
  
Series G
  
Common
  
Stock
  
Stock
  
Deficit
  
Nutra SA
  
Loss
  
(Deficit)
 
Balance, December 31, 2016
  
-
   
-
   
10,790,351
  
$
-
  
$
264,232
  
$
(259,819
)
 
$
(699
)
 
$
(4,346
)
 
$
(632
)
Issuance of common stock awards under equity incentive plans
  -   -   
550,273
   -   
613
   -   -   -   
613
 
Dividend on preferred stock - beneficial conversion feature
  
-
   
-
   
-
   
-
   
778
   
(778
)
  
-
   
-
   
-
 
Modification of senior debenture holder warrants
  
-
   
-
   
-
   
-
   
582
   
-
   
-
   
-
   
582
 
Modification of subordinated note holder warrants
  
-
   
-
   
-
   
-
   
117
   
-
   
-
   
-
   
117
 
Change in classification of preferred stock to equity from liability
  
3,000
   
2,000
   -   
1,545
   -   -   -   -   
1,545
 
Change in classification of warrants to equity from liability
  -   -   -   -   
7,851
   -   -   -   
7,851
 
Conversion of preferred stock into common stock
  
(315
)
  
(11
)
  
220,439
   
(64
)
  
203
   
(139
)
  
-
   
-
   
-
 
Other
  
-
   
-
   
14,124
   
-
   
43
   
-
   
-
   
-
   
43
 
Proceeds from sale of membership interests
  
-
   
-
   
-
   
-
   
-
   
-
   
650
   
-
   
650
 
Foreign currency translation
  
-
   
-
   
-
   
-
   
-
   
-
   
49
   
113
   
162
 
Net loss
  
-
   
-
   
-
   
-
   
-
   
(3,504
)
  
(567
)
  
-
   
(4,071
)
Balance, June 30, 2017
  
2,685
   
1,989
   
11,575,187
  
$
1,481
  
$
274,419
  
$
(264,240
)
 
$
(567
)
 
$
(4,233
)
 
$
6,860
 
 
A summary of warrant activity for the six months ended June 30, 2017, follows.

  
Equity Warrants
  
Liability Warrants
 
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
Outstanding, December 31, 2016
  
6,364,110
   
5.77
   
2.4
   
4,474,868
  
$
1.82
   
3.3
 
Issued
  
-
  
NA
  
NA
   
11,783,163
   
0.96
   
5.0
 
Impact of repricing debenture purchaser warrants:
                        
Prior to repricing
  
(875,000
)
  
5.49
   
2.1
   
-
  
NA
  
NA
 
After repricing
  
875,000
   
0.96
   
5.5
   
-
  
NA
  
NA
 
Impact of repricing subordinated note holder warants:
                        
Prior to repricing
  
(289,669
)
  
5.25
   
3.3
   
-
  
NA
  
NA
 
After repricing
  
289,669
   
0.96
   
3.3
   
-
  
NA
  
NA
 
Impact of anti-dilution clauses:
                        
Prior to impact
  
-
  
NA
  
NA
   
(1,489,868
)
  
1.50
   
0.8
 
After impact
  
-
  
NA
  
NA
   
2,327,919
   
0.96
   
0.8
 
Transfer from liability to equity
  
14,468,163
   
1.16
   
4.8
   
(14,468,163
)
  
1.16
   
4.8
 
Exercised
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Forfeited, expired or cancelled
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Outstanding, June 30, 2017
  
20,832,273
  
$
2.32
   
3.9
   
2,627,919
  
$
1.03
   
0.7
 
Exercisable, June 30, 2017
  
19,957,273
  
$
2.38
   
3.9
   
2,627,919
  
$
1.03
   
0.7
 

Common Stock

In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.

On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.

In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.  The amount was payable in either cash or stock at the chairman’s election.  The chairman elected to receive shares of common stock.

In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.  The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.

In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.  The common stock had a fair value at issuance of $0.2 million.  The difference between the fair value of the common stock issued and the carrying amount of the preferred stock was recorded as an increase in accumulated deficit.

In the third quarter of 2017, through the date of this filling, we issued 1,834,124 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 397 shares of Series G preferred stock.  The common stock had a fair value at issuance of $1.9 million.  The difference between the fair value of the common stock issued and the $0.6 million carrying amount of the preferred stock was recorded as an increase in accumulated deficit.
 
Share Sequencing

From June 2015 until March 2017, the minority interest holders in Nutra SA could elect to exchange units in Nutra SA for shares of our common stock, the number of common stock and warrants issuable upon this election, was variable and indeterminate.  For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.  Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock issued between June 2015 and March 2017, in temporary equity.  We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants’ fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks’ carrying amount on March 31, 2017.

Transactions with Preferred Stock Holders.

In February 2017, we issued and sold 2,000 shares of Series G preferred stock.  The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders’ election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.  The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.  If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.

In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).  A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.  The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.  On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.  We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.

Transactions with Senior Debenture Holders

In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).  We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.  Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.  We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.  We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.  We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.
 
Transaction with Subordinated Note Holders

In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%  to 7% (ii) an extension of the maturity date of the subordinated notes  to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of  $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.  We accounted for the transaction as an extinguishment of debt and issuance of new debt.  In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock $0.1 million for the change in the fair value of the existing warrants.

Full Ratchet Anti-Dilution

As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.
 
Equity Incentive Plan

In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).  The total shares authorized under the 2014 Plan is now 3,300,000 shares.

Option Issuances

In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.  The option vests as to 25,000 shares in August 2017 and the remaining shares vest in monthly installments through August 2020 and had a grant date fair value of $0.56 per share.

In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees.  The options vest in four equal annual installments beginning in the second quarter of 2018 at an average exercise price of $0.85 per share and had a grant date fair value of $0.62 per share.

Restricted Stock Unit Awards

In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.  The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.  Each RSU’s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.  The shares had a grant date fair value of $188 thousand which will be expensed ratably over a 3.5-year period beginning in July 2017.

Warrants

In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.  We issued 103,008 shares of common stock to the holder in a cashless transaction.
 
The following table summarizes information related to outstanding warrants as June 30, 2017 and December 31, 2016:

      
June 30, 2017
  
December 31, 2016
 
Range of
Exercise Prices
  
Type of
Warrant
  
Shares Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
 Remaining
Contractual
Life (Years)
  
Shares Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
$
0.96
  
 Liability (1)
   
2,327,919
  
$
0.96
   
0.4
   
-
  
$
-
   
-
 
$
0.96
  
 Equity
   
12,947,832
   
0.96
   
4.6
   
-
   
-
   
-
 
$
1.50
  
 Liability (2)
   
300,000
   
1.60
   
2.9
   
-
   
-
   
-
 
$
1.50 to $1.60
  
 Liability (1)(2)
   
-
   
-
   
-
   
1,789,868
   
1.52
   
1.3
 
$
2.00
  
 Liability (3)
   
-
   
-
   
-
   
2,660,000
   
2.00
   
4.6
 
$
2.00
  
 Equity
   
2,660,000
   
2.00
   
4.2
   
-
   
-
   
-
 
$
5.25
  
 Liability (3)
   
-
   
-
   
-
   
25,000
   
5.25
   
3.6
 
$
5.25 to $5.87
  
 Equity
   
3,156,670
   
5.33
   
2.2
   
4,296,339
   
5.36
   
2.7
 
$
6.55 to $16.80
  
 Equity
   
2,067,771
   
6.61
   
1.5
   
2,067,771
   
6.61
   
2.0
 
        
23,460,192
  
$
2.17
   
3.53
   
10,838,978
  
$
1.30
   
0.5
 

(1)
Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets.  Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.  In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE MEASUREMENTS
 6 Months Ended
Jun. 30, 2017
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 9. FAIR VALUE MEASUREMENTS

The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.  As of June 30, 2017, the fair value of our debt (Level 3 measurement) is approximately $4.6 million higher than the $5.9 million carrying value of that debt, based on current market rates for similar debt with similar maturities.

Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Certain assets and liabilities are presented in the financial statements at fair value.  Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.  Assets and liabilities measured at fair value on a non-recurring basis may include property.

We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

●
Level 1 – inputs include quoted prices for identical instruments and are the most observable.
●
Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.
●
Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.

For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.
 
The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
Total liabilities at fair value, as of June 30, 2017 - derivative warrant liabilities
 
$
-
  
$
-
  
$
472
  
$
472
 
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
 
$
-
  
$
-
  
$
1,527
  
$
1,527
 

Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.  The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.  The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.

  
June 30, 2017
  
December 31, 2016
 
Risk-free interest rate
  
1.1%
 
  
0.6% -1.9%
 
  
(1.1% weighted average)
  
(1.6% weighted average)
 
Expected volatility
  
65%-75%
 
  
64%
 
  
(73% weighted average)
  
(64% weighted average)
 

The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):

Total Level 3 Fair Value
 
Fair Value
as of
Beginning of
Period
  
Total
Realized and
Unrealized
Gains
(Losses)
  
Issuance of
New
Instruments
  
Reclassify to
(Deficit)
Equity
  
Fair Value,
at End of
Period
 
     
(1)
 
         
Six Months Ended June 30, 2017, derivative warrant liabilities
 
$
(1,527
)
 
$
1,121
  
$
(7,917
)
 
$
7,851
  
$
(472
)
Six Months Ended June 30, 2016, derivative warrant liabilities
 
$
(678
)
 
$
(852
)
 
$
(2,473
)
 
$
-
  
$
(4,003
)

(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Jun. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 10. COMMITMENTS AND CONTINGENCIES

In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.  These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.  Defense costs are expensed as incurred and are included in professional fees.

Irgovel Litigation

Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.  The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.  None of these labor claims is individually significant.  Management believes it’s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.

Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.  The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.  We record amounts considered sufficient by our management to cover probable losses based on these elements.
 
In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.
 
Irgovel - Events of Default

As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.  It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors.

Employment Contracts and Severance Payments

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.  In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTY TRANSACTIONS
 6 Months Ended
Jun. 30, 2017
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 11. RELATED PARTY TRANSACTIONS

Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.  As of June 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.  See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.  The notes were paid in full in July 2017 from the proceeds of the sale of HN.  In the three months ended June 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the six months ended June 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS
 6 Months Ended
Jun. 30, 2017
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Abstract]  
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS
NOTE 12. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS

On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders’ equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders’ equity for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1).  As of June 30, 2016, we reported stockholders’ deficit of $36,000.

We submitted our plan to regain compliance in October 2016.  On November 15, 2016, based on information we submitted to Nasdaq, the Staff granted us the maximum allowable 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders’ equity requirement.  On February 16, 2017, we received a determination letter from the Nasdaq Listing Qualifications Staff stating that we had not regained compliance with the minimum stockholders’ equity requirement.  The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.

We requested and were granted a hearing before the panel to appeal the Letter on March 30, 2017.  After that hearing, on April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million.  We must also at that time provide the panel with updated projections showing stockholders’ equity through May 2018. As reported herein our equity is $7.9 million and exceeds the minimum as of March 31, 2017.

On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2).  Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum price of $1.00 for 10 consecutive business days.  Nasdaq rules allow for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.  If this appears unlikely as September 6, 2017, approaches, we are committed to taking actions that would enable us to regain compliance, including, if necessary, completing a reverse split of our common stock to increase its share price above the $1 minimum bid price.

On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
RECENT ACCOUNTING GUIDANCE (Policies)
 6 Months Ended
Jun. 30, 2017
RECENT ACCOUNTING GUIDANCE [Abstract]  
RECENT ACCOUNTING GUIDANCE
Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We have not yet selected a transition method but have determined that we will utilize the deferred effective date of January 1, 2018, to adopt the standard.
 
In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  It is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019.  Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.  We adopted the standard as of January 1, 2017, with no effect on our financial position or results of operations.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  The guidance is effective for our annual and interim periods beginning in 2017 with early adoption permitted.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS (Tables)
 6 Months Ended
Jun. 30, 2017
Healthy Natural Inc [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Initial distribution of proceeds
The following table summarizes the initial distribution of proceeds (in thousands).

Purchase price, net of assumed liabilities
 
$
18,283
 
Estimated expenses
  
(934
)
Net proceeds
 
$
17,349
 
     
Repayment of senior debentures
 
$
6,600
 
Repayment of subordinated debt and related interest
  
5,963
 
Repayment of other liabilities
  
56
 
Escrow for working capital adjustments
  
225
 
Escrow for indemnity claims
  
550
 
  
$
13,394
 
Income (loss) from discontinued operations
The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestitures of HN (in thousands).

  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
5,064
  
$
5,546
  
$
9,481
  
$
10,034
 
Cost of goods sold
  
(3,336
)
  
(3,702
)
  
(6,358
)
  
(6,661
)
Selling, general and administrative expenses
  
(215
)
  
(329
)
  
(443
)
  
(704
)
Income from discontinued operations, before income taxes
  
1,513
   
1,515
   
2,680
   
2,669
 
Income taxes
  
(515
)
  
(515
)
  
(912
)
  
(907
)
Income from discontinued operations, net of tax
 
$
998
  
$
1,000
  
$
1,768
  
$
1,762
 
Assets and liabilities classified as held for sale
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale (in thousands).
 
 
June 30,
2017
  
December 31,
2016
 
Accounts receivable, net
 
$
1,362
  
$
592
 
Inventories
  
1,887
   
1,915
 
Other current asssets held for sale
  
32
   
23
 
Property and equipment
  
882
   
1,019
 
Intangible
  
791
   
791
 
Other noncurrent assets held for sale
  
24
   
24
 
Total assets held for sale
 
$
4,978
  
$
4,364
 
Accounts payable
 
$
567
  
$
443
 
Accrued expenses
  
346
   
382
 
Long term liabilities
  
41
   
44
 
Total liabilities held for sale
 
$
954
  
$
869
 
Cash flows from discontinued operations
The following table summarizes the major line items included in cash flows from discontinued operations of HN for the six months ended June 30, 2017 and 2016 (in thousands).

  
Six Months Ended
 
  
2017
  
2016
 
       
Net cash provided by operating activities
 
$
2,141
  
$
2,235
 
Net cash used in investing activities
  
(15
)
  
(75
)
Net cash used in financing activities
  
(7
)
  
-
 
Net cash provided to continuing operations
 
$
(2,119
)
 
$
(2,160
)
Nutra SA [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Income (loss) from discontinued operations
The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and six months ended June 30, 2017 and 2016 (in thousands).

  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
2,960
  
$
1,767
  
$
6,363
  
$
4,064
 
Cost of goods sold
  
(2,800
)
  
(2,428
)
  
(6,275
)
  
(4,949
)
Selling, general and administrative expenses
  
(497
)
  
(640
)
  
(1,031
)
  
(1,382
)
Goodwill impairment
  
-
   
(3,024
)
  
-
   
(3,024
)
Other expense
  
(357
)
  
(315
)
  
(708
)
  
(692
)
Loss from discontinued operations, before income taxes
  
(694
)
  
(4,640
)
  
(1,651
)
  
(5,983
)
Income taxes
  
-
   
-
   
-
   
-
 
Loss from discontinued operations, net of tax
 
$
(694
)
 
$
(4,640
)
 
$
(1,651
)
 
$
(5,983
)
Assets and liabilities classified as held for sale
The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).

  
June 30,
2017
  
December 31,
2016
 
Cash and cash equivalents
 
$
41
  
$
109
 
Accounts receivable, net (restricted $363 and $398)
  
326
   
398
 
Inventories
  
1,138
   
925
 
Other current asssets held for sale
  
912
   
373
 
Property and equipment, net (restricted $2,508 and $2,599 )
  
10,249
   
10,889
 
Other noncurrent assets held for sale
  
1,226
   
1,327
 
Total assets held for sale
 
$
13,892
  
$
14,021
 
Accounts payable
 
$
2,222
  
$
2,553
 
Accrued expenses
  
6,290
   
5,607
 
Current maturities of long-term debt (nonrecourse)
  
7,164
   
6,816
 
Total liabilities held for sale
 
$
15,676
  
$
14,976
 
Cash flows from discontinued operations
The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the six months ended June 30, 2017 and 2016 (in thousands).

  
Six Months Ended
 
  
2017
  
2016
 
       
Net cash (used) provided by operating activities
 
$
(1,236
)
 
$
1,106
 
Net cash used in investing activities
  
(93
)
  
(156
)
Net cash provided (used) by financing activities
  
1,119
   
(815
)
Effect of exchange rate changes
  
142
   
(38
)
Net change in cash and cash equivalents
  
(68
)
  
97
 
Cash and cash equivalents, beginning of period
  
109
   
104
 
Cash and cash equivalents, end of period
 
$
41
  
$
201
 
Components of debt
Nutra SA’s debt consists of the following (in thousands):
 
  
June 30
2017
  
December 31,
2016
 
Capital expansion loans
 
$
647
  
$
2,454
 
Working capital lines of credit
  
1,090
   
401
 
Advances on customer export orders
  
2,482
   
1,113
 
Special tax programs
  
2,838
   
2,767
 
Other
  
107
   
81
 
  
$
7,164
  
$
6,816
 
Summary of changes in redeemable noncontrolling interest in discontinued operations
A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying balance sheets, for the three and six months ended June 30, 2017 and 2016 (in thousands) follows.
 
  
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Redeemable noncontrolling interest in Nutra SA, beginning of period
 
$
(416
)
 
$
(224
)
 
$
(699
)
 
$
69
 
Investors' interest in net loss of Nutra SA
  
(249
)
  
(1,508
)
  
(567
)
  
(1,946
)
Investors' interest in other comprehensive loss of Nutra SA
  
(2
)
  
133
   
49
   
278
 
Investors purchase of additional membership interest
  
100
   
-
   
650
   
-
 
Redeemable noncontrolling interest in Nutra SA, end of period
 
$
(567
)
 
$
(1,599
)
 
$
(567
)
 
$
(1,599
)
                 
Investors' average interest in Nutra SA during the period
  
35.8
%
  
32.4
%
  
35.4
%
  
32.1
%
Investors' interest in Nutra SA at the end of the period
  
35.7
%
  
32.4
%
  
35.7
%
  
32.4
%
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
LOSS PER SHARE (EPS) (Tables)
 6 Months Ended
Jun. 30, 2017
LOSS PER SHARE (EPS) [Abstract]  
Reconciliations of numerators and denominators in EPS computations
Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and six months ended June 30, 2017 and 2016.
 
 
Three Months Ended
  
Six Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
NUMERATOR (in thousands):
            
Basic and diluted - loss from continuing operations
 
$
(1,774
)
 
$
(4,476
)
 
$
(4,188
)
 
$
(4,033
)
Dividend on preferred stock--beneficial conversion feature
  
-
   
-
   
(778
)
  
(551
)
Basic and diluted - adjusted loss from continuing operations
 
$
(1,774
)
 
$
(4,476
)
 
$
(4,966
)
 
$
(4,584
)
                 
DENOMINATOR:
                
Basic EPS - weighted average number of common shares outstanding
  
9,794,405
   
9,231,619
   
9,726,268
   
9,223,651
 
Effect of dilutive securities outstanding
  
-
   
-
   
-
   
-
 
Diluted EPS - weighted average number of shares outstanding
  
9,794,405
   
9,231,619
   
9,726,268
   
9,223,651
 
                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                
Stock options
  
595,252
   
353,186
   
395,262
   
355,286
 
Warrants
  
23,460,192
   
10,842,006
   
20,547,647
   
9,777,065
 
Nonvested stock
  
1,217,650
   
1,265,386
   
1,206,997
   
1,066,236
 
Convertible preferred stock
  
3,879,603
   
2,000,000
   
3,469,299
   
1,417,582
 
Restricted stock unit awards
  
261,111
   
-
   
130,556
   
-
 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONCENTRATIONS OF RISK (Tables)
 6 Months Ended
Jun. 30, 2017
CONCENTRATIONS OF RISK [Abstract]  
Concentrations of risk
Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the six months ended June 30, 2017 and 2016.

  
% of Total Revenue
Six Months Ended
  
% of Total Accounts Receivable
Six Months Ended
 
Customer
 
2017
  
2016
  
2017
  
2016
 
Customer 1
  
16
%
  
12
%
  
25
%
  
18
%
Customer 2
  
15
%
  
12
%
  
12
%
  
*
 
Customer 3
  
*
   
*
   
*
   
*
 
Customer 4
  
*
   
*
   
*
   
*
 
Customer 5
  
*
   
*
   
*
   
11
%
Others
  
69
%
  
69
%
  
63
%
  
71
%
Total
  
100
%
  
93
%
  
100
%
  
100
%
 
* Less than 10%
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the six months ended June 30, 2017 and 2016.
 
  
% of Total Purchases
Six Months Ended
 
Supplier
 
2017
  
2016
 
Supplier 1
  
11
%
  
15
%
Supplier 2
  
*
   
*
 
Supplier 3
  
*
   
*
 
Supplier 4
  
*
   
*
 
Supplier 5
  
*
   
*
 
Others
  
89
%
  
85
%
Total
  
100
%
  
100
%
 
* Less than 10%
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
DEBT (Tables)
 6 Months Ended
Jun. 30, 2017
DEBT [Abstract]  
Current and long-term debt
The following table summarizes current and long-term portions of debt (in thousands):
 
  
June 30,
2017
  
December 31,
2016
 
Senior debentures, net, maturing in February 2019, principal $6.6 million
 
$
589
  
$
-
 
Subordinated notes, net, maturing in May 2019, principal $5.9 million
  
5,285
   
6,310
 
Other
  
42
   
75
 
Senior revolving loan
  
-
   
1,725
 
Senior term loan, net
  
-
   
917
 
   
5,916
   
9,027
 
Current portion
  
24
   
3,063
 
Long-term portion
 
$
5,892
  
$
5,964
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables)
 6 Months Ended
Jun. 30, 2017
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract]  
Summary of equity activity
 
 
                   
     
Preferred
  
Common
  
Accumulated
  
Accumulated
Deficit
Attributable to
Non-controlling
Interest in
  
Accumulated
Other Comp-
rehensive
  
Equity
 
 
 
Shares
Preferred
  
Series F
  
Series G
  
Common
  
Stock
  
Stock
  
Deficit
  
Nutra SA
  
Loss
  
(Deficit)
 
Balance, December 31, 2016
  
-
   
-
   
10,790,351
  
$
-
  
$
264,232
  
$
(259,819
)
 
$
(699
)
 
$
(4,346
)
 
$
(632
)
Issuance of common stock awards under equity incentive plans
  -   -   
550,273
   -   
613
   -   -   -   
613
 
Dividend on preferred stock - beneficial conversion feature
  
-
   
-
   
-
   
-
   
778
   
(778
)
  
-
   
-
   
-
 
Modification of senior debenture holder warrants
  
-
   
-
   
-
   
-
   
582
   
-
   
-
   
-
   
582
 
Modification of subordinated note holder warrants
  
-
   
-
   
-
   
-
   
117
   
-
   
-
   
-
   
117
 
Change in classification of preferred stock to equity from liability
  
3,000
   
2,000
   -   
1,545
   -   -   -   -   
1,545
 
Change in classification of warrants to equity from liability
  -   -   -   -   
7,851
   -   -   -   
7,851
 
Conversion of preferred stock into common stock
  
(315
)
  
(11
)
  
220,439
   
(64
)
  
203
   
(139
)
  
-
   
-
   
-
 
Other
  
-
   
-
   
14,124
   
-
   
43
   
-
   
-
   
-
   
43
 
Proceeds from sale of membership interests
  
-
   
-
   
-
   
-
   
-
   
-
   
650
   
-
   
650
 
Foreign currency translation
  
-
   
-
   
-
   
-
   
-
   
-
   
49
   
113
   
162
 
Net loss
  
-
   
-
   
-
   
-
   
-
   
(3,504
)
  
(567
)
  
-
   
(4,071
)
Balance, June 30, 2017
  
2,685
   
1,989
   
11,575,187
  
$
1,481
  
$
274,419
  
$
(264,240
)
 
$
(567
)
 
$
(4,233
)
 
$
6,860
 
Summary of warrant activity
A summary of warrant activity for the six months ended June 30, 2017, follows.

  
Equity Warrants
  
Liability Warrants
 
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
Outstanding, December 31, 2016
  
6,364,110
   
5.77
   
2.4
   
4,474,868
  
$
1.82
   
3.3
 
Issued
  
-
  
NA
  
NA
   
11,783,163
   
0.96
   
5.0
 
Impact of repricing debenture purchaser warrants:
                        
Prior to repricing
  
(875,000
)
  
5.49
   
2.1
   
-
  
NA
  
NA
 
After repricing
  
875,000
   
0.96
   
5.5
   
-
  
NA
  
NA
 
Impact of repricing subordinated note holder warants:
                        
Prior to repricing
  
(289,669
)
  
5.25
   
3.3
   
-
  
NA
  
NA
 
After repricing
  
289,669
   
0.96
   
3.3
   
-
  
NA
  
NA
 
Impact of anti-dilution clauses:
                        
Prior to impact
  
-
  
NA
  
NA
   
(1,489,868
)
  
1.50
   
0.8
 
After impact
  
-
  
NA
  
NA
   
2,327,919
   
0.96
   
0.8
 
Transfer from liability to equity
  
14,468,163
   
1.16
   
4.8
   
(14,468,163
)
  
1.16
   
4.8
 
Exercised
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Forfeited, expired or cancelled
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Outstanding, June 30, 2017
  
20,832,273
  
$
2.32
   
3.9
   
2,627,919
  
$
1.03
   
0.7
 
Exercisable, June 30, 2017
  
19,957,273
  
$
2.38
   
3.9
   
2,627,919
  
$
1.03
   
0.7
 
Summary of outstanding warrants
The following table summarizes information related to outstanding warrants as June 30, 2017 and December 31, 2016:

      
June 30, 2017
  
December 31, 2016
 
Range of
Exercise Prices
  
Type of
Warrant
  
Shares Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
 Remaining
Contractual
Life (Years)
  
Shares Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
$
0.96
  
 Liability (1)
   
2,327,919
  
$
0.96
   
0.4
   
-
  
$
-
   
-
 
$
0.96
  
 Equity
   
12,947,832
   
0.96
   
4.6
   
-
   
-
   
-
 
$
1.50
  
 Liability (2)
   
300,000
   
1.60
   
2.9
   
-
   
-
   
-
 
$
1.50 to $1.60
  
 Liability (1)(2)
   
-
   
-
   
-
   
1,789,868
   
1.52
   
1.3
 
$
2.00
  
 Liability (3)
   
-
   
-
   
-
   
2,660,000
   
2.00
   
4.6
 
$
2.00
  
 Equity
   
2,660,000
   
2.00
   
4.2
   
-
   
-
   
-
 
$
5.25
  
 Liability (3)
   
-
   
-
   
-
   
25,000
   
5.25
   
3.6
 
$
5.25 to $5.87
  
 Equity
   
3,156,670
   
5.33
   
2.2
   
4,296,339
   
5.36
   
2.7
 
$
6.55 to $16.80
  
 Equity
   
2,067,771
   
6.61
   
1.5
   
2,067,771
   
6.61
   
2.0
 
        
23,460,192
  
$
2.17
   
3.53
   
10,838,978
  
$
1.30
   
0.5
 

(1)
Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets.  Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.  In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE MEASUREMENTS (Tables)
 6 Months Ended
Jun. 30, 2017
FAIR VALUE MEASUREMENTS [Abstract]  
Fair values by input hierarchy of items measured at fair value on a recurring basis
The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
Total liabilities at fair value, as of June 30, 2017 - derivative warrant liabilities
 
$
-
  
$
-
  
$
472
  
$
472
 
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
 
$
-
  
$
-
  
$
1,527
  
$
1,527
 
Additional assumptions used to calculate fair value
The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.

  
June 30, 2017
  
December 31, 2016
 
Risk-free interest rate
  
1.1%
 
  
0.6% -1.9%
 
  
(1.1% weighted average)
  
(1.6% weighted average)
 
Expected volatility
  
65%-75%
 
  
64%
 
  
(73% weighted average)
  
(64% weighted average)
 
Changes in level 3 items measured at fair value
The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):

Total Level 3 Fair Value
 
Fair Value
as of
Beginning of
Period
  
Total
Realized and
Unrealized
Gains
(Losses)
  
Issuance of
New
Instruments
  
Reclassify to
(Deficit)
Equity
  
Fair Value,
at End of
Period
 
     
(1)
 
         
Six Months Ended June 30, 2017, derivative warrant liabilities
 
$
(1,527
)
 
$
1,121
  
$
(7,917
)
 
$
7,851
  
$
(472
)
Six Months Ended June 30, 2016, derivative warrant liabilities
 
$
(678
)
 
$
(852
)
 
$
(2,473
)
 
$
-
  
$
(4,003
)

(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2017
Jul. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Initial Distribution of Proceeds [Abstract]        
Repayment of subordinated debt and related interest $ 500      
Healthy Natural Inc [Member] | Senior Debentures, Net [Member]        
Initial Distribution of Proceeds [Abstract]        
Extinguishment of debt       $ 6,000
Carrying value of debt       600
Face value of debentures upon extinguishment       6,600
Healthy Natural Inc [Member] | Subordinated Debt [Member]        
Initial Distribution of Proceeds [Abstract]        
Extinguishment of debt       700
Carrying value of debt       5,300
Face value of debentures upon extinguishment       $ 6,000
Healthy Natural Inc [Member] | Forecast [Member]        
Initial Distribution of Proceeds [Abstract]        
Net carrying value of discontinued operations     $ 4,000  
Gain on sale of business     8,800  
Tax provision for gain on sale of business     $ 4,500  
Healthy Natural Inc [Member] | Subsequent Event [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Restriction period to engage in business conducted by sold entity   5 years    
Initial Distribution of Proceeds [Abstract]        
Purchase price, net of assumed liabilities   $ 18,283    
Estimated expenses   (934)    
Net proceeds   17,349    
Repayment of senior debentures   6,600    
Repayment of subordinated debt and related interest   5,963    
Repayment of other liabilities   56    
Escrow for working capital adjustments   225    
Escrow for indemnity claims   550    
Total distribution of proceeds   $ 13,394    
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income (Loss) from Discontinued Operations [Abstract]        
Income (loss) from discontinued operations, net of tax $ 304 $ (3,640) $ 117 $ (4,221)
Healthy Natural Inc [Member]        
Income (Loss) from Discontinued Operations [Abstract]        
Revenues 5,064 5,546 9,481 10,034
Cost of goods sold (3,336) (3,702) (6,358) (6,661)
Selling, general and administrative expenses (215) (329) (443) (704)
Income (loss) from discontinued operations, before income taxes 1,513 1,515 2,680 2,669
Income taxes (515) (515) (912) (907)
Income (loss) from discontinued operations, net of tax 998 1,000 1,768 1,762
Nutra SA [Member]        
Income (Loss) from Discontinued Operations [Abstract]        
Revenues 2,960 1,767 6,363 4,064
Cost of goods sold (2,800) (2,428) (6,275) (4,949)
Selling, general and administrative expenses (497) (640) (1,031) (1,382)
Goodwill impairment 0 (3,024) 0 (3,024)
Other expense (357) (315) (708) (692)
Income (loss) from discontinued operations, before income taxes (694) (4,640) (1,651) (5,983)
Income taxes 0 0 0 0
Income (loss) from discontinued operations, net of tax $ (694) $ (4,640) $ (1,651) $ (5,983)
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Jun. 30, 2016
Dec. 31, 2015
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]        
Long term liabilities $ 41 $ 44    
Healthy Natural Inc [Member]        
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]        
Accounts receivable, net 1,362 592    
Inventories 1,887 1,915    
Other current assets held for sale 32 23    
Property and equipment, net 882 1,019    
Intangible 791 791    
Other noncurrent assets held for sale 24 24    
Total assets held for sale 4,978 4,364    
Accounts payable 567 443    
Accrued expenses 346 382    
Long term liabilities 41 44    
Total liabilities held for sale 954 869    
Nutra SA [Member]        
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]        
Cash and cash equivalents 41 109 $ 201 $ 104
Accounts receivable, net 326 398    
Inventories 1,138 925    
Other current assets held for sale 912 373    
Property and equipment, net 10,249 10,889    
Other noncurrent assets held for sale 1,226 1,327    
Total assets held for sale 13,892 14,021    
Accounts payable 2,222 2,553    
Accrued expenses 6,290 5,607    
Current maturities of long-term debt (nonrecourse) 7,164 6,816    
Total liabilities held for sale 15,676 14,976    
Accounts receivable restricted 363 398    
Property and equipment restricted $ 2,508 $ 2,599    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used) provided by operating activities $ 973 $ 3,244
Net cash used in investing activities (108) (208)
Net cash provided (used) by financing activities 1,112 (815)
Effect of exchange rate changes 142 (38)
Healthy Natural Inc [Member]    
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used) provided by operating activities 2,141 2,235
Net cash used in investing activities (15) (75)
Net cash provided (used) by financing activities (7) 0
Net cash provided to continuing operations (2,119) (2,160)
Nutra SA [Member]    
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used) provided by operating activities (1,236) 1,106
Net cash used in investing activities (93) (156)
Net cash provided (used) by financing activities 1,119 (815)
Effect of exchange rate changes 142 (38)
Net change in cash and cash equivalents (68) 97
Cash and cash equivalents, beginning of period 109 104
Cash and cash equivalents, end of period $ 41 $ 201
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Components of Debt (Details) - Nutra SA [Member] - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Components of Debt [Abstract]    
Capital expansion loans $ 647 $ 2,454
Working capital lines of credit 1,090 401
Advances on customer export orders 2,482 1,113
Special tax programs 2,838 2,767
Other 107 81
Total debt 7,164 $ 6,816
Brazil [Member]    
Components of Debt [Abstract]    
Export installment payments 200  
Irgovel [Member]    
Components of Debt [Abstract]    
Installment payments in arrears 3,700  
Tax payments in arrears $ 6,100  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) - Discontinued Operations [Member] - Nutra SA [Member]
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
USD ($)
Representative
Investor
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Representative
Investor
Jun. 30, 2016
USD ($)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Redeemable noncontrolling interest in Nutra SA, beginning of period $ (416) $ (224) $ (699) $ 69
Investors' interest in net loss of Nutra SA (249) (1,508) (567) (1,946)
Investors' interest in other comprehensive loss of Nutra SA (2) 133 49 278
Investors purchase of additional membership interest 100 0 650 0
Redeemable noncontrolling interest in Nutra SA, end of period $ (567) $ (1,599) $ (567) $ (1,599)
Investors' average interest in Nutra SA during the period 35.80% 32.40% 35.40% 32.10%
Investors' interest in Nutra SA at the end of the period 35.70% 32.40% 35.70% 32.40%
Number of representatives on management committee | Representative 3   3  
Number of Investors on Management Committee | Investor 2   2  
Number of representatives on management committee upon default | Representative 3   3  
Number of investors on management committee upon default | Investor 2   2  
EBITDA triggering default status     $ 4,000  
Investors [Member]        
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Drag along right, amount of initial public offering $ 50,000   50,000  
Amount paid exchange for termination of rights     $ 100  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) - USD ($)
$ in Thousands
 1 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2017
Jul. 31, 2017
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Line of Credit Facility [Abstract]          
Proceeds from preference stock and warrants $ 7,200   $ 1,747 $ 2,554  
Repayment of debt 3,800        
Repayment of subordinated note $ 500        
HN [Member] | Subsequent Event [Member]          
Line of Credit Facility [Abstract]          
Cash proceeds from sale of business, net of expenses   $ 18,283      
Repayment of senior debentures   6,600      
Repayment of subordinated note   $ 5,963      
Nutra SA [Member]          
Line of Credit Facility [Abstract]          
Minority partner contribution amount     $ 700   $ 1,700
Investors [Member] | Nutra SA [Member]          
Noncontrolling Interest [Abstract]          
Investments in variable interest entity         $ 1,100
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
RECENT ACCOUNTING GUIDANCE (Details) - Stock Options [Member]
 6 Months Ended
Jun. 30, 2017
Minimum [Member]  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Award vesting period 3 years
Maximum [Member]  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Award vesting period 4 years
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
LOSS PER SHARE (EPS) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
NUMERATOR [Abstract]        
Basic and diluted - loss from continuing operations $ (1,774) $ (4,476) $ (4,188) $ (4,033)
Dividend on preferred stock--beneficial conversion feature 0 0 (778) (551)
Basic and diluted - adjusted loss from continuing operations $ (1,774) $ (4,476) $ (4,966) $ (4,584)
DENOMINATOR [Abstract]        
Basic EPS - weighted average number of common shares outstanding (in shares) 9,794,405 9,231,619 9,726,268 9,223,651
Effect of dilutive securities outstanding (in shares) 0 0 0 0
Diluted EPS - weighted average number of shares outstanding (in shares) 9,794,405 9,231,619 9,726,268 9,223,651
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 595,252 353,186 395,262 355,286
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 23,460,192 10,842,006 20,547,647 9,777,065
Nonvested Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 1,217,650 1,265,386 1,206,997 1,066,236
Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 3,879,603 2,000,000 3,469,299 1,417,582
Restricted Stock Unit Awards [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 261,111 0 130,556 0
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONCENTRATIONS OF RISK (Details)
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Revenue [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 93.00%
Revenue [Member] | Customer 1 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 16.00% 12.00%
Revenue [Member] | Customer 2 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 15.00% 12.00%
Revenue [Member] | Customer 3 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Revenue [Member] | Customer 4 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Revenue [Member] | Customer 5 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Revenue [Member] | Others [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 69.00% 69.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Accounts Receivable [Member] | Customer 1 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 25.00% 18.00%
Accounts Receivable [Member] | Customer 2 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 12.00% [1]
Accounts Receivable [Member] | Customer 3 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Accounts Receivable [Member] | Customer 4 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Accounts Receivable [Member] | Customer 5 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1] 11.00%
Accounts Receivable [Member] | Others [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 63.00% 71.00%
Purchases [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Purchases [Member] | Supplier 1 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 11.00% 15.00%
Purchases [Member] | Supplier 2 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 3 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 4 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 5 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Others [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 89.00% 85.00%
[1] Less than 10%
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
DEBT (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2017
Jun. 30, 2017
Dec. 31, 2016
Debt Instrument [Line Items]      
Total debt   $ 5,916 $ 9,027
Current portion   24 3,063
Long-term portion   5,892 5,964
Senior Debentures, Net [Member] | HN [Member]      
Debt Instrument [Line Items]      
Extinguishment of debt   6,000  
Carrying value of debt   600  
Aggregate principal amount   6,600  
Senior Debentures, Net [Member] | Maturity Due February 2019 [Member]      
Debt Instrument [Line Items]      
Total debt   589 0
Aggregate principal amount   $ 6,600  
Maturity date of note   Feb. 28, 2019  
Effective interest rate   160.60%  
Subordinated Notes, Net [Member] | HN [Member]      
Debt Instrument [Line Items]      
Extinguishment of debt   $ 700  
Carrying value of debt   5,300  
Aggregate principal amount   6,000  
Subordinated Notes, Net [Member] | Maturity Due May 2019 [Member]      
Debt Instrument [Line Items]      
Total debt   5,285 $ 6,310
Aggregate principal amount   $ 5,900  
Maturity date of note   May 31, 2019  
Effective interest rate   15.00%  
Variable interest rate   7.00% 11.75%
Payment of note principal $ 200    
Payment of accrued note interest $ 300    
Other [Member]      
Debt Instrument [Line Items]      
Total debt   $ 42 $ 75
Senior Revolving Loan [Member]      
Debt Instrument [Line Items]      
Total debt   0 1,725
Senior Term Loan, Net [Member]      
Debt Instrument [Line Items]      
Total debt   $ 0 $ 917
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period $ 7,900   $ (632)  
Balance at beginning of period (in shares)     10,790,351  
Issuance of common stock awards under equity incentive plans     $ 613  
Dividend on preferred stock - beneficial conversion feature     0  
Modification of senior debenture holder warrants     582  
Modification of subordinated note holder warrants     117  
Change in classification of preferred stock to equity from liability     1,545  
Change in classification of warrants to equity from liability     7,851  
Conversion of preferred stock into common stock     0  
Other     43  
Proceeds from sale of membership interests     650  
Foreign currency translation     162  
Net loss (1,470) $ (8,116) (4,071) $ (8,254)
Balance at end of period $ 6,860 $ (36) $ 6,860 $ (36)
Balance at end of period (in shares) 11,575,187   11,575,187  
Preferred Stock [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period     $ 0  
Issuance of common stock awards under equity incentive plans     0  
Dividend on preferred stock - beneficial conversion feature     0  
Modification of senior debenture holder warrants     0  
Modification of subordinated note holder warrants     0  
Change in classification of preferred stock to equity from liability     1,545  
Change in classification of warrants to equity from liability     0  
Conversion of preferred stock into common stock     (64)  
Other     0  
Proceeds from sale of membership interests     0  
Foreign currency translation     0  
Net loss     0  
Balance at end of period $ 1,481   $ 1,481  
Preferred Stock [Member] | Series F Preferred Stock [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period (in shares)     0  
Issuance of common stock awards under equity incentive plans (in shares)     0  
Change in classification of preferred stock to equity from liability (in shares)     3,000  
Conversion of preferred stock into common stock (in shares)     (315)  
Other (in shares)     0  
Balance at end of period (in shares) 2,685   2,685  
Preferred Stock [Member] | Series G Preferred Stock [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period (in shares)     0  
Issuance of common stock awards under equity incentive plans (in shares)     0  
Change in classification of preferred stock to equity from liability (in shares)     2,000  
Conversion of preferred stock into common stock (in shares)     (11)  
Other (in shares)     0  
Balance at end of period (in shares) 1,989   1,989  
Common Stock [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period     $ 264,232  
Balance at beginning of period (in shares)     10,790,351  
Issuance of common stock awards under equity incentive plans     $ 613  
Issuance of common stock awards under equity incentive plans (in shares)     550,273  
Dividend on preferred stock - beneficial conversion feature     $ 778  
Modification of senior debenture holder warrants     582  
Modification of subordinated note holder warrants     117  
Change in classification of preferred stock to equity from liability     $ 0  
Change in classification of preferred stock to equity from liability (in shares)     0  
Change in classification of warrants to equity from liability     $ 7,851  
Conversion of preferred stock into common stock     $ 203  
Conversion of preferred stock into common stock (in shares)     220,439  
Other     $ 43  
Other (in shares)     14,124  
Proceeds from sale of membership interests     $ 0  
Foreign currency translation     0  
Net loss     0  
Balance at end of period $ 274,419   $ 274,419  
Balance at end of period (in shares) 11,575,187   11,575,187  
Accumulated Deficit [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period     $ (259,819)  
Issuance of common stock awards under equity incentive plans     0  
Dividend on preferred stock - beneficial conversion feature     (778)  
Modification of senior debenture holder warrants     0  
Modification of subordinated note holder warrants     0  
Change in classification of preferred stock to equity from liability     0  
Change in classification of warrants to equity from liability     0  
Conversion of preferred stock into common stock     (139)  
Other     0  
Proceeds from sale of membership interests     0  
Foreign currency translation     0  
Net loss     (3,504)  
Balance at end of period $ (264,240)   (264,240)  
Accumulated Deficit Attributable to Noncontrolling Interest in Nutra SA [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period     (699)  
Issuance of common stock awards under equity incentive plans     0  
Dividend on preferred stock - beneficial conversion feature     0  
Modification of senior debenture holder warrants     0  
Modification of subordinated note holder warrants     0  
Change in classification of preferred stock to equity from liability     0  
Change in classification of warrants to equity from liability     0  
Conversion of preferred stock into common stock     0  
Other     0  
Proceeds from sale of membership interests     650  
Foreign currency translation     49  
Net loss     (567)  
Balance at end of period (567)   (567)  
Accumulated Other Comprehensive Loss [Member]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance at beginning of period     (4,346)  
Issuance of common stock awards under equity incentive plans     0  
Dividend on preferred stock - beneficial conversion feature     0  
Modification of senior debenture holder warrants     0  
Modification of subordinated note holder warrants     0  
Change in classification of preferred stock to equity from liability     0  
Change in classification of warrants to equity from liability     0  
Conversion of preferred stock into common stock     0  
Other     0  
Proceeds from sale of membership interests     0  
Foreign currency translation     113  
Net loss     0  
Balance at end of period $ (4,233)   $ (4,233)  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 14, 2017
Jun. 30, 2017
Sep. 30, 2017
Sep. 30, 2017
Mar. 31, 2017
Jun. 30, 2017
Dec. 31, 2016
Dec. 31, 2016
Feb. 28, 2017
Jan. 31, 2017
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                    
Outstanding at beginning of period (in dollars per share)       $ 2.17 $ 1.30 $ 1.30        
Outstanding at end of period (in dollars per share)   $ 2.17       $ 2.17 $ 1.30 $ 1.30    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Outstanding, weighted average remaining contractual life           3 years 6 months 11 days   6 months    
Increase in authorized number of shares of common stock (in shares)   50,000,000       50,000,000 50,000,000 50,000,000 50,000,000 25,000,000
Fair value of common stock issued           $ 0        
Former Employee [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Common stock issued for former employee (in shares) 108,696                  
Cash paid in lieu of bonus $ 100,000                  
Board of Directors Chairman [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Shares issued (in shares)   96,372                
Transitional monthly compensation awarded         $ 8,333   $ 10,000      
Transitional monthly compensation awarded in lieu of cash (in shares)         9,027   7,035      
Director [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Shares issued (in shares)   345,205                
Grant date fair value (in dollars per share)   $ 0.90                
Equity Warrants [Member]                    
Shares Under Warrants [Roll Forward]                    
Outstanding at beginning of period (in shares)       20,832,273 6,364,110 6,364,110        
Issued (in shares)           0        
Impact of repricing debenture purchaser warrants, Prior to repricing (in shares)           (875,000)        
Impact of repricing debenture purchaser warrants, After repricing (in shares)           875,000        
Impact of repricing subordinated note holder warrants, Prior to repricing (in shares)           (289,669)        
Impact of repricing subordinated note holder warrants, After repricing (in shares)           289,669        
Impact of anti-dilution clauses, Prior to impact (in shares)           0        
Impact of anti-dilution clauses, After impact (in shares)           0        
Transfer from liability to equity (in shares)           14,468,163        
Exercised (in shares)           0        
Forfeited, expired or cancelled (in shares)           0        
Outstanding at end of period (in shares)   20,832,273       20,832,273 6,364,110 6,364,110    
Exercisable at end of period (in shares)   19,957,273       19,957,273        
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                    
Outstanding at beginning of period (in dollars per share)       $ 2.32 $ 5.77 $ 5.77        
Impact of repricing debenture purchaser warrants, Prior to repricing (in dollars per share)           5.49        
Impact of repricing debenture purchaser warrants, After repricing (in dollars per share)           0.96        
Impact of repricing subordinated note holder warrants, Prior to repricing (in dollars per share)           5.25        
Impact of repricing subordinated note holder warrants, After repricing (in dollars per share)           0.96        
Transfer from liability to equity (in dollars per share)           1.16        
Outstanding at end of period (in dollars per share)   $ 2.32       2.32 $ 5.77 $ 5.77    
Exercisable at end of period (in dollars per share)   $ 2.38       $ 2.38        
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Outstanding, weighted average remaining contractual life           3 years 10 months 24 days   2 years 4 months 24 days    
Impact of repricing debenture purchaser warrants, Prior to repricing           2 years 1 month 6 days        
Impact of repricing debenture purchaser warrants, After repricing           5 years 6 months        
Impact of repricing subordinated note holder warrants, Prior to repricing           3 years 3 months 18 days        
Impact of repricing subordinated note holder warrants, After pricing           3 years 3 months 18 days        
Transfer from liability to equity           4 years 9 months 18 days        
Exercisable, weighted average remaining contractual life           3 years 10 months 24 days        
Liability Warrants [Member]                    
Shares Under Warrants [Roll Forward]                    
Outstanding at beginning of period (in shares)       2,627,919 4,474,868 4,474,868        
Issued (in shares)           11,783,163        
Impact of repricing debenture purchaser warrants, Prior to repricing (in shares)           0        
Impact of repricing debenture purchaser warrants, After repricing (in shares)           0        
Impact of repricing subordinated note holder warrants, Prior to repricing (in shares)           0        
Impact of repricing subordinated note holder warrants, After repricing (in shares)           0        
Impact of anti-dilution clauses, Prior to impact (in shares)           (1,489,868)        
Impact of anti-dilution clauses, After impact (in shares)           2,327,919        
Transfer from liability to equity (in shares)           (14,468,163)        
Exercised (in shares)           0        
Forfeited, expired or cancelled (in shares)           0        
Outstanding at end of period (in shares)   2,627,919       2,627,919 4,474,868 4,474,868    
Exercisable at end of period (in shares)   2,627,919       2,627,919        
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                    
Outstanding at beginning of period (in dollars per share)       $ 1.03 $ 1.82 $ 1.82        
Issued (in dollars per share)           0.96        
Impact of anti-dilution clauses, Prior to impact (in dollars per share)           1.50        
Impact of anti-dilution clauses, After impact (in dollars per share)           0.96        
Transfer from liability to equity (in dollars per share)           1.16        
Outstanding at end of period (in dollars per share)   $ 1.03       1.03 $ 1.82 $ 1.82    
Exercisable at end of period (in dollars per share)   $ 1.03       $ 1.03        
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Outstanding, weighted average remaining contractual life           8 months 12 days   3 years 3 months 18 days    
Issued           5 years        
Impact of anti-dilution clauses, Prior to impact           9 months 18 days        
Impact of anti-dilution clauses, After impact           9 months 18 days        
Transfer from liability to equity           4 years 9 months 18 days        
Exercisable, weighted average remaining contractual life           8 months 12 days        
Series F Convertible Preferred Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Carrying value of preferred stock   $ 493,000       $ 493,000 $ 0 $ 0    
Series F Convertible Preferred Stock [Member] | Forecast [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)     2,186              
Number of preferred stock for conversion (in shares)     2,186              
Series G Convertible Preferred Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Carrying value of preferred stock   $ 988,000       $ 988,000 $ 0 $ 0    
Series G Convertible Preferred Stock [Member] | Forecast [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)     397              
Number of preferred stock for conversion (in shares)     397              
Common Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)           220,439        
Number of preferred stock for conversion (in shares)           220,439        
Fair value of common stock issued           $ 203,000        
Common Stock [Member] | Forecast [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)       1,834,124            
Number of preferred stock for conversion (in shares)       1,834,124            
Fair value of common stock issued       $ 1,900,000            
Preferred Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Fair value of common stock issued           $ (64,000)        
Preferred Stock [Member] | Forecast [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Carrying value of preferred stock     $ 600,000 $ 600,000            
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)           (315)        
Number of preferred stock for conversion (in shares)           (315)        
Preferred Stock [Member] | Series G Convertible Preferred Stock [Member]                    
Equity and Liability Warrants, Additional Disclosures [Abstract]                    
Preferred shares converted into common stock (in shares)           (11)        
Number of preferred stock for conversion (in shares)           (11)        
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
shares
Feb. 28, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
Installment
$ / shares
shares
Mar. 31, 2017
$ / shares
shares
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
shares
Jun. 30, 2016
USD ($)
Dec. 31, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Warrants to purchase shares of common stock (in shares) | shares   23,460,192   23,460,192     23,460,192   10,838,978
Loss on extinguishment of debt       $ 0   $ 0 $ (1,680,000) $ 0  
Proceeds from issuance of debt and warrants, net of issuance costs             5,518,000 300,000  
Repayment of subordinated note $ 500,000                
Repayment of debt             $ 7,159,000 $ 15,703,000  
2014 Equity Incentive Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Increase in common shares authorized (in shares) | shares   1,700,000              
Number of shares authorized (in shares) | shares   3,300,000   3,300,000     3,300,000    
Warrants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Warrants to purchase shares of common stock (in shares) | shares 2,327,919   2,327,919           1,489,868
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96   $ 0.96           $ 1.50
Warrants [Member] | Expiration February, 2022 [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Warrants to purchase shares of common stock (in shares) | shares 1,423,488   1,423,488            
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96   $ 0.96            
Series F Preferred Stock [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Preferred stock issued (in shares) | shares   2,685   2,685     2,685    
Series G Convertible Preferred Stock [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Preferred stock issued (in shares) | shares 2,000 1,989 2,000 1,989     1,989    
Preferred shares converted into common stock (in shares) | shares 1,897,983   1,897,983            
Preferred stock conversion ratio to common stock     948.9915            
Preferred stock, dividend     $ 1,000            
Debt conversion amount     $ 100,000            
Debt conversion, stock (in shares) | shares     180            
Net proceeds from the exchange of subordinated notes     $ 1,700,000            
Cash offering expenses     100,000            
Proceeds allocated to derivative warrant liability     1,000,000            
Warrants recorded at fair value     100,000            
Loss on extinguishment of debt     (100,000)            
Decrease in subordinated debt     (100,000)            
Proceed recorded as preferred stock     1,200,000            
Recorded dividend for preferred stock     $ 800,000            
Subordinated Debt [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Warrants to purchase shares of common stock (in shares) | shares 3,484,675   3,484,675            
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96   $ 0.96            
Loss on extinguishment of debt     $ (1,500,000)            
Decrease in subordinated debt     (900,000)            
Fair value of derivative warrant liabilities     2,300,000            
Fair value increase in common stock     $ 100,000            
Annual interest rate 7.00%   7.00%           11.75%
Repayment of debt     $ 500,000            
Subordinated Debt [Member] | Warrants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96   $ 0.96           $ 5.25
Amendment of existing warrants (in shares) | shares     289,669            
Chief Executive Officer [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Granted (in shares) | shares         100,000        
Granted exercise price (in dollars per share) | $ / shares         $ 0.76        
Vested in August 2017 (in shares) | shares         25,000        
Grant date fair value (in dollars per share) | $ / shares         $ 0.56        
Executive Officer and Employees [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Granted (in shares) | shares       355,500          
Granted exercise price (in dollars per share) | $ / shares       $ 0.85          
Number of equal annual installments | Installment       4          
Grant date fair value (in dollars per share) | $ / shares       $ 0.62          
Senior Secured Debt [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Proceeds from issuance of debt and warrants, net of issuance costs     $ 5,500,000            
Placement fees and allocation expenses     $ 500,000            
Warrants exercisable term                 2 years 1 month 6 days
Senior Secured Debt [Member] | Warrants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Warrants to purchase shares of common stock (in shares) | shares 6,875,000   6,875,000            
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96   $ 0.96            
Aggregate subscription amount $ 6,000,000   $ 6,000,000            
Aggregate principal amount $ 6,600,000   $ 6,600,000            
Amendment of existing warrants (in shares) | shares     875,000            
Exercise price per warrant one (in dollars per share) | $ / shares $ 5.49   $ 5.49            
Warrants exercisable term     5 years 6 months            
Fair value of derivative warrant liabilities     $ 4,600,000            
Fair value increase in common stock     500,000            
Debt issuance cost $ 400,000   400,000            
Extinguishment of term loan     3,800,000            
Repayment of subordinated note     200,000            
Interest expense debt     $ 300,000            
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2017
Warrant
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
Warrant
$ / shares
shares
Dec. 31, 2016
$ / shares
shares
Summary of information related to outstanding and exercisable warrants [Abstract]        
Shares under warrants, outstanding (in shares) | shares   23,460,192 23,460,192 10,838,978
Weighted average exercise price (in dollars per share)   $ 2.17 $ 2.17 $ 1.30
Weighted average remaining contractual life     3 years 6 months 11 days 6 months
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Common stock issued (in shares) | shares   1,175,000    
Number of trading days     65 days  
Grant date fair value | $   $ 188    
Expensed ratably term     3 years 6 months  
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $5.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   10.00%    
Vesting price (in dollars per share)   $ 5.00    
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $10.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   30.00%    
Vesting price (in dollars per share)   $ 10.00    
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $15.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   60.00%    
Vesting price (in dollars per share)   $ 15.00    
Equity Warrants [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Weighted average exercise price (in dollars per share)   $ 2.32 $ 2.32 $ 5.77
Weighted average remaining contractual life     3 years 10 months 24 days 2 years 4 months 24 days
Equity Warrants [Member] | $0.96 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share)     $ 0.96  
Shares under warrants, outstanding (in shares) | shares   12,947,832 12,947,832 0
Weighted average exercise price (in dollars per share)   $ 0.96 $ 0.96 $ 0
Weighted average remaining contractual life     4 years 7 months 6 days 0 years
Equity Warrants [Member] | $2.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share)     $ 2.00  
Shares under warrants, outstanding (in shares) | shares   2,660,000 2,660,000 0
Weighted average exercise price (in dollars per share)   $ 2.00 $ 2.00 $ 0
Weighted average remaining contractual life     4 years 2 months 12 days 0 years
Equity Warrants [Member] | $5.25 to $5.87 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share)     $ 5.25  
Exercise price range, upper range limit (in dollars per share)     $ 5.87  
Shares under warrants, outstanding (in shares) | shares   3,156,670 3,156,670 4,296,339
Weighted average exercise price (in dollars per share)   $ 5.33 $ 5.33 $ 5.36
Weighted average remaining contractual life     2 years 2 months 12 days 2 years 8 months 12 days
Equity Warrants [Member] | $6.55 to $16.80 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share)     $ 6.55  
Exercise price range, upper range limit (in dollars per share)     $ 16.80  
Shares under warrants, outstanding (in shares) | shares   2,067,771 2,067,771 2,067,771
Weighted average exercise price (in dollars per share)   $ 6.61 $ 6.61 $ 6.61
Weighted average remaining contractual life     1 year 6 months 2 years
Liability Warrants [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Weighted average exercise price (in dollars per share)   $ 1.03 $ 1.03 $ 1.82
Weighted average remaining contractual life     8 months 12 days 3 years 3 months 18 days
Number of warrants | Warrant     2  
Liability Warrants [Member] | Subsequent Event [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Shares under warrants, outstanding (in shares) | shares 781,522      
Weighted average exercise price (in dollars per share) $ 0.96      
Common stock issued (in shares) | shares 103,008      
Conversion price (in dollars per share) $ 0.98      
Number of warrants exercised | Warrant 1      
Liability Warrants [Member] | $0.96 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [1]     $ 0.96  
Shares under warrants, outstanding (in shares) | shares [1]   2,327,919 2,327,919 0
Weighted average exercise price (in dollars per share) [1]   $ 0.96 $ 0.96 $ 0
Weighted average remaining contractual life [1]     4 months 24 days 0 years
Liability Warrants [Member] | $1.50 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [2]     $ 1.50  
Shares under warrants, outstanding (in shares) | shares [2]   300,000 300,000 0
Weighted average exercise price (in dollars per share) [2]   $ 1.60 $ 1.60 $ 0
Weighted average remaining contractual life [2]     2 years 10 months 24 days 0 years
Liability Warrants [Member] | $1.50 to $1.60 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share) [1],[2]     $ 1.50  
Exercise price range, upper range limit (in dollars per share) [1],[2]     $ 1.60  
Shares under warrants, outstanding (in shares) | shares [1],[2]   0 0 1,789,868
Weighted average exercise price (in dollars per share) [1],[2]   $ 0 $ 0 $ 1.52
Weighted average remaining contractual life [1],[2]     0 years 1 year 3 months 18 days
Liability Warrants [Member] | $2.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [3]     $ 2.00  
Shares under warrants, outstanding (in shares) | shares [3]   0 0 2,660,000
Weighted average exercise price (in dollars per share) [3]   $ 0 $ 0 $ 2.00
Weighted average remaining contractual life [3]     0 years 4 years 7 months 6 days
Liability Warrants [Member] | $5.25 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [3]     $ 5.25  
Shares under warrants, outstanding (in shares) | shares [3]   0 0 25,000
Weighted average exercise price (in dollars per share) [3]   $ 0 $ 0 $ 5.25
Weighted average remaining contractual life [3]     0 years 3 years 7 months 6 days
[1] Includes two warrants which contain full ratchet anti-dilution provisions and are classified as derivative warrant liabilities in our balance sheets. Under the anti-dilution clauses contained in these warrants, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise prices of these warrants, we are required to lower the exercise price on these warrants and increase the number of shares underlying these warrants. In July 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.
[2] Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision. Under that provision, in the event of issuances of stock options and/or convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant we may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
[3] The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value of debt $ 4,600  
Carrying value of debt 5,916 $ 9,027
Derivative Warrant Liabilities [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 472 $ 1,527
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate 1.10%  
Expected volatility   64.00%
Derivative Warrant Liabilities [Member] | Recurring [Member] | Minimum [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate   0.60%
Expected volatility 65.00%  
Derivative Warrant Liabilities [Member] | Recurring [Member] | Maximum [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate   1.90%
Expected volatility 75.00%  
Derivative Warrant Liabilities [Member] | Recurring [Member] | Weighted Average [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate 1.10% 1.60%
Expected volatility 73.00% 64.00%
Derivative Warrant Liabilities [Member] | Level 1 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 0 $ 0
Derivative Warrant Liabilities [Member] | Level 2 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value 0 0
Derivative Warrant Liabilities [Member] | Level 3 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 472 $ 1,527
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) - Recurring [Member] - Derivative Warrant Liabilities [Member] - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Changes in level 3 items measured at fair value on a recurring basis [Roll Forward]    
Fair Value as of Beginning of Period $ (1,527) $ (678)
Total Realized and Unrealized Gains (Losses) [1] 1,121 (852)
Issuance of New Instruments (7,917) (2,473)
Reclassify to (Deficit) Equity 7,851 0
Fair Value, at End of Period $ (472) $ (4,003)
[1] Included in change in fair value of derivative warrant liabilities in our unaudited condensed consolidated statements of operations.
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES (Details) - 6 months ended Jun. 30, 2017 - Irgovel [Member]
BRL in Millions, $ in Millions
BRL
USD ($)
Loss Contingencies [Line Items]    
Damages sought by plaintiff   $ 1.1
Contingent liability   $ 0.3
Minimum [Member]    
Irgovel - Events of Default [Abstract]    
EBITDA triggering default status | BRL BRL 4.0  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Related Party Transaction [Line Items]        
Interest paid     $ 922 $ 942
Halpern [Member]        
Related Party Transaction [Line Items]        
Percentage of outstanding debt retained by related party     43.00%  
Halpern [Member] | Subordinated Notes [Member]        
Related Party Transaction [Line Items]        
Interest paid $ 100 $ 100 $ 200 $ 200
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
Aug. 01, 2017
Jun. 30, 2017
Mar. 31, 2017
Mar. 10, 2017
Dec. 31, 2016
Aug. 18, 2016
Jun. 30, 2016
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Line Items]              
Nasdaq minimum stockholders' equity listing requirement           $ 2,500  
Stockholders' equity (deficit)   $ 6,860 $ 7,900   $ (632)   $ (36)
Nasdaq grant of extension period to regain compliance under minimum stockholders' equity requirement   180 days          
Nasdaq minimum bid price requirement (in dollars per share)       $ 1.0      
Number of consecutive business days under minimum bid requirement   10 days          
Nasdaq grant of extension period to regain compliance under minimum bid requirement   180 days          
Subsequent Event [Member]              
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Line Items]              
Nasdaq minimum bid price requirement (in dollars per share) $ 1.0            
Number of consecutive business days under minimum bid requirement 10 days            
EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 57 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 264 328 1 true 78 0 false 9 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://ricebrantech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 020000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 3 false false R4.htm 030000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 4 false false R5.htm 030100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ricebrantech.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 5 false false R6.htm 040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 060100 - Disclosure - BASIS OF PRESENTATION Sheet http://ricebrantech.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 060200 - Disclosure - DISCONTINUED OPERATIONS Sheet http://ricebrantech.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS Notes 8 false false R9.htm 060300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Sheet http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlan LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Notes 9 false false R10.htm 060400 - Disclosure - RECENT ACCOUNTING GUIDANCE Sheet http://ricebrantech.com/role/RecentAccountingGuidance RECENT ACCOUNTING GUIDANCE Notes 10 false false R11.htm 060500 - Disclosure - LOSS PER SHARE (EPS) Sheet http://ricebrantech.com/role/LossPerShareEps LOSS PER SHARE (EPS) Notes 11 false false R12.htm 060600 - Disclosure - CONCENTRATIONS OF RISK Sheet http://ricebrantech.com/role/ConcentrationsOfRisk CONCENTRATIONS OF RISK Notes 12 false false R13.htm 060700 - Disclosure - DEBT Sheet http://ricebrantech.com/role/Debt DEBT Notes 13 false false R14.htm 060800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrants EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Notes 14 false false R15.htm 060900 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://ricebrantech.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 061000 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://ricebrantech.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 061100 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://ricebrantech.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 17 false false R18.htm 061200 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Sheet http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirements FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Notes 18 false false R19.htm 070400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Policies) Sheet http://ricebrantech.com/role/RecentAccountingGuidancePolicies RECENT ACCOUNTING GUIDANCE (Policies) Policies 19 false false R20.htm 080200 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://ricebrantech.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://ricebrantech.com/role/DiscontinuedOperations 20 false false R21.htm 080500 - Disclosure - LOSS PER SHARE (EPS) (Tables) Sheet http://ricebrantech.com/role/LossPerShareEpsTables LOSS PER SHARE (EPS) (Tables) Tables http://ricebrantech.com/role/LossPerShareEps 21 false false R22.htm 080600 - Disclosure - CONCENTRATIONS OF RISK (Tables) Sheet http://ricebrantech.com/role/ConcentrationsOfRiskTables CONCENTRATIONS OF RISK (Tables) Tables http://ricebrantech.com/role/ConcentrationsOfRisk 22 false false R23.htm 080700 - Disclosure - DEBT (Tables) Sheet http://ricebrantech.com/role/DebtTables DEBT (Tables) Tables http://ricebrantech.com/role/Debt 23 false false R24.htm 080800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsTables EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) Tables http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrants 24 false false R25.htm 080900 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://ricebrantech.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://ricebrantech.com/role/FairValueMeasurements 25 false false R26.htm 090200 - Disclosure - DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsInitialDistributionOfProceedsDetails DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) Details 26 false false R27.htm 090204 - Disclosure - DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsIncomeLossFromDiscontinuedOperationsDetails DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) Details 27 false false R28.htm 090206 - Disclosure - DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) Details 28 false false R29.htm 090208 - Disclosure - DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsCashFlowsFromDiscontinuedOperationsDetails DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) Details 29 false false R30.htm 090210 - Disclosure - DISCONTINUED OPERATIONS, Components of Debt (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsComponentsOfDebtDetails DISCONTINUED OPERATIONS, Components of Debt (Details) Details 30 false false R31.htm 090212 - Disclosure - DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsRedeemableNoncontrollingInterestDetails DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) Details 31 false false R32.htm 090300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) Sheet http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlanDetails LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) Details http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlan 32 false false R33.htm 090400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Details) Sheet http://ricebrantech.com/role/RecentAccountingGuidanceDetails RECENT ACCOUNTING GUIDANCE (Details) Details http://ricebrantech.com/role/RecentAccountingGuidancePolicies 33 false false R34.htm 090500 - Disclosure - LOSS PER SHARE (EPS) (Details) Sheet http://ricebrantech.com/role/LossPerShareEpsDetails LOSS PER SHARE (EPS) (Details) Details http://ricebrantech.com/role/LossPerShareEpsTables 34 false false R35.htm 090600 - Disclosure - CONCENTRATIONS OF RISK (Details) Sheet http://ricebrantech.com/role/ConcentrationsOfRiskDetails CONCENTRATIONS OF RISK (Details) Details http://ricebrantech.com/role/ConcentrationsOfRiskTables 35 false false R36.htm 090700 - Disclosure - DEBT (Details) Sheet http://ricebrantech.com/role/DebtDetails DEBT (Details) Details http://ricebrantech.com/role/DebtTables 36 false false R37.htm 090800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsSummaryOfEquityActivityDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) Details 37 false false R38.htm 090802 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsWarrantActivityDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) Details 38 false false R39.htm 090804 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) Details http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsTables 39 false false R40.htm 090806 - Disclosure - EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) Sheet http://ricebrantech.com/role/EquityAndSharebasedCompensationWarrantsOutstandingDetails EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) Details 40 false false R41.htm 090900 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://ricebrantech.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://ricebrantech.com/role/FairValueMeasurementsTables 41 false false R42.htm 090902 - Disclosure - FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) Sheet http://ricebrantech.com/role/FairValueMeasurementsUnobservableInputReconciliationDetails FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) Details 42 false false R43.htm 091000 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://ricebrantech.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://ricebrantech.com/role/CommitmentsAndContingencies 43 false false R44.htm 091100 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://ricebrantech.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://ricebrantech.com/role/RelatedPartyTransactions 44 false false R45.htm 091200 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) Sheet http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirementsDetails FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) Details http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirements 45 false false All Reports Book All Reports ribt-20170630.xml ribt-20170630.xsd ribt-20170630_cal.xml ribt-20170630_def.xml ribt-20170630_lab.xml ribt-20170630_pre.xml true true ZIP 62 0001140361-17-031484-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-17-031484-xbrl.zip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